OMB APPROVAL
OMB Number: 3235-0570
Expires: August 31, 2020
Estimated average burden
hours per response 20.6
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT
INVESTMENT COMPANIES
Investment Company Act file number 811-07986
The Alger Institutional Funds
(Exact name of registrant as specified in charter)
360 Park Avenue South New York, New York 10010
(Address of principal executive offices) (Zip code)
Mr. Hal Liebes
Fred Alger Management, Inc.
360 Park Avenue South
New York, New York 10010
(Name and address of agent for service)
Registrant's telephone number, including area code: 212-806-8800
Date of fiscal year end: October 31
Date of reporting period: October 31, 2017
ITEM 1. REPORTS TO STOCKHOLDERS.
Table of Contents
The Alger Institutional Funds
Shareholders’ Letter (Unaudited) | 1 |
Fund Highlights (Unaudited) | 10 |
Portfolio Summary (Unaudited) | 18 |
Schedules of Investments | 19 |
Statements of Assets and Liabilities | 38 |
Statements of Operations | 42 |
Statements of Changes in Net Assets | 44 |
Financial Highlights | 48 |
Notes to Financial Statements | 63 |
Report of Independent Registered Public Accounting Firm | 90 |
Additional Information (Unaudited) | 91 |
Go Paperless With Alger Electronic Delivery Service
Alger is pleased to provide you with the ability to access regulatory materials online.
When documents such as prospectuses and annual and semi-annual reports are
available, we’ll send you an e-mail notification with a convenient link that will take you
directly to the fund information on our website. To sign up for this free service, simply
enroll at www.icsdelivery.com/alger.
Shareholders’ Letter October 31, 2017
Dear Shareholders,
Corporate Earnings Strengthen as Growth Stocks Trounce Value Stocks
During the one-year period ended October 31, 2017, strong corporate fundamentals and
economic growth continued to support the vibrant equity rally, with the S&P 500 Index
generating a noteworthy 23.63% gain. An equally dramatic trend of growth equities
outperforming value stocks continued with the 26.50% return of the S&P 500 Growth
Index substantially beating the 19.60% return of the index’s value-oriented counterpart.
Corporate Earnings Shine
The discussion in Washington of potential tax reform and other pro-growth initiatives, we
believe, appears to favorably support corporate America, and as a result, has contributed
to positive sentiment for U.S equities. We maintain, however, that corporate fundamentals,
including strong earnings combined with economic growth, have been the primary driver
of equity gains. As of the end of the reporting period, third-quarter S&P 500 earnings were
expected to increase 5.9%. As I write this letter, it appears that this past quarter will mark
the fifth consecutive quarter of earnings growth.
At Alger, our fundamental research seeks companies with strong potential for earnings
growth. We believe that a broad theme of companies developing innovative technology,
including cloud computing services, internet-connected devices, and artificial intelligence,
that can disrupt existing business models is creating attractive growth opportunities. This
trend was clearly apparent during the one year period ended September 30, 2017 of this
year with the Information Technology sector generating nearly twice the earnings-per-share
growth of the overall S&P 500 Index (11.9% vs. 6.0%).
We note that past periods of strong corporate earnings growth have resulted in increased
business spending and we believe the recent uptick in corporate earnings is likely to again
support business spending, which in turn could improve corporate productivity and provide
an additional boost to the economy.
The Economic Recovery Continues
Investors during the reporting period also reacted favorably to encouraging economic data,
such as the following developments:
• The U.S. Consumer Confidence Index climbed from 100.8 to 125.9.
• Wage growth continued with a 3.2% year-over-year increase in September.
• The Conference Board’s Leading Economic Indicator Index continued
climbing and hit a record high of 128.8 in August. The index’s September
reading of 128.6 was still high by historical standards.
Investor sentiment has also been supported by expectations for improving economic
growth globally. Indeed, Europe, Asia, and most of the Americas are on track to produce
economic growth in 2017. Corporate earnings in both developed and emerging markets
during the reporting period continued to strengthen while Purchasing Managers’ Index
readings in Europe and China were also encouraging. A perception that geopolitical
- 1 -
risks were moderating combined with fiscal and monetary stimulus in many countries
also supported investor sentiment. Those developments supported investor sentiment
relating to multinational corporations and extended the equity rally beyond the U.S. For
the reporting period, the MSCI ACWI ex USA Index generated a 24.20% return while the
MSCI Emerging Markets Index advanced 26.91%.
Growth Outperforms Value
The strong outperformance for growth equities during the reporting period and for the 10-
year period ended October 31, 2017 is also noteworthy. For the 10-year period, the S&P 500
Growth Index has outperformed the S&P 500 Value Index by 40.75 percent. As detailed
in a recent Alger paper “A New Perspective on Growth Versus Value” (available on Alger.
com), the biggest contributors to this “growth advantage” are the aforementioned strength
in technology companies’ earnings-per-share (EPS) growth and the weak performance of
low price-to-book stocks commonly found in the value category. The underperformance of
low price-to-book value stocks can be partially explained by a combination of corporations’
increasing reliance on intangible assets, accounting standards that fail to reflect those
changing business models, and the heavy reliance on one particular metric for style
classification (price-to-book value). 1
Today, many businesses use fewer tangible assets, such as plants and equipment, than in the
past and they are increasingly more reliant on intangible resources, including research and
development, advertising, marketing, and training. Accounting professors Baruch Lev and
Feng Gu have observed that over the past 40 years the investment rate in physical capital fell
by 35% while the investment rate in intangible assets grew by almost 60%. 2
Internet businesses are an example. They use far fewer tangible assets relative to the income
they generate than do more traditional companies, such as auto manufacturers, that have to
build large factories. For internet companies, intangible assets can include search algorithms
that attract users who in turn drive advertising revenues. User data can also be considered
an intangible asset. Such data can support advertising revenue for digital media companies
and sales for online retailers. In these examples, intangible assets generate revenues that in
turn drive earnings growth.
The problem is that accounting practices haven’t kept up with the changing economy.
Spending on intangible assets (done organically rather than through acquisitions) is not
capitalized in current accounting standards and therefore is not included in book value,
rendering the price-to-book value metric less effective in our view. New economy companies
are therefore more likely to have high market values relative to their book values and be
classified as growth companies. By relying heavily on price-to-book valuations rather
than other methods of valuation such as price-to-earnings, style classification increasingly
separates companies based on business models. For example, digital companies with higher
returns on capital are more likely to be classified as growth even if their cash flows are large
relative to their market value. These companies, broadly speaking, have used innovation
to create products and services that have resulted in high returns on capital and strong
earnings growth. In doing so, they have outperformed companies with greater capital needs,
particularly tangible assets. Indeed, low price-to-book equities have underperformed not
just the broad market, but other value equities such as those with low price-to-earnings. Slow
economic growth during the past few years has also been a headwind for value stocks, which
- 2 -
tend to be cyclical. Low interest rates, furthermore, have hurt the performance of banks,
which have more significant representation in value indexes than in growth benchmarks.
The Accelerating Speed of Innovation
The divergence in growth and value is also being driven by technological advances that
are expanding at an exponential rate, which means the rate of change is accelerating.
This acceleration is apparent most famously in Moore’s law, which explains the rate of
improvement in transistors, but we also see it in information storage (e.g., hard drives),
information transportation (e.g., fiber-optic cables), wireless telecommunications, energy,
and even illumination.3 Technology is thus creating a potent engine to drive the economy
forward. The increasing pace of change means that newer innovations are spreading through
society faster. Older innovations such as the dishwasher and washing machine took many
decades to reach 50% penetration of the U.S. market, but more recent innovations such as
the internet and social media have taken 14 years and 9 years, respectively. The accelerating
rate of innovation may wreak havoc on value investing, which is essentially dependent on
the improvement of cheap valuations and depressed fundamentals. With change happening
more rapidly, value stocks that appear cheap may often simply be victims of change while
growth stocks may benefit as purveyors of change.
Conclusion
While we are ardent believers in growth investing, we are not suggesting that value investing
will always underperform. Rather, we maintain that the definitions of growth vs. value and
accounting standards need to evolve with the economy. We believe that investors reflexively
using “standard” but increasingly outdated valuation measures are at risk of missing
attractive equity opportunities that arise from the positive fundamental changes occurring
across industries and economies because of innovation.
At Alger, we are valuation-sensitive and our analysts and portfolio managers think intensely
about valuation and risk. However, we believe that when seeking attractive investment
returns, the fundamentals of a company, of a sector, and, indeed, of the economy matter
much more than valuations. Classically, for Alger, that means investing in growth companies
and fundamental growth that is the hallmark of the beginning of new eras and stages in
industries and in markets. Our observations of innovation and the other secular trends
that are supporting growth equities lead us to believe that this is an exciting time to be an
investor or shareholder. Our task at Alger, which has been our focus for more than 50 years,
is to continue to identify the winners and losers emerging from change.
Portfolio Matters
Alger Capital Appreciation Institutional Fund
The Alger Capital Appreciation Institutional Fund returned 29.38% for the fiscal 12-month
period ended October 31, 2017, compared to the 29.71% return of the Russell 1000 Growth
Index.
During the reporting period, the largest portfolio sector weightings were Information
Technology and Consumer Discretionary. The largest sector overweight was Information
Technology and the largest sector underweight was Consumer Staples. The Information
Technology and Financials sectors contributed to relative performance while Industrials and
- 3 -
Health Care were among sectors that detracted from results.
Apple, Inc.; Amazon.com, Inc.; Microsoft Corp.; Alphabet, Inc., Cl. C; and Facebook,
Inc., Cl A. were the top contributors to performance. Apple is a well-known provider of
smartphones, laptops, and other computing devices. Its shares outperformed during the
reporting period in response to the rapid growth of users for its iOS operating system,
excitement over new product launches, and strong sales of iPhones.
Conversely, Anadarko Petroleum Corp.; Molson Coors Brewing Co., Cl. B; Pioneer Natural
Resources Co.; QUALCOMM, Inc.; and Newell Brands, Inc. were the top detractors from
results. Newell Brands is a leading global consumer products company. Its brands include
Rubbermaid, Paper Mate, Calphalon, Graco, and Levolor. Newell Brand’s significant Jarden
acquisition has been a transformational positive life cycle event. Jarden has an impressive
stable of brands such as Coleman, Rawlings, Marmot, and Yankee Candle. Newell shares
detracted from performance late in the reporting period after the company lowered earnings
guidance due to increased spending to stimulate categories where revenue growth has been
sluggish. The company also cited increased resin import costs associated with Hurricane
Harvey’s destruction in Texas. Resin is a very important component of Newell’s plastic
products.
Alger Capital Appreciation Focus Fund
The Alger Capital Appreciation Focus Fund returned 32.50% for the fiscal 12-month period
ended October 31, 2017, compared to the 29.71% return of its benchmark, the Russell 1000
Growth Index.
During the reporting period, the largest sector weightings were Information Technology
and Consumer Discretionary. The largest sector overweight was Information Technology
and the largest underweight was Industrials. Relative outperformance in the Information
Technology and Financials sectors was the most important contributor to performance,
while Industrials and Materials were among sectors that detracted from results.
Apple, Inc.; Amazon.com, Inc.; Microsoft Corp.; Alphabet, Inc., Cl. C; and Alibaba Group
Holding Ltd. were among the top contributors to performance. Shares of Apple performed
strongly in response to developments described in the Alger Capital Appreciation
Institutional Fund discussion.
Conversely, Anadarko Petroleum Corp.; Pioneer Natural Resources Co.; Molson Coors
Brewing Co., Cl. B; Newell Brands, Inc.; and Expedia, Inc. were the largest detractors from
performance. Pioneer Natural Resources is an oil and gas exploration and production
company with industry-leading leverage to the Permian Basin in Texas and New Mexico. The
company has been generating strong unit volume production growth. However, the shares
detracted from performance late in the reporting period after the company said it missed its
oil production target and lowered full-year guidance due to delays in well completions beset
by operational issues. Additionally, the performance of oil-related equities was weak because
of soft energy commodity prices.
Alger Mid Cap Growth Institutional Fund
The Alger Mid Cap Growth Institutional Fund returned 32.70% for the fiscal 12-month
- 4 -
period ended October 31, 2017, compared to the 26.25% return of the Russell Midcap
Growth Index.
During the reporting period, the largest sector weightings were Information Technology
and Health Care. The largest sector overweight was Health Care and the largest underweight
was Consumer Discretionary. The Health Care and Information Technology sectors
provided the greatest contributions to relative performance while Consumer Discretionary
and Materials were among sectors that detracted from results.
Tolero Pharmaceutical, Inc., Series B Convertible Preferred Stock, Lam Research Corp.;
Tolero Pharmaceuticals, Inc., CDR; Autodesk, Inc.; and Broadcom Ltd. were the top
contributors to performance. Tolero Pharmaceuticals is a clinical-stage biopharmaceutical
company with a single purpose: alleviate human suffering through the development
of meaningful medicines to treat cancer and other serious human diseases. Early in the
reporting period, Sumitomo Dainippon Pharma announced plans to acquire Tolero. The
terms of the deal caused investors to revalue the company higher. As such, the Tolero
position contributed to the portfolio’s performance.
Conversely, TransDigm Group, Inc.; TreeHouse Foods, Inc.; Viacom, Inc., Cl. B; O'Reilly
Automotive, Inc.; and Advance Auto Parts, Inc. were the top detractors from results.
TransDigm Group produces, designs, and provides highly engineered aerospace components,
systems, and subsystems that are used in commercial and military aircraft. TransDigm came
under scrutiny for allegations that its various subsidiaries did not conform to a 2014 rule
that requires registrants to a federal procurement database to disclose their parent company.
Alger Small Cap Growth Institutional Fund
The Alger Small Cap Growth Institutional Fund returned 38.37% for the fiscal 12-month
period ended October 31, 2017, compared to the 31.00% return of the Russell 2000 Growth
Index.
During the reporting period, the largest sector weightings were Health Care and Information
Technology. The largest sector overweight was Health Care and the largest underweight was
Industrials. The Information Technology and Health Care sectors provided the greatest
contributions to relative performance while Industrials and Materials were among the
sectors that detracted from results.
Cognex Corp.; Take-Two Interactive Software, Inc.; Quidel Corp.; TubeMogul, Inc.;
and Tolero Pharmaceuticals Series B Convertible Preferred were the top contributors to
performance. Cognex is a leader in machine vision technology that helps manufacturers
reduce costs and maintain quality. Its software and other products capture and analyze visual
information to automate and improve manufacturing and associated processes. Among
other functions, manufacturers use Cognex technology to locate, track, identify, and inspect
items in the production process. Cognex shares performed strongly after the company said
it had generated better-than-expected results driven by strength in logistics and automotive
markets. Additionally, Cognex provided strong guidance that came from an expected surge
in demand from the consumer electronics industry.
Conversely, Lions Gate Entertainment Corp., Cl. B; US Silica Holdings, Inc.; Endologix,
Inc.; Manhattan Associates, Inc.; and American Eagle Outfitters, Inc. were the top detractors
- 5 -
from results. US Silica is a leading producer of industrial minerals including sand that is
used when extracting oil with “fracking.” Performance of US Silica stock weakened largely
as a result of a pullback in oil prices. We believe a variety of factors differentiate it from
its competition. The company is a market share leader in fracking sand and in the silica
industry. It is also the lowest cost provider of sand and it has the largest distribution network
and strong logistics. Those factors make it well positioned to benefit from a potential multi-
year increase in upstream spending, which primarily refers to investments in exploration
and production.
I thank you for putting your trust in Alger.
Daniel C. Chung, CFA
Chief Investment Officer
Fred Alger Management, Inc.
1 According to Russell’s U.S. Equity Indexes Institutional Benchmark Survey, December 2014, most institutional equity products
are benchmarked to a style index and, of those, 99% use Russell indexes. In total, $5.7 trillion is benchmarked to Russell indexes.
For each base index (the Russell 1000 and Russell 2000, and Russell Microcap), a composite value score is used to weight stocks
in the style indexes. Price-to-book value makes up 50% of that score. The other 50% is comprised of the Institutional Brokers’
Estimate Systems forecast medium-term growth (2 year) and sales per share historical growth (5 year) statistics.
2 Baruch Lev and Feng Gu, “The End of Accounting,” John Wiley & Sons, 2016.
3 Brad Neuman, “The Enduring Force of Innovation,” Fred Alger & Company, Incorporated.
Investors cannot invest directly in an index. Index performance does not reflect the
deduction for fees, expenses or taxes.
This report and the financial statements contained herein are submitted for the general
information of shareholders of the funds. This report is not authorized for distribution to
prospective investors in a fund unless preceded or accompanied by an effective prospectus
for the fund. Fund returns represent the fiscal 12 month period return of Class I shares.
The performance data quoted represent past performance, which is not an
indication or guarantee of future results.
Standardized performance results can be found on the following pages. The investment
return and principal value of an investment in a fund will fluctuate so that an investor’s shares,
when redeemed, may be worth more or less than their original cost. Current performance
may be lower or higher than the performance quoted. For performance data current to the
most recent month-end, visit us at www.alger.com, or call us at (800) 992-3863.
The views and opinions of the funds’ management in this report are as of the date of the
Shareholders’ Letter and are subject to change at any time subsequent to this date. There
is no guarantee that any of the assumptions that formed the basis for the opinions stated
herein are accurate or that they will materialize. Moreover, the information forming the
basis for such assumptions is from sources believed to be reliable; however, there is no
- 6 -
guarantee that such information is accurate. Any securities mentioned, whether owned in a
fund or otherwise, are considered in the context of the construction of an overall portfolio
of securities and therefore reference to them should not be construed as a recommendation
or offer to purchase or sell any such security. Inclusion of such securities in a fund and
transactions in such securities, if any, may be for a variety of reasons, including, without
limitation, in response to cash flows, inclusion in a benchmark, and risk control. The
reference to a specific security should also be understood in such context and not viewed as
a statement that the security is a significant holding in a fund. Please refer to the Schedule of
Investments for each fund that is included in this report for a complete list of fund holdings
as of October 31, 2017. Securities mentioned in the Shareholders’ Letter, if not found in
the Schedule of Investments, may have been held by the funds during the 12-month period.
A Word about Risk
Growth stocks tend to be more volatile than other stocks as the price of growth stocks tends
to be higher in relation to their companies’ earnings and may be more sensitive to market,
political and economic developments. Investing in the stock market involves gains and
losses and may not be suitable for all investors. Stocks of small- and mid-sized companies
are subject to greater risk than stocks of larger, more established companies owing to such
factors as limited liquidity, inexperienced management, and limited financial resources.
Funds that participate in leveraging, such as the Capital Appreciation Institutional Fund, are
subject to the risk that the cost of borrowing money to leverage will exceed the returns for
securities purchased or that the securities purchased may actually go down in value; thus, a
fund’s net asset value can decrease more quickly than if the fund had not borrowed.
A small investment in derivatives could have a potentially large impact on a fund’s
performance. When purchasing options, a fund bears the risk that if the market value of
the underlying security does not move to a level that would make exercise of the option
profitable, the option will expire unexercised. When a call option written by a fund is
exercised, the fund will not participate in any increase in the underlying security’s value
above the exercise price. When a put option written by a fund is exercised, the fund will
be required to purchase the underlying security at a price in excess of its market value. Use
of options on securities indexes is subject to the risk that trading in the options may be
interrupted if trading in certain securities included in the index is interrupted, the risk that
price movements in a fund’s portfolio securities may not correlate precisely with movements
in the level of an index, and the risk that Fred Alger Management, Inc. may not predict
correctly movements in the direction of a particular market or of the stock market generally.
Because certain options may require settlement in cash, a fund may be forced to liquidate
portfolio securities to meet settlement obligations. For a more detailed discussion of the
risks associated with these funds, please see the prospectus.
Before investing, carefully consider a fund’s investment objective, risks, charges,
and expenses. For a prospectus or a summary prospectus containing this and other
information about The Alger Institutional Funds call us at (800) 992-3863 or visit us
at www.alger.com. Read it carefully before investing.
Fred Alger & Company, Incorporated, Distributor. Member NYSE Euronext,
SIPC.
NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE.
Definitions:
- 7 -
• The S&P 500 Index is an index of large company stocks considered repre-
sentative of the U.S. stock market
• The S&P 500 Growth Index is an index consisting of stocks within the S&P
500 Index that exhibit strong growth characteristics.
• The S&P 500 Value Index is an index consisting of stocks within the S&P
500 Index that exhibit strong value characteristics.
• The Conference Board’s Leading Economic Indicator Index is based on a va-
riety of economic data and is part of the Conference Board’s analytic system
that seeks to signal peaks and troughs in the business cycle.
• The Purchasing Managers' Index (PMI) is an indicator of the economic
health of the manufacturing sector.
• The U.S. Consumer Confidence Index (CCI) is an indicator designed to mea-
sure consumer confidence, which is defined as the degree of optimism on
the state of the economy that consumers are expressing through their activi-
ties of savings and spending.
• The Morgan Stanley Capital International (MSCI) All Country World Index
(ACWI) ex USA is an unmanaged, market capitalization-weighted index de-
signed to provide a broad measure of equity market performance throughout
the world, including both developing and emerging markets, but excluding
the United States.
• MSCI Emerging Markets Index: A free float-adjusted market capitalization
index designed to measure equity market performance in the global emerging
markets.
• Russell 1000 Growth Index: An index of common stocks designed to track
performance of large-capitalization companies with greater than average
growth orientation.
• Russell Midcap Growth Index: An index of common stocks designed to
track performance of medium-capitalization companies with greater than
average growth orientation.
• Russell 2000 Growth Index: An index of common stocks designed to track
performance of small-capitalization companies with greater than average
growth orientation.
- 8 -
| | | | | | | | | |
FUND PERFORMANCE AS OF 9/30/17 (Unaudited) |
AVERAGE ANNUAL TOTAL RETURNS |
| | 1 | | 5 | | 10 | | SINCE | |
| | YEAR | | YEARS | | YEARS | | INCEPTION | |
Alger Capital Appreciation Class I (Inception | | | | | | | | | |
11/8/93) | | 20.51 | % | 14.74 | % | 8.80 | % | 12.00 | % |
Alger Capital Appreciation Class R (Inception | | | | | | | | | |
1/27/03)* | | 19.91 | % | 14.18 | % | 8.26 | % | 11.44 | % |
Alger Capital Appreciation Class Y (Inception | | | | | | | | | |
2/28/17) | | n/a | | n/a | | n/a | | 12.79 | % |
Alger Capital Appreciation Class Z-2 (Inception | | | | | | | | | |
10/14/16) | | n/a | | n/a | | n/a | | 23.01 | % |
|
Alger Capital Appreciation Focus Class A | | | | | | | | | |
(Inception 12/31/12) | | 16.44 | % | n/a | | n/a | | 15.38 | % |
Alger Capital Appreciation Focus Class C | | | | | | | | | |
(Inception 12/31/12) | | 20.89 | % | n/a | | n/a | | 15.81 | % |
Alger Capital Appreciation Focus Class I | | | | | | | | | |
(Inception 11/8/93) | | 22.84 | % | 15.37 | % | 6.71 | % | 8.84 | % |
Alger Capital Appreciation Focus Class Y | | | | | | | | | |
(Inception 2/28/17) | | n/a | | n/a | | n/a | | 14.67 | % |
Alger Capital Appreciation Focus Class Z | | | | | | | | | |
(Inception 12/31/12) | | 23.14 | % | n/a | | n/a | | 17.09 | % |
|
Alger Mid Cap Growth Class I (Inception 11/8/93) | | 22.46 | % | 13.08 | % | 4.21 | % | 11.76 | % |
Alger Mid Cap Growth Class R (Inception 1/27/03)* | | 21.74 | % | 12.48 | % | 3.66 | % | 11.19 | % |
Alger Mid Cap Growth Class Z-2 (Inception 10/14/16) | | n/a | | n/a | | n/a | | 26.47 | % |
|
Alger Small Cap Growth Class I (Inception 11/8/93) | | 25.31 | % | 11.41 | % | 6.14 | % | 9.31 | % |
Alger Small Cap Growth Class R (Inception 1/27/03)* | | 24.69 | % | 10.86 | % | 5.63 | % | 8.78 | % |
Alger Small Cap Growth Class Z-2 (Inception 8/1/16) | | 25.74 | % | n/a | | n/a | | 25.41 | % |
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s
average annual total returns include changes in share price and reinvestment of dividends and capital gains.
* Since inception performance is calculated from 11/08/93. Performance figures prior to 1/27/03, inception of Class R shares,
are those of the Fund's Class I Shares. The performance figures prior to 1/27/03 have been reduced to reflect the higher
operating expenses of Class R shares.
- 9 -
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Fund Highlights Through October 31, 2017 (Unaudited)
The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Capital
Appreciation Institutional Fund Class I shares and the Russell 1000 Growth Index (an unmanaged index of common
stocks) for the ten years ended October 31, 2017. Figures for the Alger Capital Appreciation Institutional Fund Class
I shares and the Russell 1000 Growth Index include reinvestment of dividends. Performance for the Alger Capital
Appreciation Institutional Fund Class R, Class Y and Class Z-2 shares may vary from the results shown above due
to differences in expenses the class bears. Investors cannot invest directly in any index. Index performance does not
reflect deduction for fees, expenses, or taxes.
- 10 -
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Fund Highlights Through October 31, 2017 (Unaudited) (Continued)
| | | | | | | | |
PERFORMANCE COMPARISON AS OF 10/31/17 |
AVERAGE ANNUAL TOTAL RETURNS |
| | | | | | | Since | |
| 1 YEAR | | 5 YEARS | | 10 YEARS | | 11/8/1993 | |
Class I (Inception 11/8/93) | 29.38 | % | 16.41 | % | 8.60 | % | 12.16 | % |
Class R (Inception 1/27/03)* | 28.78 | % | 15.84 | % | 8.06 | % | 11.60 | % |
Russell 1000 Growth Index | 29.71 | % | 16.83 | % | 9.13 | % | 9.30 | % |
|
|
| | | | | | | Since | |
| 1 YEAR | | 5 YEARS | | 10 YEARS | | 2/28/2017 | |
Class Y (Inception 2/28/17) | n/a | | n/a | | n/a | | 18.02 | % |
Russell 1000 Growth Index | n/a | | n/a | | n/a | | 16.47 | % |
|
|
| | | | | | | Since | |
| 1 YEAR | | 5 YEARS | | 10 YEARS | | 10/14/2016 | |
Class Z-2 (Inception 10/14/16) | 29.83 | % | n/a | | n/a | | 27.44 | % |
Russell 1000 Growth Index | 29.71 | % | n/a | | n/a | | 27.67 | % |
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s
average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above
do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares.
Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost.
Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call
us at (800) 992-3863.
* Since inception performance is calculated from 11/08/93. Performance figures prior to 1/27/03, inception of Class R
shares, are those of the Fund's Class I Shares. The performance figures prior to 1/27/03 have been reduced to reflect the
higher operating expenses of Class R shares.
- 11 -
ALGER CAPITAL APPRECIATION FOCUS FUND
Fund Highlights Through October 31, 2017 (Unaudited)
The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Capital
Appreciation Focus Fund Class I shares and the Russell 1000 Growth Index (an unmanaged index of common
stocks) for the ten years ended October 31, 2017. Beginning December 31, 2012 Alger Capital Appreciation Focus
Fund changed its investment strategy to invest a smaller number of issuers. The figures for the Alger Capital
Appreciation Focus Fund Class I shares and the Russell 1000 Growth Index include reinvestment of dividends.
Performance for the Alger Capital Appreciation Focus Fund Class A, Class C, Class Y and Class Z shares may vary
from the results shown above due to differences in expenses the class bears. Investors cannot invest directly in any
index. Index performance does not reflect deduction for fees, expenses, or taxes.
- 12 -
ALGER CAPITAL APPRECIATION FOCUS FUND
Fund Highlights Through October 31, 2017 (Unaudited) (Continued)
| | | | | | | | |
PERFORMANCE COMPARISON AS OF 10/31/17 |
AVERAGE ANNUAL TOTAL RETURNS |
| | | | | | | Since | |
| 1 YEAR | | 5 YEARS | | 10 YEARS | | 11/8/1993 | |
Class I (Inception 11/8/93) | 32.50 | % | 17.28 | % | 6.81 | % | 9.02 | % |
Russell 1000 Growth Index | 29.71 | % | 16.83 | % | 9.13 | % | 9.30 | % |
|
|
| | | | | | | Since | |
| 1 YEAR | | 5 YEARS | | 10 YEARS | | 12/31/2012 | |
Class A (Inception 12/31/12) | 25.55 | % | n/a | | n/a | | 16.24 | % |
Class C (Inception 12/31/12) | 30.46 | % | n/a | | n/a | | 16.65 | % |
Class Z (Inception 12/31/12) | 32.84 | % | n/a | | n/a | | 17.94 | % |
Russell 1000 Growth Index | 29.71 | % | n/a | | n/a | | 17.06 | % |
|
|
| | | | | | | Since | |
| 1 YEAR | | 5 YEARS | | 10 YEARS | | 2/28/2017 | |
Class Y (Inception 2/28/17) | n/a | | n/a | | n/a | | 20.36 | % |
Russell 1000 Growth Index | n/a | | n/a | | n/a | | 16.47 | % |
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average
annual total returns include changes in share price and reinvestment of dividends and capital gains. Class A returns reflect the maximum
initial sales charge and Class C returns reflect the applicable contingent deferred sales charge. The chart and table above do not reflect the
deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return
and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance
may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.
- 13 -
ALGER MID CAP GROWTH INSTITUTIONAL FUND
Fund Highlights Through October 31, 2017 (Unaudited)
The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Mid Cap
Growth Institutional Fund Class I shares and the Russell Midcap Growth Index (an unmanaged index of common
stocks) for the ten years ended October 31, 2017. Figures for the Alger Mid Cap Growth Institutional Fund Class I
shares and the Russell Midcap Growth Index include reinvestment of dividends. Performance for the Alger Mid Cap
Growth Institutional Fund Class R and Class Z-2 shares may vary from the results shown above due to differences in
expenses the class bears. Investors cannot invest directly in any index. Index performance does not reflect deduction
for fees, expenses, or taxes.
- 14 -
ALGER MID CAP GROWTH INSTITUTIONAL FUND
Fund Highlights Through October 31, 2017 (Unaudited) (Continued)
| | | | | | | | |
PERFORMANCE COMPARISON AS OF 10/31/17 |
AVERAGE ANNUAL TOTAL RETURNS |
| | | | | | | Since | |
| 1 YEAR | | 5 YEARS | | 10 YEARS | | 11/8/1993 | |
Class I (Inception 11/8/93) | 32.70 | % | 14.49 | % | 3.98 | % | 11.87 | % |
Class R (Inception 1/27/03)* | 32.01 | % | 13.90 | % | 3.44 | % | 11.31 | % |
Russell Midcap Growth Index | 26.25 | % | 15.34 | % | 8.23 | % | 9.68 | % |
|
|
| | | | | | | Since | |
| 1 YEAR | | 5 YEARS | | 10 YEARS | | 10/14/2016 | |
Class Z-2 (Inception 10/14/16) | 33.02 | % | n/a | | n/a | | 29.46 | % |
Russell Midcap Growth Index | 26.25 | % | n/a | | n/a | | 23.75 | % |
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s
average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above
do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares.
Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost.
Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call
us at (800) 992-3863.
* Since inception performance is calculated from 11/08/93. Performance figures prior to 1/27/03, inception of Class R
shares, are those of the Fund's Class I Shares. The performance figures prior to 1/27/03 have been reduced to reflect the
higher operating expenses of Class R shares.
- 15 -
ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Fund Highlights Through October 31, 2017 (Unaudited)
The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Small Cap
Growth Institutional Fund Class I shares and the Russell 2000 Growth Index (an unmanaged index of common
stocks) for the ten years ended October 31, 2017. The figures for the Alger Small Cap Growth Institutional Fund
Class I shares and the Russell 2000 Growth Index include reinvestment of dividends. Performance for the Alger
Small Cap Growth Institutional Fund Class R and Class Z-2 shares may vary from the results shown above due to
differences in expenses the class bears. Investors cannot invest directly in any index. Index performance does not
reflect deduction for fees, expenses, or taxes.
- 16 -
ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Fund Highlights Through October 31, 2017 (Unaudited) (Continued)
| | | | | | | | |
PERFORMANCE COMPARISON AS OF 10/31/17 |
AVERAGE ANNUAL TOTAL RETURNS |
| | | | | | | Since | |
| 1 YEAR | | 5 YEARS | | 10 YEARS | | 11/8/1993 | |
Class I (Inception 11/8/93) | 38.37 | % | 12.62 | % | 5.80 | % | 9.41 | % |
Class R (Inception 1/27/03)* | 37.65 | % | 12.06 | % | 5.29 | % | 8.88 | % |
Russell 2000 Growth Index | 31.00 | % | 15.36 | % | 8.16 | % | 7.60 | % |
|
| | | | | | |
| 1 YEAR | | 5 YEARS | | 10 YEARS | | Since 8/1/2016 | |
Class Z-2 (Inception 8/1/16) | 38.81 | % | n/a | | n/a | | 26.55 | % |
Russell 2000 Growth Index | 31.00 | % | n/a | | n/a | | 20.04 | % |
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s
average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above
do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares.
Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost.
Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call
us at (800) 992-3863.
* Since inception performance is calculated from 11/08/93. Performance figures prior to 1/27/03, inception of Class R
shares, are those of the Fund's Class I Shares. The performance figures prior to 1/27/03 have been reduced to reflect the
higher operating expenses of Class R shares.
- 17 -
PORTFOLIO SUMMARY†
October 31, 2017 (Unaudited)
| | | | | | | | | | | | | |
| | Alger Capital | | | | | | | | | | | |
| Appreciation Institutional | | | Alger Capital | | | Alger Mid Cap Growth | | | Alger Small Cap Growth | |
SECTORS | | Fund | | | Appreciation Focus Fund | | | Institutional Fund | | | Institutional Fund | |
Consumer Discretionary | | 18.1 | % | | 16.6 | % | | 13.9 | % | | 5.5 | % |
Consumer Staples | | 2.1 | | | | 0.7 | | | 1.9 | | | 1.0 | |
Energy | | 1.3 | | | | 1.6 | | | 1.1 | | | 1.2 | |
Financials | | 6.6 | | | | 8.2 | | | 7.2 | | | 5.0 | |
Health Care | | 13.2 | | | 13.6 | | | 21.2 | | | 39.3 | |
Industrials | | 6.1 | | | | 5.7 | | | 13.7 | | | 5.8 | |
Information Technology | | 45.9 | | | 45.1 | | | 29.6 | | | 37.2 | |
Materials | | 3.8 | | | | 1.9 | | | 5.3 | | | 1.9 | |
Real Estate | | 2.2 | | | | 3.2 | | | 2.3 | | | 1.0 | |
Telecommunication Services | 0.4 | | | | 0.6 | | | 0.0 | | | 0.0 | |
Short-Term Investments and | | | | | | | | | | | | | |
Net Other Assets | | 0.3 | | | | 2.8 | | | 3.8 | | | 2.1 | |
| | 100.0 | % | | 100.0 | % | | 100.0 | % | | 100.0 | % |
† Based on net assets for each Fund.
- 18 -
THE ALGER INSTITUTIONAL FUNDS |
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments October 31, 2017
| | | | | |
COMMON STOCKS—96.2% | | SHARES | | | VALUE |
AEROSPACE & DEFENSE—0.6% | | | | | |
General Dynamics Corp. | | 92,307 | | $ | 18,736,475 |
The Boeing Co. | | 13,426 | | | 3,463,639 |
| | | | | 22,200,114 |
APPAREL ACCESSORIES & LUXURY GOODS—0.8% | | | | | |
Adidas AG | | 47,083 | | | 10,479,889 |
PVH Corp. | | 141,961 | | | 18,002,074 |
| | | | | 28,481,963 |
APPLICATION SOFTWARE—4.0% | | | | | |
Adobe Systems, Inc. * | | 189,078 | | | 33,118,902 |
Autodesk, Inc. * | | 297,285 | | | 37,148,734 |
salesforce. com, Inc. * | | 733,542 | | | 75,070,688 |
| | | | 145,338,324 |
ASSET MANAGEMENT & CUSTODY BANKS—0.4% | | | | | |
BlackRock, Inc. | | 33,882 | | | 15,952,662 |
AUTO PARTS & EQUIPMENT—0.5% | | | | | |
Delphi Automotive PLC. | | 187,235 | | | 18,607,414 |
BIOTECHNOLOGY—4.1% | | | | | |
AbbVie, Inc. | | 120,080 | | | 10,837,220 |
ACADIA Pharmaceuticals, Inc. * | | 242,974 | | | 8,462,784 |
BioMarin Pharmaceutical, Inc. * | | 153,659 | | | 12,613,867 |
Celgene Corp. * | | 406,878 | | | 41,082,472 |
Clovis Oncology, Inc. * | | 64,781 | | | 4,882,544 |
Exact Sciences Corp. * | | 241,697 | | | 13,290,918 |
Incyte Corp. * | | 32,056 | | | 3,630,342 |
Sarepta Therapeutics, Inc. * | | 214,317 | | | 10,567,971 |
Vertex Pharmaceuticals, Inc. * | | 303,973 | | | 44,449,972 |
| | | | 149,818,090 |
BROADCASTING—0.9% | | | | | |
CBS Corp. , Cl. B | | 594,667 | | | 33,372,712 |
BUILDING PRODUCTS—0.2% | | | | | |
Johnson Controls International PLC. | | 219,335 | | | 9,078,276 |
CABLE & SATELLITE—1.2% | | | | | |
Charter Communications, Inc. , Cl. A* | | 17,398 | | | 5,813,890 |
Comcast Corp. , Cl. A | | 1,022,643 | | | 36,845,827 |
| | | | | 42,659,717 |
COMMUNICATIONS EQUIPMENT—0.3% | | | | | |
Palo Alto Networks, Inc. * | | 62,667 | | | 9,224,582 |
CONSTRUCTION MATERIALS—0.8% | | | | | |
Vulcan Materials Co. | | 234,449 | | | 28,544,166 |
DATA PROCESSING & OUTSOURCED SERVICES—3.8% | | | | |
Visa, Inc. , Cl. A | | 1,251,022 | | 137,587,400 |
DIVERSIFIED BANKS—2.4% | | | | | |
Bank of America Corp. | | 1,955,374 | | | 53,557,694 |
Citigroup, Inc. | | 240,025 | | | 17,641,838 |
- 19 -
THE ALGER INSTITUTIONAL FUNDS |
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments (Continued) October 31, 2017
| | | | | |
COMMON STOCKS—96.2% (CONT. ) | | SHARES | | | VALUE |
DIVERSIFIED BANKS—2.4% (CONT. ) | | | | | |
JPMorgan Chase & Co. | | 174,612 | | $ | 17,567,713 |
| | | | | 88,767,245 |
DIVERSIFIED CHEMICALS—0.5% | | | | | |
DowDuPont, Inc. | | 240,972 | | | 17,424,685 |
FINANCIAL EXCHANGES & DATA—1.8% | | | | | |
Intercontinental Exchange, Inc. | | 729,898 | | | 48,246,258 |
S&P Global, Inc. | | 105,879 | | | 16,566,887 |
| | | | | 64,813,145 |
HEALTH CARE EQUIPMENT—2.9% | | | | | |
Boston Scientific Corp. * | | 970,328 | | | 27,305,030 |
Danaher Corp. | | 485,595 | | | 44,805,851 |
Intuitive Surgical, Inc. * | | 29,139 | | | 10,937,615 |
Medtronic PLC. | | 272,377 | | | 21,931,796 |
| | | | 104,980,292 |
HOME ENTERTAINMENT SOFTWARE—0.7% | | | | | |
Electronic Arts, Inc. * | | 208,460 | | | 24,931,816 |
HOME IMPROVEMENT RETAIL—2.0% | | | | | |
The Home Depot, Inc. | | 430,900 | | | 71,434,602 |
HOTELS RESORTS & CRUISE LINES—0.7% | | | | | |
Norwegian Cruise Line Holdings Ltd. * | | 431,038 | | | 24,030,368 |
HOUSEWARES & SPECIALTIES—0.6% | | | | | |
Newell Brands, Inc. | | 550,065 | | | 22,431,651 |
HYPERMARKETS & SUPER CENTERS—0.7% | | | | | |
Wal-Mart Stores, Inc. | | 297,656 | | | 25,988,345 |
INDUSTRIAL CONGLOMERATES—2.4% | | | | | |
Honeywell International, Inc. | | 611,499 | | | 88,153,696 |
INDUSTRIAL GASES—1.3% | | | | | |
Air Products & Chemicals, Inc. | | 290,791 | | | 46,360,809 |
INDUSTRIAL MACHINERY—1.4% | | | | | |
Stanley Black & Decker, Inc. | | 307,855 | | | 49,733,975 |
INTERNET & DIRECT MARKETING RETAIL—9.6% | | | | | |
Amazon. com, Inc. * | | 252,839 | | | 279,457,890 |
Expedia, Inc. | | 221,748 | | | 27,643,106 |
Netflix, Inc. * | | 171,892 | | | 33,764,746 |
The Priceline Group, Inc. * | | 4,579 | | | 8,754,865 |
| | | | 349,620,607 |
INTERNET SOFTWARE & SERVICES—13.8% | | | | | |
Alibaba Group Holding Ltd. #* | | 541,779 | | | 100,169,519 |
Alphabet, Inc. , Cl. C* | | 180,507 | | | 183,510,636 |
Altaba, Inc. * | | 369,801 | | | 25,930,446 |
Facebook, Inc. , Cl. A* | | 1,068,937 | | | 192,472,796 |
Palantir Technologies, Inc. , Cl. A*,@,(a) | | 239,030 | | | 1,374,423 |
| | | | 503,457,820 |
- 20 -
THE ALGER INSTITUTIONAL FUNDS |
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments (Continued) October 31, 2017
| | | | | |
COMMON STOCKS—96.2% (CONT. ) | | SHARES | | | VALUE |
INVESTMENT BANKING & BROKERAGE—0.9% | | | | | |
Morgan Stanley | | 691,709 | | $ | 34,585,450 |
IT CONSULTING & OTHER SERVICES—1.0% | | | | | |
Cognizant Technology Solutions Corp. , Cl. A | | 493,561 | | | 37,347,761 |
LEISURE FACILITIES—0.4% | | | | | |
Vail Resorts, Inc. | | 64,148 | | | 14,691,175 |
LIFE SCIENCES TOOLS & SERVICES—1.0% | | | | | |
Illumina, Inc. * | | 96,725 | | | 19,847,003 |
Thermo Fisher Scientific, Inc. | | 92,635 | | | 17,955,442 |
| | | | | 37,802,445 |
MANAGED HEALTH CARE—4.7% | | | | | |
Aetna, Inc. | | 321,085 | | | 54,594,082 |
Humana, Inc. | | 60,582 | | | 15,469,614 |
UnitedHealth Group, Inc. | | 474,580 | | | 99,766,208 |
| | | | 169,829,904 |
MOVIES & ENTERTAINMENT—0.2% | | | | | |
Time Warner, Inc. | | 77,611 | | | 7,628,385 |
OIL & GAS EQUIPMENT & SERVICES—0.5% | | | | | |
Halliburton Co. | | 415,901 | | | 17,775,609 |
OIL & GAS EXPLORATION & PRODUCTION—0.8% | | | | | |
Pioneer Natural Resources Co. | | 190,432 | | | 28,501,957 |
PERSONAL PRODUCTS—0.5% | | | | | |
The Estee Lauder Cos, Inc. , Cl. A | | 163,049 | | | 18,230,509 |
PHARMACEUTICALS—0.4% | | | | | |
Bristol-Myers Squibb Co. | | 197,289 | | | 12,164,840 |
RAILROADS—0.7% | | | | | |
Union Pacific Corp. | | 232,968 | | | 26,975,365 |
RESTAURANTS—1.2% | | | | | |
McDonald's Corp. | | 272,067 | | | 45,410,703 |
SEMICONDUCTOR EQUIPMENT—1.3% | | | | | |
Applied Materials, Inc. | | 812,295 | | | 45,837,807 |
SEMICONDUCTORS—6.1% | | | | | |
Broadcom Ltd. | | 417,832 | | | 110,270,043 |
Cavium, Inc. * | | 207,232 | | | 14,296,936 |
Microchip Technology, Inc. | | 565,255 | | | 53,586,174 |
Micron Technology, Inc. * | | 611,316 | | | 27,087,412 |
NVIDIA Corp. | | 79,523 | | | 16,446,151 |
| | | | 221,686,716 |
SOFT DRINKS—0.2% | | | | | |
PepsiCo, Inc. | | 65,766 | | | 7,249,386 |
SPECIALTY CHEMICALS—1.2% | | | | | |
The Sherwin-Williams Co. | | 113,104 | | | 44,693,046 |
SYSTEMS SOFTWARE—7.7% | | | | | |
Choicestream, Inc. *,@,(a),(b) | | 124,658 | | | – |
Microsoft Corp. | | 2,782,102 | | | 231,415,244 |
- 21 -
THE ALGER INSTITUTIONAL FUNDS |
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments (Continued) October 31, 2017
| | | | | |
COMMON STOCKS—96.2% (CONT. ) | | SHARES | | | VALUE |
SYSTEMS SOFTWARE—7.7% (CONT. ) | | | | | |
Oracle Corp. | | 187,454 | | $ | 9,541,409 |
Red Hat, Inc. * | | 158,443 | | | 19,144,668 |
ServiceNow, Inc. * | | 172,674 | | | 21,820,814 |
| | | | 281,922,135 |
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—7.2% | | | |
Apple, Inc. | | 1,428,529 | | | 241,478,542 |
Western Digital Corp. | | 227,127 | | | 20,275,627 |
| | | | 261,754,169 |
TOBACCO—0.7% | | | | | |
Philip Morris International, Inc. | | 238,794 | | | 24,987,404 |
TRADING COMPANIES & DISTRIBUTORS—0.7% | | | | | |
HD Supply Holdings, Inc. * | | 293,521 | | | 10,387,708 |
United Rentals, Inc. * | | 108,339 | | | 15,327,802 |
| | | | | 25,715,510 |
WIRELESS TELECOMMUNICATION SERVICES—0.4% | | | | | |
T-Mobile US, Inc. * | | 227,377 | | | 13,590,323 |
TOTAL COMMON STOCKS | | | | | |
(Cost $2,474,598,652) | | | | 3,501,375,075 |
PREFERRED STOCKS—0.3% | | SHARES | | | VALUE |
INTERNET SOFTWARE & SERVICES—0.1% | | | | | |
Palantir Technologies, Inc. , Cl. B*,@,(a) | | 974,841 | | | 5,605,336 |
Palantir Technologies, Inc. , Cl. D*,@,(a) | | 127,007 | | | 730,290 |
| | | | | 6,335,626 |
PHARMACEUTICALS—0.2% | | | | | |
Intarcia Therapeutics, Inc. , Series DD*,@,(a) | | 111,655 | | | 6,412,347 |
|
SYSTEMS SOFTWARE—0.0% | | | | | |
Choicestream, Inc. , Series A*,@,(a),(b) | | 1,074,935 | | | – |
Choicestream, Inc. , Series B*,@,(a),(b) | | 2,500,538 | | | – |
TOTAL PREFERRED STOCKS | | | | | |
(Cost $13,252,335) | | | | | 12,747,973 |
WARRANTS—0.0% | | SHARES | | | VALUE |
SYSTEMS SOFTWARE—0.0% | | | | | |
Choicestream, Inc. , 6/22/26*,@,(a),(b) | | 574,662 | | | – |
(Cost $574,087) | | | | | – |
MASTER LIMITED PARTNERSHIP—1.0% | | SHARES | | | VALUE |
ASSET MANAGEMENT & CUSTODY BANKS—1.0% | | | | | |
The Blackstone Group LP. | | 1,101,244 | | | 36,660,413 |
(Cost $31,061,144) | | | | | 36,660,413 |
REAL ESTATE INVESTMENT TRUST—2.2% | | SHARES | | | VALUE |
SPECIALIZED—2.2% | | | | | |
Crown Castle International Corp. | | 212,239 | | | 22,726,552 |
- 22 -
THE ALGER INSTITUTIONAL FUNDS |
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments (Continued) October 31, 2017
| | | | | | |
REAL ESTATE INVESTMENT TRUST—2.2% (CONT. ) | | SHARES | | | | VALUE |
SPECIALIZED—2.2% (CONT. ) | | | | | | |
Equinix, Inc. | | 122,208 | | $ | | 56,643,408 |
| | | | | | 79,369,960 |
TOTAL REAL ESTATE INVESTMENT TRUST | | | | | | |
(Cost $69,863,968) | | | | | | 79,369,960 |
| | PRINCIPAL | | | | |
CORPORATE BONDS—0.0% | | AMOUNT | | | | VALUE |
SYSTEMS SOFTWARE—0.0% | | | | | | |
Choicestream, Inc. , 11.00%, 8/05/18@,(a),(b) | | 574,662 | | | | – |
(Cost $575) | | | | | | – |
Total Investments | | | | | | |
(Cost $2,589,350,761) | | 99.7 | % | | 3,630,153,421 |
Affiliated Securities (Cost $2,970,741) | | | | | | – |
Unaffiliated Securities (Cost $2,586,380,020) | | | | | | 3,630,153,421 |
Other Assets in Excess of Liabilities | | 0.3 | % | | | 10,669,233 |
NET ASSETS | | 100.0 | % | $ | 3,640,822,654 |
# American Depositary Receipts.
(a) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the
Board.
(b) Deemed an affiliate of the Alger fund complex during the year for purposes of Section 2(a)(3) of the Investment Company Act of
1940. See Affiliated Securities Note 11.
* Non-income producing security.
@ Restricted security - Investment in security not registered under the Securities Act of 1933. The investment is deemed to not be liquid
and may be sold only to qualified buyers.
| | | | | | | | | |
| | | | % of net assets | | | | % of net assets | |
| Acquisition | | Acquisition | (Acquisition | | | Market | as of | |
Security | Date(s) | | Cost | Date) | | | Value | 10/31/2017 | |
Choicestream, Inc. | 03/14/14 | $ | 36,151 | 0.00 | % | $ | 0 | 0.00 | % |
Choicestream, Inc. , 11.00%, | | | | | | | | | |
8/05/18 | 08/04/16 | | 575 | 0.00 | % | | 0 | 0.00 | % |
Choicestream, Inc. , 6/22/26 | 08/04/16 | | 574,087 | 0.02 | % | | 0 | 0.00 | % |
Choicestream, Inc. , Series A | 12/17/13 | | 859,605 | 0.03 | % | | 0 | 0.00 | % |
Choicestream, Inc. , Series B | 07/10/14 | | 1,500,323 | 0.05 | % | | 0 | 0.00 | % |
Intarcia Therapeutics, Inc. , Series | | | | | | | | | |
DD | 03/27/14 | | 3,616,505 | 0.14 | % | | 6,412,347 | 0.18 | % |
Palantir Technologies, Inc. , Cl. A | 10/07/14 | | 1,555,368 | 0.05 | % | | 1,374,423 | 0.04 | % |
Palantir Technologies, Inc. , Cl. B | 10/07/14 | | 6,437,297 | 0.22 | % | | 5,605,336 | 0.15 | % |
Palantir Technologies, Inc. , Cl. D | 10/14/14 | | 838,605 | 0.03 | % | | 730,290 | 0.02 | % |
Total | | | | | | $ | 14,122,396 | 0.39 | % |
| | | | | | | | | |
Industry classifications are unaudited.
See Notes to Financial Statements.
- 23 -
THE ALGER INSTITUTIONAL FUNDS | ALGER CAPITAL APPRECIATION FOCUS FUND
Schedule of Investments October 31, 2017
| | | | |
COMMON STOCKS—92.0% | | SHARES | | VALUE |
AIR FREIGHT & LOGISTICS—0.8% | | | | |
XPO Logistics, Inc. * | | 16,102 | $ | 1,116,674 |
APPAREL ACCESSORIES & LUXURY GOODS—0.5% | | | | |
PVH Corp. | | 5,555 | | 704,430 |
APPLICATION SOFTWARE—4.5% | | | | |
Adobe Systems, Inc. * | | 6,917 | | 1,211,582 |
Autodesk, Inc. * | | 12,647 | | 1,580,369 |
salesforce. com, Inc. * | | 30,911 | | 3,163,432 |
| | | | 5,955,383 |
ASSET MANAGEMENT & CUSTODY BANKS—0.6% | | | | |
BlackRock, Inc. Cl. A | | 1,804 | | 849,377 |
BIOTECHNOLOGY—4.7% | | | | |
Celgene Corp. * | | 17,475 | | 1,764,451 |
Exact Sciences Corp. * | | 20,996 | | 1,154,570 |
Sarepta Therapeutics, Inc. * | | 23,682 | | 1,167,759 |
Vertex Pharmaceuticals, Inc. * | | 14,078 | | 2,058,626 |
| | | | 6,145,406 |
BROADCASTING—1.1% | | | | |
CBS Corp. , Cl. B | | 25,790 | | 1,447,335 |
CABLE & SATELLITE—1.2% | | | | |
Comcast Corp. , Cl. A | | 42,539 | | 1,532,680 |
DATA PROCESSING & OUTSOURCED SERVICES—3.8% | | | |
Visa, Inc. , Cl. A | | 45,840 | | 5,041,483 |
DIVERSIFIED BANKS—2.2% | | | | |
Bank of America Corp. | | 108,341 | | 2,967,460 |
FINANCIAL EXCHANGES & DATA—2.1% | | | | |
Intercontinental Exchange, Inc. | | 42,251 | | 2,792,791 |
HEALTH CARE EQUIPMENT—3.9% | | | | |
ABIOMED, Inc. * | | 8,952 | | 1,727,020 |
Danaher Corp. | | 37,778 | | 3,485,776 |
| | | | 5,212,796 |
HOME IMPROVEMENT RETAIL—2.0% | | | | |
The Home Depot, Inc. | | 15,660 | | 2,596,115 |
HOTELS RESORTS & CRUISE LINES—0.5% | | | | |
Norwegian Cruise Line Holdings Ltd. * | | 10,725 | | 597,919 |
HOUSEWARES & SPECIALTIES—0.6% | | | | |
Newell Brands, Inc. | | 20,581 | | 839,293 |
INDUSTRIAL CONGLOMERATES—2.7% | | | | |
Honeywell International, Inc. | | 24,669 | | 3,556,283 |
INDUSTRIAL GASES—1.9% | | | | |
Air Products & Chemicals, Inc. | | 15,928 | | 2,539,401 |
INDUSTRIAL MACHINERY—1.8% | | | | |
Stanley Black & Decker, Inc. | | 14,831 | | 2,395,948 |
INTERNET & DIRECT MARKETING RETAIL—10.3% | | | | |
Amazon. com, Inc. * | | 9,785 | | 10,815,165 |
- 24 -
THE ALGER INSTITUTIONAL FUNDS | ALGER CAPITAL APPRECIATION FOCUS FUND
Schedule of Investments October 31, 2017 (Continued)
| | | | | |
COMMON STOCKS—92.0% (CONT. ) | | SHARES | | | VALUE |
INTERNET & DIRECT MARKETING RETAIL—10.3% (CONT. ) | | | |
Expedia, Inc. | | 12,806 | | $ | 1,596,396 |
Netflix, Inc. * | | 5,957 | | | 1,170,134 |
| | | | | 13,581,695 |
INTERNET SOFTWARE & SERVICES—13.7% | | | | | |
Alibaba Group Holding Ltd. #* | | 25,718 | | | 4,755,001 |
Alphabet, Inc. , Cl. C* | | 6,529 | | | 6,637,643 |
Facebook, Inc. , Cl. A* | | 37,401 | | | 6,734,424 |
| | | | | 18,127,068 |
INVESTMENT BANKING & BROKERAGE—1.5% | | | | | |
Morgan Stanley | | 39,044 | | | 1,952,200 |
IT CONSULTING & OTHER SERVICES—1.3% | | | | | |
Cognizant Technology Solutions Corp. Cl. A | | 22,360 | | | 1,691,981 |
LEISURE FACILITIES—0.5% | | | | | |
Vail Resorts, Inc. | | 2,833 | | | 648,814 |
MANAGED HEALTH CARE—4.8% | | | | | |
Aetna, Inc. | | 14,155 | | | 2,406,775 |
UnitedHealth Group, Inc. | | 18,769 | | | 3,945,619 |
| | | | | 6,352,394 |
OIL & GAS EQUIPMENT & SERVICES—0.5% | | | | | |
Halliburton Co. | | 14,060 | | | 600,924 |
OIL & GAS EXPLORATION & PRODUCTION—1.1% | | | | | |
Pioneer Natural Resources Co. | | 9,933 | | | 1,486,672 |
SEMICONDUCTORS—7.9% | | | | | |
Broadcom Ltd. | | 18,958 | | | 5,003,206 |
Cavium, Inc. * | | 13,691 | | | 944,542 |
Microchip Technology, Inc. | | 37,629 | | | 3,567,229 |
Micron Technology, Inc. * | | 22,337 | | | 989,753 |
| | | | | 10,504,730 |
SYSTEMS SOFTWARE—7.3% | | | | | |
Microsoft Corp. | | 101,657 | | | 8,455,829 |
ServiceNow, Inc. * | | 9,800 | | | 1,238,426 |
| | | | | 9,694,255 |
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—6.6% | | | |
Apple, Inc. | | 51,981 | | | 8,786,868 |
TOBACCO—0.7% | | | | | |
Philip Morris International, Inc. | | 8,661 | | | 906,287 |
TRADING COMPANIES & DISTRIBUTORS—0.3% | | | | | |
HD Supply Holdings, Inc. * | | 12,609 | | | 446,232 |
WIRELESS TELECOMMUNICATION SERVICES—0.6% | | | | | |
T-Mobile US, Inc. * | | 12,437 | | | 743,359 |
TOTAL COMMON STOCKS | | | | | |
(Cost $95,663,392) | | | | 121,814,253 |
- 25 -
THE ALGER INSTITUTIONAL FUNDS | ALGER CAPITAL APPRECIATION FOCUS FUND
Schedule of Investments October 31, 2017 (Continued)
| | | | | | |
PREFERRED STOCKS—0.2% | | SHARES | | | | VALUE |
BIOTECHNOLOGY—0.2% | | | | | | |
Prosetta Biosciences, Inc. , Series D*,@,(a),(b) | | 76,825 | | $ | | 239,694 |
(Cost $345,713) | | | | | | 239,694 |
MASTER LIMITED PARTNERSHIP—1.7% | | SHARES | | | | VALUE |
ASSET MANAGEMENT & CUSTODY BANKS—1.7% | | | | | | |
The Blackstone Group LP. | | 67,715 | | | | 2,254,232 |
(Cost $1,940,215) | | | | | | 2,254,232 |
REAL ESTATE INVESTMENT TRUST—3.3% | | SHARES | | | | VALUE |
SPECIALIZED—3.3% | | | | | | |
Equinix, Inc. | | 7,363 | | | | 3,412,750 |
SBA Communications Corp. , Cl. A* | | 5,610 | | | | 881,780 |
| | | | | | 4,294,530 |
TOTAL REAL ESTATE INVESTMENT TRUST | | | | | | |
(Cost $4,125,047) | | | | | | 4,294,530 |
Total Investments | | | | | | |
(Cost $102,074,367) | | 97.2 | % | | 128,602,709 |
Affiliated Securities (Cost $345,713) | | | | | | 239,694 |
Unaffiliated Securities (Cost $101,728,654) | | | | | | 128,363,015 |
Other Assets in Excess of Liabilities | | 2.8 | % | | | 3,741,923 |
NET ASSETS | | 100.0 | % | $ | 132,344,632 |
# American Depositary Receipts.
(a) Deemed an affiliate of the Alger fund complex during the year for purposes of Section 2(a)(3) of the Investment Company Act of
1940. See Affiliated Securities Note 11.
(b) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the
Board.
* Non-income producing security.
@ Restricted security - Investment in security not registered under the Securities Act of 1933. The investment is deemed to not be liquid
and may be sold only to qualified buyers.
| | | | | | | | | |
| | | | % of net assets | | | | % of net assets | |
| Acquisition | | Acquisition | (Acquisition | | | Market | as of | |
Security | Date(s) | | Cost | Date) | | | Value | 10/31/2017 | |
Prosetta Biosciences, Inc. , Series D | 02/06/15 | $ | 345,713 | 0.80 | % | $ | 239,694 | 0.18 | % |
Total | | | | | | $ | 239,694 | 0.18 | % |
| | | | | | | | | |
Industry Classifications are Unaudited.
See Notes to Financial Statements.
- 26 -
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments October 31, 2017
| | | | |
COMMON STOCKS—91.3% | | SHARES | | VALUE |
AEROSPACE & DEFENSE—0.8% | | | | |
HEICO Corp. | | 9,419 | $ | 854,115 |
AIR FREIGHT & LOGISTICS—0.4% | | | | |
XPO Logistics, Inc. * | | 6,963 | | 482,884 |
APPAREL ACCESSORIES & LUXURY GOODS—1.4% | | | | |
Michael Kors Holdings Ltd. * | | 9,004 | | 439,485 |
PVH Corp. | | 8,514 | | 1,079,661 |
| | | | 1,519,146 |
APPAREL RETAIL—1.7% | | | | |
Burlington Stores, Inc. * | | 8,942 | | 839,564 |
Ross Stores, Inc. | | 16,001 | | 1,015,904 |
| | | | 1,855,468 |
APPLICATION SOFTWARE—3.7% | | | | |
Autodesk, Inc. * | | 14,225 | | 1,777,556 |
Paylocity Holding Corp. * | | 10,902 | | 582,276 |
Splunk, Inc. * | | 13,436 | | 904,243 |
Workday, Inc. , Cl. A* | | 6,430 | | 713,665 |
| | | | 3,977,740 |
ASSET MANAGEMENT & CUSTODY BANKS—1.0% | | | | |
WisdomTree Investments, Inc. | | 98,618 | | 1,093,674 |
AUTO PARTS & EQUIPMENT—0.6% | | | | |
Delphi Automotive PLC. | | 6,653 | | 661,175 |
BIOTECHNOLOGY—6.3% | | | | |
Alexion Pharmaceuticals, Inc. * | | 3,082 | | 368,792 |
BioMarin Pharmaceutical, Inc. * | | 6,485 | | 532,354 |
Bluebird Bio, Inc. * | | 7,345 | | 1,021,690 |
Clovis Oncology, Inc. * | | 13,189 | | 994,055 |
Exact Sciences Corp. * | | 10,964 | | 602,910 |
Incyte Corp. * | | 2,968 | | 336,126 |
Sarepta Therapeutics, Inc. * | | 15,739 | | 776,090 |
Spark Therapeutics, Inc. * | | 3,051 | | 246,826 |
TESARO, Inc. * | | 7,256 | | 840,027 |
Vertex Pharmaceuticals, Inc. * | | 7,227 | | 1,056,804 |
| | | | 6,775,674 |
BROADCASTING—0.5% | | | | |
CBS Corp. , Cl. B | | 9,449 | | 530,278 |
BUILDING PRODUCTS—1.5% | | | | |
Fortune Brands Home & Security, Inc. | | 12,298 | | 812,406 |
Johnson Controls International PLC. | | 5,979 | | 247,471 |
Lennox International, Inc. | | 2,770 | | 529,430 |
| | | | 1,589,307 |
CASINOS & GAMING—0.8% | | | | |
Wynn Resorts Ltd. | | 5,553 | | 819,012 |
COMMUNICATIONS EQUIPMENT—2.6% | | | | |
Lumentum Holdings, Inc. * | | 21,290 | | 1,344,463 |
Palo Alto Networks, Inc. * | | 9,529 | | 1,402,669 |
| | | | 2,747,132 |
- 27 -
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments October 31, 2017 (Continued)
| | | | |
COMMON STOCKS—91.3% (CONT. ) | | SHARES | | VALUE |
CONSTRUCTION MACHINERY & HEAVY TRUCKS—0.9% | | | |
WABCO Holdings, Inc. * | | 6,794 | $ | 1,002,591 |
CONSTRUCTION MATERIALS—1.3% | | | | |
Vulcan Materials Co. | | 11,091 | | 1,350,329 |
CONSUMER ELECTRONICS—0.0% | | | | |
Roku, Inc. , Cl. A | | 2,597 | | 52,927 |
CONSUMER FINANCE—0.3% | | | | |
LendingClub Corp. * | | 50,355 | | 286,520 |
DATA PROCESSING & OUTSOURCED SERVICES—4.1% | | | |
Alliance Data Systems Corp. | | 4,211 | | 942,127 |
Fiserv, Inc. * | | 12,355 | | 1,599,108 |
FleetCor Technologies, Inc. * | | 2,837 | | 468,871 |
Total System Services, Inc. | | 9,800 | | 706,090 |
WNS Holdings Ltd. #* | | 19,545 | | 741,146 |
| | | | 4,457,342 |
DIVERSIFIED SUPPORT SERVICES—0.6% | | | | |
Cintas Corp. | | 4,132 | | 615,833 |
ELECTRICAL COMPONENTS & EQUIPMENT—2.5% | | | | |
AMETEK, Inc. | | 7,263 | | 490,180 |
Hubbell, Inc. , Cl. B | | 8,228 | | 1,035,247 |
Rockwell Automation, Inc. | | 5,852 | | 1,175,198 |
| | | | 2,700,625 |
ELECTRONIC COMPONENTS—0.8% | | | | |
Universal Display Corp. | | 5,596 | | 819,814 |
ELECTRONIC EQUIPMENT & INSTRUMENTS—1.3% | | | | |
Cognex Corp. | | 2,942 | | 362,307 |
Trimble, Inc. * | | 26,571 | | 1,086,222 |
| | | | 1,448,529 |
FERTILIZERS & AGRICULTURAL CHEMICALS—0.6% | | | | |
FMC Corp. | | 7,497 | | 696,171 |
FINANCIAL EXCHANGES & DATA—3.1% | | | | |
Intercontinental Exchange, Inc. | | 18,846 | | 1,245,721 |
MarketAxess Holdings, Inc. | | 5,808 | | 1,010,592 |
S&P Global, Inc. | | 6,462 | | 1,011,109 |
| | | | 3,267,422 |
GENERAL MERCHANDISE STORES—1.1% | | | | |
Dollar Tree, Inc. * | | 13,389 | | 1,221,746 |
HEALTH CARE EQUIPMENT—5.1% | | | | |
ABIOMED, Inc. * | | 8,459 | | 1,631,910 |
Edwards Lifesciences Corp. * | | 2,868 | | 293,196 |
IDEXX Laboratories, Inc. * | | 6,931 | | 1,151,724 |
Insulet Corp. * | | 21,970 | | 1,292,056 |
Intuitive Surgical, Inc. | | 1,537 | | 576,928 |
Masimo Corp. * | | 6,156 | | 540,251 |
| | | | 5,486,065 |
- 28 -
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments October 31, 2017 (Continued)
| | | | |
COMMON STOCKS—91.3% (CONT. ) | | SHARES | | VALUE |
HEALTH CARE SUPPLIES—1.3% | | | | |
Align Technology, Inc. * | | 5,783 | $ | 1,382,021 |
HEALTH CARE TECHNOLOGY—0.7% | | | | |
Medidata Solutions, Inc. * | | 10,102 | | 759,973 |
HOME ENTERTAINMENT SOFTWARE—1.0% | | | | |
Electronic Arts, Inc. * | | 8,981 | | 1,074,128 |
HOME FURNISHINGS—0.6% | | | | |
Mohawk Industries, Inc. * | | 2,512 | | 657,541 |
HOMEBUILDING—0.6% | | | | |
Lennar Corp. , Cl. A | | 11,347 | | 631,687 |
HOTELS RESORTS & CRUISE LINES—2.1% | | | | |
Extended Stay America, Inc. | | 64,521 | | 1,278,806 |
Norwegian Cruise Line Holdings Ltd. * | | 17,385 | | 969,214 |
| | | | 2,248,020 |
HOUSEHOLD PRODUCTS—0.8% | | | | |
Church & Dwight Co. , Inc. | | 19,879 | | 897,934 |
HOUSEWARES & SPECIALTIES—0.6% | | | | |
Newell Brands, Inc. | | 15,208 | | 620,182 |
INDUSTRIAL CONGLOMERATES—1.5% | | | | |
Roper Technologies, Inc. | | 6,173 | | 1,593,684 |
INDUSTRIAL GASES—1.1% | | | | |
Air Products & Chemicals, Inc. | | 7,094 | | 1,130,996 |
INDUSTRIAL MACHINERY—3.4% | | | | |
Fortive Corp. | | 14,374 | | 1,038,665 |
Parker-Hannifin Corp. | | 4,399 | | 803,301 |
Stanley Black & Decker, Inc. | | 7,916 | | 1,278,831 |
Welbilt, Inc. * | | 22,221 | | 490,195 |
| | | | 3,610,992 |
INTERNET & DIRECT MARKETING RETAIL—1.4% | | | | |
Despegar. com Corp. * | | 14,044 | | 432,555 |
Expedia, Inc. | | 8,936 | | 1,113,962 |
| | | | 1,546,517 |
INTERNET SOFTWARE & SERVICES—1.2% | | | | |
LogMeIn, Inc. | | 5,060 | | 612,513 |
Match Group, Inc. * | | 22,832 | | 610,527 |
Palantir Technologies, Inc. , Cl. A*,@,(a) | | 12,426 | | 71,450 |
| | | | 1,294,490 |
IT CONSULTING & OTHER SERVICES—2.4% | | | | |
DXC Technology Co. | | 8,533 | | 780,940 |
EPAM Systems, Inc. * | | 11,898 | | 1,084,503 |
Gartner, Inc. * | | 5,966 | | 747,599 |
| | | | 2,613,042 |
LEISURE FACILITIES—1.1% | | | | |
Vail Resorts, Inc. | | 5,272 | | 1,207,393 |
LIFE SCIENCES TOOLS & SERVICES—3.2% | | | | |
Agilent Technologies, Inc. | | 11,119 | | 756,426 |
- 29 -
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments October 31, 2017 (Continued)
| | | | |
COMMON STOCKS—91.3% (CONT. ) | | SHARES | | VALUE |
LIFE SCIENCES TOOLS & SERVICES—3.2% (CONT. ) | | | | |
Illumina, Inc. * | | 6,729 | $ | 1,380,723 |
Mettler-Toledo International, Inc. * | | 1,293 | | 882,641 |
PRA Health Sciences, Inc. * | | 5,337 | | 434,592 |
| | | | 3,454,382 |
MANAGED HEALTH CARE—0.6% | | | | |
Cigna Corp. | | 1,344 | | 265,064 |
WellCare Health Plans, Inc. * | | 1,731 | | 342,288 |
| | | | 607,352 |
METAL & GLASS CONTAINERS—1.0% | | | | |
Ball Corp. | | 25,230 | | 1,083,124 |
OIL & GAS EXPLORATION & PRODUCTION—1.1% | | | | |
Encana Corp. | | 47,819 | | 559,482 |
Pioneer Natural Resources Co. | | 4,311 | | 645,228 |
| | | | 1,204,710 |
PACKAGED FOODS & MEATS—1.0% | | | | |
McCormick & Co. , Inc. | | 6,549 | | 651,822 |
Pinnacle Foods, Inc. | | 8,548 | | 465,182 |
| | | | 1,117,004 |
PAPER PACKAGING—0.9% | | | | |
International Paper Co. | | 17,091 | | 978,802 |
PHARMACEUTICALS—2.0% | | | | |
Aerie Pharmaceuticals, Inc. * | | 17,936 | | 1,107,548 |
GW Pharmaceuticals PLC. #* | | 1,705 | | 184,055 |
Zoetis, Inc. , Cl. A | | 12,517 | | 798,835 |
Zogenix, Inc. * | | 3,077 | | 115,388 |
| | | | 2,205,826 |
PROPERTY & CASUALTY INSURANCE—1.1% | | | | |
The Progressive Corp. | | 23,265 | | 1,131,842 |
RAILROADS—0.4% | | | | |
Kansas City Southern | | 3,729 | | 388,636 |
REGIONAL BANKS—1.6% | | | | |
Citizens Financial Group, Inc. | | 14,134 | | 537,233 |
Regions Financial Corp. | | 73,170 | | 1,132,672 |
| | | | 1,669,905 |
RESEARCH & CONSULTING SERVICES—0.5% | | | | |
FTI Consulting, Inc. * | | 12,208 | | 521,892 |
RESTAURANTS—0.5% | | | | |
Dunkin' Brands Group, Inc. | | 9,657 | | 570,439 |
SEMICONDUCTOR EQUIPMENT—2.3% | | | | |
Lam Research Corp. | | 12,006 | | 2,504,091 |
SEMICONDUCTORS—5.0% | | | | |
Broadcom Ltd. | | 6,937 | | 1,830,744 |
Cavium, Inc. * | | 18,663 | | 1,287,560 |
Microchip Technology, Inc. | | 12,871 | | 1,220,171 |
- 30 -
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments October 31, 2017 (Continued)
| | | | |
COMMON STOCKS—91.3% (CONT. ) | | SHARES | | VALUE |
SEMICONDUCTORS—5.0% (CONT. ) | | | | |
Skyworks Solutions, Inc. | | 9,330 | $ | 1,062,314 |
| | | | 5,400,789 |
SPECIALIZED CONSUMER SERVICES—0.7% | | | | |
ServiceMaster Global Holdings, Inc. * | | 16,825 | | 792,626 |
SPECIALTY CHEMICALS—0.4% | | | | |
Axalta Coating Systems Ltd. * | | 14,494 | | 481,926 |
SYSTEMS SOFTWARE—4.1% | | | | |
Choicestream, Inc. *,@,(a),(b) | | 8,930 | | – |
Dell Technologies, Inc. , Cl. V* | | 9,327 | | 771,996 |
Proofpoint, Inc. * | | 7,875 | | 727,729 |
Red Hat, Inc. * | | 13,790 | | 1,666,246 |
ServiceNow, Inc. * | | 9,745 | | 1,231,475 |
| | | | 4,397,446 |
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—0.8% | | |
Western Digital Corp. | | 9,499 | | 847,976 |
TRADING COMPANIES & DISTRIBUTORS—0.8% | | | | |
United Rentals, Inc. * | | 6,226 | | 880,854 |
TRUCKING—0.5% | | | | |
Old Dominion Freight Line, Inc. | | 4,322 | | 523,524 |
TOTAL COMMON STOCKS | | | | |
(Cost $93,002,102) | | | | 98,343,265 |
PREFERRED STOCKS—1.2% | | SHARES | | VALUE |
BIOTECHNOLOGY—0.5% | | | | |
Prosetta Biosciences, Inc. , Series D*,@,(a),(b) | | 166,009 | | 517,948 |
INTERNET SOFTWARE & SERVICES—0.3% | | | | |
Palantir Technologies, Inc. , Cl. B*,@,(a) | | 50,675 | | 291,381 |
Palantir Technologies, Inc. , Cl. D*,@,(a) | | 6,602 | | 37,962 |
| | | | 329,343 |
PHARMACEUTICALS—0.4% | | | | |
Intarcia Therapeutics, Inc. , Series DD*,@,(a) | | 7,588 | | 435,779 |
|
SYSTEMS SOFTWARE—0.0% | | | | |
Choicestream, Inc. , Series A*,@,(a),(b) | | 77,008 | | – |
Choicestream, Inc. , Series B*,@,(a),(b) | | 144,793 | | – |
TOTAL PREFERRED STOCKS | | | | |
(Cost $1,519,495) | | | | 1,283,070 |
RIGHTS—1.1% | | SHARES | | VALUE |
BIOTECHNOLOGY—1.1% | | | | |
Tolero CDR*,@,(a),(c) | | 422,928 | | 1,207,798 |
|
TOTAL RIGHTS | | | | |
(Cost $226,186) | | | | 1,207,798 |
- 31 -
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments October 31, 2017 (Continued)
| | | | | | |
WARRANTS—0.0% | | SHARES | | | | VALUE |
SYSTEMS SOFTWARE—0.0% | | | | | | |
Choicestream, Inc. , 6/22/26*,@,(a),(b) | | 17,128 | | | $ | – |
(Cost $17,111) | | | | | | – |
REAL ESTATE INVESTMENT TRUST—2.3% | | SHARES | | | | VALUE |
HEALTH CARE—0.4% | | | | | | |
Omega Healthcare Investors, Inc. | | 13,610 | | | | 392,785 |
SPECIALIZED—1.9% | | | | | | |
CyrusOne, Inc. | | 15,246 | | | | 935,952 |
SBA Communications Corp. , Cl. A* | | 7,324 | | | | 1,151,186 |
| | | | | | 2,087,138 |
TOTAL REAL ESTATE INVESTMENT TRUST | | | | | | |
(Cost $2,374,625) | | | | | | 2,479,923 |
| | PRINCIPAL | | | | |
CORPORATE BONDS—0.0% | | AMOUNT | | | | VALUE |
SYSTEMS SOFTWARE—0.0% | | | | | | |
Choicestream, Inc. , 11.00%, 8/5/18 @,(a),(b) | | 17,128 | | | | – |
(Cost $17) | | | | | | – |
SPECIAL PURPOSE VEHICLE—0.3% | | SHARES | | | | VALUE |
CONSUMER FINANCE—0.3% | | | | | | |
JS Kred SPV I, LLC. *,@,(a) | | 240,362 | | | | 290,165 |
(Cost $240,362) | | | | | | 290,165 |
Total Investments | | | | | | |
(Cost $97,379,898) | | 96.2 | % | | 103,604,221 |
Affiliated Securities (Cost $915,216) | | | | | | 517,948 |
Unaffiliated Securities (Cost $96,464,682) | | | | | | 103,086,273 |
Other Assets in Excess of Liabilities | | 3.8 | % | | | 4,039,013 |
NET ASSETS | | 100.0 | % | $ | 107,643,234 |
# American Depositary Receipts.
(a) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the
Board.
(b) Deemed an affiliate of the Alger fund complex during the year for purposes of Section 2(a)(3) of the Investment Company Act of
1940. See Affiliated Securities Note 11.
(c) Contingent deferred rights.
* Non-income producing security.
- 32 -
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments October 31, 2017 (Continued)
@ Restricted security - Investment in security not registered under the Securities Act of 1933. The investment is deemed to not be liquid
and may be sold only to qualified buyers.
| | | | | | | | | |
| | | | % of net assets | | | | % of net assets | |
| Acquisition | | Acquisition | (Acquisition | | | Market | as of | |
Security | Date(s) | | Cost | Date) | | | Value | 10/31/2017 | |
Choicestream, Inc. | 03/14/14 | $ | 2,590 | 0.00 | % | $ | 0 | 0.00 | % |
Choicestream, Inc. , 11.00%, | | | | | | | | | |
8/05/18 | 08/04/16 | | 17 | 0.00 | % | | 0 | 0.00 | % |
Choicestream, Inc. , 6/22/26 | 08/04/16 | | 17,111 | 0.02 | % | | 0 | 0.00 | % |
Choicestream, Inc. , Series A | 12/17/13 | | 61,582 | 0.03 | % | | 0 | 0.00 | % |
Choicestream, Inc. , Series B | 07/10/14 | | 86,876 | 0.05 | % | | 0 | 0.00 | % |
Intarcia Therapeutics, Inc. , Series | | | | | | | | | |
DD | 3/27/14 | | 245,775 | 0.14 | % | | 435,779 | 0.40 | % |
JS Kred SPV I, LLC. | 06/26/15 | | 240,362 | 0.15 | % | | 290,165 | 0.27 | % |
Palantir Technologies, Inc. , Cl. A | 10/07/14 | | 80,856 | 0.05 | % | | 71,450 | 0.07 | % |
Palantir Technologies, Inc. , Cl. B | 10/07/14 | | 334,629 | 0.22 | % | | 291,381 | 0.27 | % |
Palantir Technologies, Inc. , Cl. D | 10/14/14 | | 43,592 | 0.03 | % | | 37,962 | 0.04 | % |
Prosetta Biosciences, Inc. , Series D | 02/06/15 | | 747,040 | 0.50 | % | | 517,948 | 0.48 | % |
Tolero CDR | 02/06/17 | | 226,186 | 0.23 | % | | 1,207,798 | 1.12 | % |
Total | | | | | | $ | 2,852,483 | 2.65 | % |
Industry classifications are unaudited.
See Notes to Financial Statements.
- 33 -
THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments October 31, 2017
| | | | |
COMMON STOCKS—94.4% | | SHARES | | VALUE |
AEROSPACE & DEFENSE—1.0% | | | | |
Hexcel Corp. | | 35,045 | $ | 2,126,881 |
APPAREL RETAIL—0.4% | | | | |
Burlington Stores, Inc. * | | 7,867 | | 738,633 |
APPLICATION SOFTWARE—14.0% | | | | |
ACI Worldwide, Inc. * | | 150,116 | | 3,614,793 |
Blackbaud, Inc. | | 61,370 | | 6,216,781 |
Ellie Mae, Inc. * | | 19,255 | | 1,731,987 |
Everbridge, Inc. * | | 39,082 | | 1,041,144 |
Guidewire Software, Inc. * | | 37,316 | | 2,984,534 |
HubSpot, Inc. * | | 32,224 | | 2,788,987 |
Manhattan Associates, Inc. * | | 62,600 | | 2,620,436 |
Paycom Software, Inc. * | | 28,280 | | 2,324,616 |
Tyler Technologies, Inc. * | | 33,435 | | 5,927,691 |
| | | | 29,250,969 |
ASSET MANAGEMENT & CUSTODY BANKS—2.0% | | | | |
WisdomTree Investments, Inc. | | 379,470 | | 4,208,322 |
BIOTECHNOLOGY—5.0% | | | | |
ACADIA Pharmaceuticals, Inc. * | | 67,672 | | 2,357,016 |
Bluebird Bio, Inc. * | | 6,104 | | 849,066 |
CareDx, Inc. * | | 18,024 | | 105,440 |
Clovis Oncology, Inc. * | | 13,557 | | 1,021,791 |
Halozyme Therapeutics, Inc. * | | 80,722 | | 1,431,201 |
Incyte Corp. * | | 5,229 | | 592,184 |
Ironwood Pharmaceuticals, Inc. , Cl. A* | | 42,723 | | 657,080 |
Sarepta Therapeutics, Inc. * | | 19,705 | | 971,654 |
TESARO, Inc. * | | 13,672 | | 1,582,807 |
Ultragenyx Pharmaceutical, Inc. * | | 20,398 | | 940,144 |
| | | | 10,508,383 |
BREWERS—0.4% | | | | |
Craft Brew Alliance, Inc. * | | 44,524 | | 812,563 |
COMMUNICATIONS EQUIPMENT—1.9% | | | | |
Lumentum Holdings, Inc. * | | 27,728 | | 1,751,023 |
NetScout Systems, Inc. * | | 77,943 | | 2,213,581 |
| | | | 3,964,604 |
CONSUMER FINANCE—2.0% | | | | |
LendingClub Corp. * | | 733,529 | | 4,173,780 |
ELECTRONIC COMPONENTS—2.1% | | | | |
Dolby Laboratories, Inc. , Cl. A | | 30,638 | | 1,775,166 |
Universal Display Corp. | | 18,308 | | 2,682,122 |
| | | | 4,457,288 |
ELECTRONIC EQUIPMENT & INSTRUMENTS—6.2% | | | | |
Cognex Corp. | | 84,044 | | 10,350,019 |
FLIR Systems, Inc. | | 52,243 | | 2,446,017 |
| | | | 12,796,036 |
- 34 -
THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments October 31, 2017 (Continued)
| | | | |
COMMON STOCKS—94.4% (CONT. ) | | SHARES | | VALUE |
FINANCIAL EXCHANGES & DATA—0.5% | | | | |
MarketAxess Holdings, Inc. | | 6,015 | $ | 1,046,610 |
HEALTH CARE EQUIPMENT—11.7% | | | | |
Abaxis, Inc. | | 65,618 | | 3,175,911 |
ABIOMED, Inc. * | | 29,158 | | 5,625,162 |
Cantel Medical Corp. | | 68,652 | | 6,733,388 |
Cardiovascular Systems, Inc. * | | 41,447 | | 997,629 |
DexCom, Inc. * | | 24,653 | | 1,108,645 |
Inogen, Inc. * | | 29,965 | | 2,964,437 |
Insulet Corp. * | | 66,371 | | 3,903,279 |
| | | | 24,508,451 |
HEALTH CARE SUPPLIES—7.3% | | | | |
Meridian Bioscience, Inc. | | 91,394 | | 1,366,340 |
Neogen Corp. * | | 87,068 | | 6,982,854 |
Quidel Corp. * | | 170,017 | | 6,962,196 |
| | | | 15,311,390 |
HEALTH CARE TECHNOLOGY—7.3% | | | | |
Medidata Solutions, Inc. * | | 77,854 | | 5,856,956 |
Veeva Systems, Inc. , Cl. A* | | 88,697 | | 5,405,195 |
Vocera Communications, Inc. * | | 140,039 | | 3,951,901 |
| | | | 15,214,052 |
HOME ENTERTAINMENT SOFTWARE—3.4% | | | | |
Take-Two Interactive Software, Inc. * | | 65,126 | | 7,206,192 |
HUMAN RESOURCE & EMPLOYMENT SERVICES—2.1% | | | |
WageWorks, Inc. * | | 69,765 | | 4,447,519 |
INDUSTRIAL MACHINERY—2.6% | | | | |
DMC Global, Inc. | | 43,254 | | 940,774 |
Sun Hydraulics Corp. | | 79,507 | | 4,574,038 |
| | | | 5,514,812 |
INTERNET & DIRECT MARKETING RETAIL—0.3% | | | | |
Despegar. com Corp. * | | 18,630 | | 573,804 |
INTERNET SOFTWARE & SERVICES—3.8% | | | | |
Cornerstone OnDemand, Inc. * | | 30,083 | | 1,153,984 |
NIC, Inc. | | 86,959 | | 1,478,303 |
Q2 Holdings, Inc. * | | 52,453 | | 2,231,875 |
Shopify, Inc. , Cl. A* | | 18,037 | | 1,794,501 |
SPS Commerce, Inc. * | | 24,817 | | 1,220,004 |
| | | | 7,878,667 |
IT CONSULTING & OTHER SERVICES—1.3% | | | | |
InterXion Holding NV* | | 50,144 | | 2,677,188 |
LEISURE FACILITIES—1.1% | | | | |
Planet Fitness, Inc. , Cl. A | | 83,861 | | 2,234,057 |
LIFE SCIENCES TOOLS & SERVICES—4.0% | | | | |
Bio-Techne Corp. | | 42,485 | | 5,566,385 |
PRA Health Sciences, Inc. * | | 33,418 | | 2,721,227 |
| | | | 8,287,612 |
- 35 -
THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments October 31, 2017 (Continued)
| | | | | |
COMMON STOCKS—94.4% (CONT. ) | | SHARES | | | VALUE |
MANAGED HEALTH CARE—0.9% | | | | | |
HealthEquity, Inc. * | | 38,731 | | $ | 1,945,071 |
MOVIES & ENTERTAINMENT—1.5% | | | | | |
Lions Gate Entertainment Corp. , Cl. A | | 33,692 | | | 977,742 |
Lions Gate Entertainment Corp. , Cl. B* | | 33,692 | | | 931,921 |
Live Nation Entertainment, Inc. * | | 27,035 | | | 1,183,592 |
| | | | | 3,093,255 |
OIL & GAS EQUIPMENT & SERVICES—0.8% | | | | | |
RPC, Inc. | | 69,636 | | | 1,692,851 |
OIL & GAS EXPLORATION & PRODUCTION—0.4% | | | | | |
Parsley Energy, Inc. , Cl. A* | | 31,031 | | | 825,425 |
PERSONAL PRODUCTS—0.6% | | | | | |
elf Beauty, Inc. * | | 63,164 | | | 1,338,445 |
PHARMACEUTICALS—1.1% | | | | | |
Aerie Pharmaceuticals, Inc. * | | 37,457 | | | 2,312,970 |
RESTAURANTS—1.8% | | | | | |
Shake Shack, Inc. , Cl. A* | | 51,822 | | | 1,967,163 |
Wingstop, Inc. | | 52,186 | | | 1,767,540 |
| | | | | 3,734,703 |
SEMICONDUCTORS—2.3% | | | | | |
Cavium, Inc. * | | 33,896 | | | 2,338,485 |
Microsemi Corp. * | | 47,503 | | | 2,535,235 |
| | | | | 4,873,720 |
SPECIALTY CHEMICALS—1.9% | | | | | |
Balchem Corp. | | 40,399 | | | 3,405,232 |
Flotek Industries, Inc. * | | 94,739 | | | 466,116 |
| | | | | 3,871,348 |
SPECIALTY STORES—0.5% | | | | | |
Five Below, Inc. * | | 18,802 | | | 1,038,811 |
SYSTEMS SOFTWARE—2.2% | | | | | |
Proofpoint, Inc. * | | 50,878 | | | 4,701,636 |
TOTAL COMMON STOCKS | | | | | |
(Cost $133,363,241) | | | | 197,366,048 |
PREFERRED STOCKS—1.3% | | SHARES | | | VALUE |
BIOTECHNOLOGY—0.2% | | | | | |
Prosetta Biosciences, Inc. , Series D*,@,(a),(b) | | 133,263 | | | 415,781 |
PHARMACEUTICALS—1.1% | | | | | |
Intarcia Therapeutics, Inc. , Series DD*,@,(b) | | 41,238 | | | 2,368,298 |
TOTAL PREFERRED STOCKS | | | | | |
(Cost $1,935,382) | | | | | 2,784,079 |
RIGHTS—0.8% | | SHARES | | | VALUE |
BIOTECHNOLOGY—0.8% | | | | | |
Tolero CDR*,@,(b),(c) | | 528,559 | | | 1,509,459 |
Dyax Corp. *,@,(b) | | 21,650 | | | 61,486 |
- 36 -
THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments October 31, 2017 (Continued)
| | | | | | |
RIGHTS—0.8% (CONT. ) | | SHARES | | | | VALUE |
BIOTECHNOLOGY—0.8% (CONT. ) | | | | | | |
Neuralstem, Inc. , Strike Price: 47.32, 1/8/2019*,(b) | | 19,260 | | $ | | – |
| | | | | | 1,570,945 |
TOTAL RIGHTS | | | | | | |
(Cost $285,725) | | | | | | 1,570,945 |
REAL ESTATE INVESTMENT TRUST—1.0% | | SHARES | | | | VALUE |
SPECIALIZED—1.0% | | | | | | |
CyrusOne, Inc. | | 32,622 | | | | 2,002,665 |
(Cost $1,090,753) | | | | | | 2,002,665 |
SPECIAL PURPOSE VEHICLE—0.5% | | SHARES | | | | VALUE |
CONSUMER FINANCE—0.5% | | | | | | |
JS Kred SPV I, LLC. *,@,(b) | | 775,134 | | | | 935,742 |
(Cost $775,134) | | | | | | 935,742 |
Total Investments | | | | | | |
(Cost $137,450,235) | | 97.9 | % | | 204,659,479 |
Affiliated Securities (Cost $599,684) | | | | | | 415,781 |
Unaffiliated Securities (Cost $136,850,551) | | | | | | 204,243,698 |
Other Assets in Excess of Liabilities | | 2.1 | % | | | 4,388,432 |
NET ASSETS | | 100.0 | % | $ | 209,047,911 |
(a) Deemed an affiliate of the Alger fund complex during the year for purposes of Section 2(a)(3) of the Investment Company Act of
1940. See Affiliated Securities Note 11.
(b) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the
Board.
(c) Contingent deferred rights.
* Non-income producing security.
@ Restricted security - Investment in security not registered under the Securities Act of 1933. The investment is deemed to not be liquid
and may be sold only to qualified buyers.
| | | | | | | | | |
| | | | % of net assets | | | | % of net assets | |
| Acquisition | | Acquisition | (Acquisition | | | Market | as of | |
Security | Date(s) | | Cost | Date) | | | Value | 10/31/2017 | |
Dyax Corp. Rights | 05/01/15 | $ | 0 | 0.00 | % | $ | 37,488 | 0.02 | % |
Dyax Corp. Rights | 08/14/15 | | 0 | 0.00 | % | | 23,998 | 0.01 | % |
Intarcia Therapeutics, Inc. , Series | | | | | | | | | |
DD | 03/27/14 | | 1,335,699 | 0.15 | % | | 2,368,298 | 1.13 | % |
JS Kred SPV I, LLC. | 06/26/15 | | 775,134 | 0.15 | % | | 935,742 | 0.45 | % |
Prosetta Biosciences, Inc. , Series D | 02/06/15 | | 599,684 | 0.10 | % | | 415,781 | 0.20 | % |
Tolero CDR | 02/06/17 | | 285,725 | 0.16 | % | | 1,509,459 | 0.72 | % |
Total | | | | | | $ | 5,290,766 | 2.53 | % |
| | | | | | | | | |
Industry classifications are unaudited.
See Notes to Financial Statements.
- 37 -
THE ALGER INSTITUTIONAL FUNDS
Statement of Assets and Liabilities October 31, 2017
| | | | | | |
| | Alger Capital | Alger Capital | |
| | | Appreciation | Appreciation | |
| | Institutional Fund | | Focus Fund | |
|
ASSETS: | | | | | | |
Investments in unaffiliated securities, at value (Identified cost | | | | | | |
below)* | | | | | | |
see accompanying schedules of investments | | $ | 3,630,153,421 | $ | 128,363,015 | |
Investments in affiliated securities, at value (Identified cost | | | | | | |
below)** see accompanying schedules of investments | | | — | | 239,694 | |
Cash and cash equivalents | | | 2,628,274 | | 4,069,153 | |
Receivable for investment securities sold | | | 35,050,048 | | 263,376 | |
Receivable for shares of beneficial interest sold | | | 5,994,891 | | 629,281 | |
Dividends and interest receivable | | | 1,143,489 | | 52,333 | |
Receivable from Investment Manager | | | 7,842 | | 579 | |
Prepaid expenses | | | 260,487 | | 20,555 | |
Total Assets | | | 3,675,238,452 | | 133,637,986 | |
|
LIABILITIES: | | | | | | |
Payable for investment securities purchased | | | 18,713,320 | | 838,940 | |
Payable for shares of beneficial interest redeemed | | | 10,859,919 | | 268,157 | |
Accrued investment advisory fees | | | 2,292,865 | | 61,564 | |
Accrued transfer agent fees | | | 1,028,359 | | 15,933 | |
Accrued distribution fees | | | 280,999 | | 21,067 | |
Accrued administrative fees | | | 86,204 | | 3,078 | |
Accrued shareholder servicing fees | | | 671,719 | | 4,959 | |
Accrued shareholder administrative fees | | | 31,347 | | 1,355 | |
Accrued other expenses | | | 451,066 | | 78,301 | |
Total Liabilities | | | 34,415,798 | | 1,293,354 | |
NET ASSETS | $ | 3,640,822,654 | $ | 132,344,632 | |
|
NET ASSETS CONSIST OF: | | | | | | |
Paid in capital (par value of $. 001 per share) | | | 2,389,726,420 | | 101,448,555 | |
Undistributed net investment income (accumulated loss) | | | 649,644 | | 54,619 | |
Undistributed net realized gain | | | 209,713,132 | | 4,313,116 | |
Net unrealized appreciation on investments | | | 1,040,733,458 | | 26,528,342 | |
NET ASSETS | $ | 3,640,822,654 | $ | 132,344,632 | |
* Identified cost | $ | | 2,586,380,020(a) | $ | 101,728,654 | (b) |
** Identified cost | $ | | 2,970,741(a) | $ | 345,713 | (b) |
| | | | | | |
See Notes to Financial Statements.- 38 -
THE ALGER INSTITUTIONAL FUNDS
Statement of Assets and Liabilities October 31, 2017 (Continued)
| | | | |
| | Alger Capital | | Alger Capital |
| | Appreciation | | Appreciation |
| Institutional Fund | | Focus Fund |
|
NET ASSETS BY CLASS: | | | | |
Class A | $ | — | $ | 23,692,504 |
Class C | $ | — | $ | 18,660,193 |
Class I | $ | 2,451,822,441 | $ | 23,952,292 |
Class R | $ | 654,966,341 | $ | — |
Class Y | $ | 97,889,066 | $ | 4,318,592 |
Class Z | $ | — | $ | 61,721,051 |
Class Z-2 | $ | 436,144,806 | $ | — |
|
SHARES OF BENEFICIAL INTEREST OUTSTANDING — NOTE 6: | | |
Class A | | — | | 746,542 |
Class C | | — | | 609,954 |
Class I | | 72,190,509 | | 751,292 |
Class R | | 21,333,834 | | — |
Class Y | | 2,874,873 | | 133,574 |
Class Z | | — | | 1,911,773 |
Class Z-2 | | 12,798,834 | | — |
|
NET ASSET VALUE PER SHARE: | | | | |
Class A — Net Asset Value Per Share Class A | $ | — | $ | 31.74 |
Class A — Offering Price Per Share | | | | |
(includes a 5.25% sales charge) | $ | — | $ | 33.49 |
Class C — Net Asset Value Per Share Class C | $ | — | $ | 30.59 |
Class I — Net Asset Value Per Share Class I | $ | 33.96 | $ | 31.88 |
Class R — Net Asset Value Per Share Class R | $ | 30.70 | $ | — |
Class Y — Net Asset Value Per Share Class Y | $ | 34.05 | $ | 32.33 |
Class Z — Net Asset Value Per Share Class Z | $ | — | $ | 32.28 |
Class Z-2 — Net Asset Value Per Share Class Z-2 | $ | 34.08 | $ | — |
| | | | |
See Notes to Financial Statements.(a) At October 31, 2017, the net unrealized appreciation on investments, based on cost for federal income tax purposes of
$2,615,010,391, amounted to $1,015,143,030 which consisted of aggregate gross unrealized appreciation of
$1,059,568,209 and aggregate gross unrealized depreciation of $44,425,179.
(b) At October 31, 2017, the net unrealized appreciation on investments, based on cost for federal income tax purposes of
$102,940,100, amounted to $25,662,609 which consisted of aggregate gross unrealized appreciation of $27,938,298
and aggregate gross unrealized depreciation of $2,275,689.
- 39 -
THE ALGER INSTITUTIONAL FUNDS
Statement of Assets and Liabilities October 31, 2017 (Continued)
| | | | | | |
| | Alger Mid | | | Alger Small | |
| | Cap Growth | | | Cap Growth | |
| Institutional Fund | | Institutional Fund | |
|
ASSETS: | | | | | | |
Investments in unaffiliated securities, at value (Identified cost | | | | | | |
below)* | | | | | | |
see accompanying schedules of investments | $ | 103,086,273 | | $ | 204,243,698 | |
Investments in affiliated securities, at value (Identified cost | | | | | | |
below)** see accompanying schedules of investments | | 517,948 | | | 415,781 | |
Cash and cash equivalents | | 5,690,657 | | | 4,934,292 | |
Receivable for investment securities sold | | 6,423,174 | | | — | |
Receivable for shares of beneficial interest sold | | 48,840 | | | 260,562 | |
Dividends and interest receivable | | 18,130 | | | 4,380 | |
Receivable from Investment Manager | | 296 | | | 1,903 | |
Receivable for escrow, at value (Identified cost below) *** | | 486,113 | | | 607,526 | |
Prepaid expenses | | 34,832 | | | 33,002 | |
Total Assets | | 116,306,263 | | | 210,501,144 | |
|
LIABILITIES: | | | | | | |
Payable for investment securities purchased | | 7,980,771 | | | 208,065 | |
Payable for shares of beneficial interest redeemed | | 460,355 | | | 874,269 | |
Accrued investment advisory fees | | 71,373 | | | 147,735 | |
Accrued transfer agent fees | | 41,293 | | | 70,950 | |
Accrued distribution fees | | 6,020 | | | 5,028 | |
Accrued administrative fees | | 2,583 | | | 5,016 | |
Accrued shareholder servicing fees | | 21,576 | | | 30,846 | |
Accrued shareholder administrative fees | | 939 | | | 1,824 | |
Accrued other expenses | | 78,119 | | | 109,500 | |
Total Liabilities | | 8,663,029 | | | 1,453,233 | |
NET ASSETS | $ | 107,643,234 | | $ | 209,047,911 | |
|
NET ASSETS CONSIST OF: | | | | | | |
Paid in capital (par value of $. 001 per share) | | 101,592,854 | | | 140,073,921 | |
Undistributed net investment income (accumulated loss) | | (610,145 | ) | | (1,549,751 | ) |
Undistributed net realized gain (accumulated realized loss) | | 29,556 | | | 2,804,750 | |
Net unrealized appreciation on investments | | 6,630,969 | | | 67,718,991 | |
NET ASSETS | $ | 107,643,234 | | $ | 209,047,911 | |
* Identified cost | $ | 96,464,682(a) | | $ | 136,850,551 | (b) |
** Identified cost | $ | 915,216(a) | | $ | 599,684 | (b) |
*** Identified cost escrow receivable | $ | 77,404(a) | | $ | 97,779 | (b) |
| | | | | | |
See Notes to Financial Statements.- 40 -
THE ALGER INSTITUTIONAL FUNDS
Statement of Assets and Liabilities October 31, 2017 (Continued)
| | | | |
| | Alger Mid | | Alger Small |
| | Cap Growth | | Cap Growth |
| Institutional Fund | Institutional Fund |
|
NET ASSETS BY CLASS: | | | | |
Class I | $ | 85,889,653 | $ | 130,526,657 |
Class R | $ | 12,943,160 | $ | 11,253,410 |
Class Z-2 | $ | 8,810,421 | $ | 67,267,844 |
|
SHARES OF BENEFICIAL INTEREST OUTSTANDING — NOTE 6: | | |
Class I | | 2,997,990 | | 6,361,839 |
Class R | | 491,287 | | 645,368 |
Class Z-2 | | 306,769 | | 3,265,229 |
|
NET ASSET VALUE PER SHARE: | | | | |
Class I — Net Asset Value Per Share Class I | $ | 28.65 | $ | 20.52 |
Class R — Net Asset Value Per Share Class R | $ | 26.35 | $ | 17.44 |
Class Z-2 — Net Asset Value Per Share Class Z-2 | $ | 28.72 | $ | 20.60 |
| | | | |
See Notes to Financial Statements.(a) At October 31, 2017, the net unrealized appreciation on investments, based on cost for federal income tax purposes of
$97,428,633, amounted to $6,661,701 which consisted of aggregate gross unrealized appreciation of $8,221,813
and aggregate gross unrealized depreciation of $1,560,112.
(b) At October 31, 2017, the net unrealized appreciation on investments, based on cost for federal income tax purposes of
$140,148,802, amounted to $65,118,203 which consisted of aggregate gross unrealized appreciation of $71,979,927
and aggregate gross unrealized depreciation of $6,861,724.
- 41 -
THE ALGER INSTITUTIONAL FUNDS
Statement of Operations For the year ended October 31, 2017
| | | | | | |
| | Alger Capital | | | Alger Capital | |
| | Appreciation | | | Appreciation | |
| Institutional Fund | | | Focus Fund | |
|
INCOME: | | | | | | |
Dividends (net of foreign withholding taxes*) | $ | 38,985,135 | | $ | 1,113,497 | |
Interest from unaffiliated securities | | 190,713 | | | 16,289 | |
Interest from affiliated securities – Note 11 | | 11,368 | | | | |
Total Income | | 39,187,216 | | | 1,129,786 | |
|
EXPENSES: | | | | | | |
Advisory fees — Note 3(a) | | 25,237,037 | | | 559,134 | |
Distribution fees — Note 3(c) | | | | | | |
Class A | | — | | | 54,108 | |
Class C | | — | | | 164,091 | |
Class R | | 3,046,915 | | | — | |
Shareholder servicing fees — Note 3(k) | | 7,736,336 | | | 54,082 | |
Shareholder administrative fees — Note 3(f) | | 342,284 | | | 12,639 | |
Administration fees — Note 3(b) | | 941,281 | | | 27,957 | |
Custodian fees | | 197,704 | | | 38,797 | |
Interest expenses | | 4,226 | | | 272 | |
Transfer agent fees and expenses — Note 3(f) | | 2,152,420 | | | 52,189 | |
Printing fees | | 261,200 | | | 35,200 | |
Professional fees | | 211,595 | | | 49,593 | |
Registration fees | | 92,183 | | | 61,425 | |
Trustee fees — Note 3(g) | | 143,343 | | | 4,373 | |
Fund accounting fees | | 439,426 | | | 18,879 | |
Miscellaneous | | 261,471 | | | 15,078 | |
Total Expenses | | 41,067,421 | | | 1,147,817 | |
Less, expense reimbursements/waivers — Note 3(a) | | (17,543 | ) | | (2,763 | ) |
Net Expenses | | 41,049,878 | | | 1,145,054 | |
NET INVESTMENT LOSS | | (1,862,662 | ) | | (15,268 | ) |
|
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN | |
CURRENCY: | | | | | | |
Net realized gain on unaffiliated investments | | 263,525,602 | | | 8,631,002 | |
Net realized (loss) on foreign currency transactions | | (6,565 | ) | | — | |
Net change in unrealized appreciation on unaffiliated | | | | | | |
investments | | 614,762,984 | | | 20,161,980 | |
Net change in unrealized (depreciation) on affiliated | | | | | | |
investments | | (2,613,149 | ) | | (70,680 | ) |
Net realized and unrealized gain on investments and foreign | | | | | | |
currency | | 875,668,872 | | | 28,722,302 | |
NET INCREASE IN NET ASSETS RESULTING | | | | | | |
FROM OPERATIONS | $ | 873,806,210 | | $ | 28,707,034 | |
* Foreign withholding taxes | $ | (68,292 | ) | $ | — | |
| | | | | | |
See Notes to Financial Statements.- 42 -
THE ALGER INSTITUTIONAL FUNDS
Statement of Operations For the year ended October 31, 2017 (Continued)
| | | | | | |
| | Alger Mid | | | Alger Small | |
| | Cap Growth | | | Cap Growth | |
| Institutional Fund | | Institutional Fund | |
|
INCOME: | | | | | | |
Dividends (net of foreign withholding taxes*) | $ | 755,585 | | $ | 989,671 | |
Interest from unaffiliated securities | | 19,015 | | | 15,076 | |
Interest from affiliated securities – Note 11 | | 337 | | | — | |
Total Income | | 774,937 | | | 1,004,747 | |
|
EXPENSES: | | | | | | |
Advisory fees — Note 3(a) | | 762,410 | | | 1,535,176 | |
Distribution fees — Note 3(c) | | | | | | |
Class R | | 66,536 | | | 59,803 | |
Shareholder servicing fees — Note 3(k) | | 237,287 | | | 334,080 | |
Shareholder administrative fees — Note 3(f) | | 10,032 | | | 18,953 | |
Administration fees — Note 3(b) | | 27,587 | | | 52,120 | |
Custodian fees | | 40,561 | | | 28,985 | |
Interest expenses | | 371 | | | 1,738 | |
Transfer agent fees and expenses — Note 3(f) | | 76,158 | | | 110,094 | |
Printing fees | | 7,469 | | | 34,975 | |
Professional fees | | 62,350 | | | 67,559 | |
Registration fees | | 7,349 | | | 79,854 | |
Trustee fees — Note 3(g) | | 4,171 | | | 7,872 | |
Fund accounting fees | | 15,953 | | | 26,779 | |
Miscellaneous | | 26,297 | | | 43,457 | |
Total Expenses | | 1,344,531 | | | 2,401,445 | |
Less, expense reimbursements/waivers — Note 3(a) | | (4,607 | ) | | (21,769 | ) |
Net Expenses | | 1,339,924 | | | 2,379,676 | |
NET INVESTMENT LOSS | | (564,987 | ) | | (1,374,929 | ) |
|
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND ESCROW | |
RECEIVABLE: | | | | | | |
Net realized gain on unaffiliated investments | | 23,865,772 | | | 13,341,081 | |
Net change in unrealized appreciation on unaffiliated | | | | | | |
investments and escrow receivable | | 4,464,629 | | | 49,157,496 | |
Net change in unrealized appreciation on affiliated | | | | | | |
investments | | 340,465 | | | 651,181 | |
Net realized and unrealized gain on investments and escrow | | | | | | |
receivable | | 28,670,866 | | | 63,149,758 | |
NET INCREASE IN NET ASSETS RESULTING | | | | | | |
FROM OPERATIONS | $ | 28,105,879 | | $ | 61,774,829 | |
* Foreign withholding taxes | $ | 428 | | $ | — | |
| | | | | | |
See Notes to Financial Statements.- 43 -
THE ALGER INSTITUTIONAL FUNDS
Statements of Changes in Net Assets
| | | | | | | | |
| | | | Alger Capital Appreciation | |
| | | | Institutional Fund | |
| | | | For the | | | For the | |
| | | | Year Ended | | | Year Ended | |
| | | | October 31, 2017 | | | October 31, 2016 | |
|
Net investment loss | | $ | (1,862,662 | ) | $ | (201,055 | ) |
Net realized gain on investments and foreign currency | | | | 263,519,037 | | | 37,343,440 | |
Net change in unrealized appreciation (depreciation) on | | | | | | | | |
investments and foreign currency | | | | 612,149,835 | | | (44,333,940 | ) |
Net increase (decrease) in net assets resulting from operations | | | | 873,806,210 | | | (7,191,555 | ) |
|
Dividends and distributions to shareholders from: | | | | | | | | |
Net realized gains: | | | | | | | | |
Class I | | | | (19,820,400 | ) | | (229,560,756 | ) |
Class R | | | | (4,624,888 | ) | | (50,476,174 | ) |
Class Z-2 | | | | (1,189,367 | ) | | — | |
Total dividends and distributions to shareholders | | | | (25,634,655 | ) | | (280,036,930 | ) |
|
Increase (decrease) from shares of beneficial interest transactions: | | | | | | |
Class I | | | | (1,124,431,159 | ) | | 2,523,291 | |
Class R | | | | (72,815,333 | ) | | (22,254,736 | ) |
Class Y | | | | 92,176,269 | | | — | |
Class Z-2 | | | | 351,709,750 | | | 2,241,803 | |
Net decrease from shares of beneficial interest transactions | | | | | | | | |
— Note 6(a) | | | | (753,360,473 | ) | | (17,489,642 | ) |
Total increase (decrease) | | | | 94,811,082 | | | (304,718,127 | ) |
|
Net Assets: | | | | | | | | |
Beginning of period | | | | 3,546,011,572 | | | 3,850,729,699 | |
END OF PERIOD | $ | 3,640,822,654 | | $ | 3,546,011,572 | |
Undistributed net investment income (accumulated loss) | $ | | 649,644 | | $ | (1,995,590 | ) |
See Notes to Financial Statements. | | | | | | | | |
- 44 -
THE ALGER INSTITUTIONAL FUNDS
Statements of Changes in Net Assets (Continued)
| | | | | | | |
| | Alger Capital Appreciation Focus | |
| | | Fund | | |
| | | For the | | | For the | |
| | | Year Ended | | | Year Ended | |
| | | October 31, 2017 | | | October 31, 2016 | |
|
Net investment loss | $ | (15,268 | ) | $ | (126,586 | ) |
Net realized gain (loss) on investments and foreign currency | | | 8,631,002 | | | (2,931,971 | ) |
Net change in unrealized appreciation on investments and | | | | | | | |
foreign currency | | | 20,091,300 | | | 3,016,621 | |
Net increase (decrease) in net assets resulting from operations | | | 28,707,034 | | | (41,936 | ) |
|
Dividends and distributions to shareholders from: | | | | | | | |
Net realized gains: | | | | | | | |
Class A | | | — | | | (316,452 | ) |
Class C | | | — | | | (87,313 | ) |
Class I | | | — | | | (274,831 | ) |
Class Z | | | — | | | (120,412 | ) |
Total dividends and distributions to shareholders | | | — | | | (799,008 | ) |
|
Increase (decrease) from shares of beneficial interest transactions: | | | | | | |
Class A | | | (7,858,588 | ) | | 1,889,920 | |
Class C | | | 2,099,824 | | | 5,527,847 | |
Class I | | | (4,667,192 | ) | | (1,671,101 | ) |
Class Y | | | 4,131,666 | | | — | |
Class Z | | | 34,166,838 | | | 12,186,549 | |
Net increase from shares of beneficial interest transactions — | | | | | | | |
Note 6(a) | | | 27,872,548 | | | 17,933,215 | |
Total increase | | | 56,579,582 | | | 17,092,271 | |
|
Net Assets: | | | | | | | |
Beginning of period | | | 75,765,050 | | | 58,672,779 | |
END OF PERIOD | $ | 132,344,632 | | $ | 75,765,050 | |
Undistributed net investment income (accumulated loss) | $ | 54,619 | | $ | (201,584 | ) |
| | | | | | | |
See Notes to Financial Statements.- 45 -
THE ALGER INSTITUTIONAL FUNDS
Statements of Changes in Net Assets (Continued)
| | | | | | | |
| | Alger Mid Cap Growth Institutional | |
| | | Fund | | |
| | | For the | | | For the | |
| | | Year Ended | | | Year Ended | |
| | | October 31, 2017 | | | October 31, 2016 | |
|
Net investment loss | $ | (564,987 | ) | $ | (358,218 | ) |
Net realized gain (loss) on investments and foreign currency | | | 23,865,772 | | | (1,167,951 | ) |
Net change in unrealized appreciation (depreciation) on | | | | | | | |
investments and escrow receivable | | | 4,805,094 | | | (3,985,970 | ) |
Net increase (decrease) in net assets resulting from operations | | | 28,105,879 | | | (5,512,139 | ) |
|
Increase (decrease) from shares of beneficial interest transactions: | | | | | | |
Class I | | | (18,928,722 | ) | | (28,525,268 | ) |
Class R | | | (3,822,468 | ) | | (3,868,604 | ) |
Class Z-2 | | | 7,301,003 | | | 115,000 | |
Net decrease from shares of beneficial interest transactions | | | | | | | |
— Note 6(a) | | | (15,450,187 | ) | | (32,278,872 | ) |
Total increase (decrease) | | | 12,655,692 | | | (37,791,011 | ) |
|
Net Assets: | | | | | | | |
Beginning of period | | | 94,987,542 | | | 132,778,553 | |
END OF PERIOD | $ | 107,643,234 | | $ | 94,987,542 | |
Undistributed net investment income (accumulated loss) | $ | (610,145 | ) | $ | (414,655 | ) |
See Notes to Financial Statements. | | | | | | | |
- 46 -
THE ALGER INSTITUTIONAL FUNDS
Statements of Changes in Net Assets (Continued)
| | | | | | | |
| Alger Small Cap Growth Institutional | |
| | | Fund | | |
| | | For the | | | For the | |
| | | Year Ended | | | Year Ended | |
| | | October 31, 2017 | | | October 31, 2016 | |
|
Net investment loss | $ | (1,374,929 | ) | $ | (1,823,495 | ) |
Net realized gain (loss) on investments and foreign currency | | | 13,341,081 | | | (4,997,816 | ) |
Net change in unrealized appreciation (depreciation) on | | | | | | | |
investments and escrow receivable | | | 49,808,677 | | | (11,918,205 | ) |
Net increase (decrease) in net assets resulting from operations | | | 61,774,829 | | | (18,739,516 | ) |
|
Dividends and distributions to shareholders from: | | | | | | | |
Net realized gains: | | | | | | | |
Class I | | | — | | | (112,158,310 | ) |
Class R | | | — | | | (6,331,284 | ) |
Total dividends and distributions to shareholders | | | — | | | (118,489,594 | ) |
|
Increase (decrease) from shares of beneficial interest transactions: | | | | | | |
Class I | | | (38,794,988 | ) | | (100,429,539 | ) |
Class R | | | (5,270,974 | ) | | 1,229,629 | |
Class Z-2 | | | 7,688,642 | | | 44,313,480 | |
Net decrease from shares of beneficial interest transactions | | | | | | | |
— Note 6(a) | | | (36,377,320 | ) | | (54,886,430 | ) |
Total increase (decrease) | | | 25,397,509 | | | (192,115,540 | ) |
|
Net Assets: | | | | | | | |
Beginning of period | | | 183,650,402 | | | 375,765,942 | |
END OF PERIOD | $ | 209,047,911 | | $ | 183,650,402 | |
Undistributed net investment income (accumulated loss) | $ | (1,549,751 | ) | $ | (1,414,336 | ) |
See Notes to Financial Statements. | | | | | | | |
- 47 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | | | | | | | | | | | | | | | |
Alger Capital Appreciation | | | | | | | | | | | | | | | | | | | | |
Institutional Fund | | | | | | | | | | | Class I | | | | | | | | | |
| | Year ended | | | Year ended | | | Year ended | | | Year ended | | | Year ended | |
| | 10/31/2017 | | | 10/31/2016 | | | 10/31/2015 | | | 10/31/2014 | | | 10/31/2013 | |
Net asset value, beginning of period | | $ | 26.44 | | | $ | 28.48 | | | $ | 29.34 | | | $ | 28.21 | | | $ | 22.85 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | | | | | | | | |
Net investment income (loss)(i) | | | – | | | | 0.02 | | | | (0.02 | ) | | | (0.02 | ) | | | 0.16 | |
Net realized and unrealized gain (loss) on | | | | | | | | | | | | | | | | | | | | |
investments | | | 7.71 | | | | (0.02 | ) | | | 2.46 | | | | 4.57 | | | | 6.21 | |
Total from investment operations | | | 7.71 | | | | – | | | | 2.44 | | | | 4.55 | | | | 6.37 | |
Dividends from net investment income | | | – | | | | – | | | | – | | | | (0.01 | ) | | | (0.17 | ) |
Distributions from net realized gains | | | (0.19 | ) | | | (2.04 | ) | | | (3.30 | ) | | | (3.41 | ) | | | (0.84 | ) |
Net asset value, end of period | | $ | 33.96 | | | $ | 26.44 | | | $ | 28.48 | | | $ | 29.34 | | | $ | 28.21 | |
Total return | | | 29.38 | % | | | (0.08 | )% | | | 8.96 | % | | | 17.63 | % | | | 29.02 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | | | | | | | | |
Net assets, end of period (000's omitted) | $ | 2,451,822 | | $ | 2,965,503 | | $ | 3,194,261 | | $ | 2,555,737 | | $ | 1,958,405 | |
Ratio of gross expenses to average net assets | | | 1.14 | % | | | 1.12 | % | | | 1.12 | % | | | 1.16 | % | | | 1.19 | % |
Ratio of net expenses to average net assets | | | 1.14 | % | | | 1.12 | % | | | 1.12 | % | | | 1.16 | % | | | 1.19 | % |
Ratio of net investment income (loss) to average | | | | | | | | | | | | | | | | | | | | |
net assets | | | 0.01 | % | | | 0.07 | % | | | (0.07 | )% | | | (0.07 | )% | | | 0.65 | % |
Portfolio turnover rate | | | 66.72 | % | | | 94.56 | % | | | 136.03 | %(ii) | | 136.20 | %(iii) | | | 124.43 | % |
See Notes to Financial Statements. | | | | | | | | | | | | | | | | | | | | |
(i) Amount was computed based on average shares outstanding during the period.
(ii) Amount excludes redemption in kind transaction of $294,638,130.
(iii) Amount excludes redemption in kind transaction of $71,436,408
- 48 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | | | | | | | | | | |
Alger Capital Appreciation | | | | | | | | | | | | | | | |
Institutional Fund | | | | | | | | Class R | | | | | | | |
| Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | | 10/31/2013 | |
Net asset value, beginning of period | $ | 24.03 | | $ | 26.19 | | $ | 27.35 | | $ | 26.63 | | $ | 21.76 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | | | |
Net investment income (loss)(i) | | (0.13 | ) | | (0.10 | ) | | (0.15 | ) | | (0.14 | ) | | 0.04 | |
Net realized and unrealized gain (loss) on | | | | | | | | | | | | | | | |
investments | | 6.99 | | | (0.02 | ) | | 2.29 | | | 4.27 | | | 5.87 | |
Total from investment operations | | 6.86 | | | (0.12 | ) | | 2.14 | | | 4.13 | | | 5.91 | |
Dividends from net investment income | | – | | | – | | | – | | | – | | | (0.20 | ) |
Distributions from net realized gains | | (0.19 | ) | | (2.04 | ) | | (3.30 | ) | | (3.41 | ) | | (0.84 | ) |
Net asset value, end of period | $ | 30.70 | | $ | 24.03 | | $ | 26.19 | | $ | 27.35 | | $ | 26.63 | |
Total return | | 28.78 | % | | (0.57 | )% | | 8.46 | % | | 17.04 | % | | 28.35 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | | | |
Net assets, end of period (000's omitted) | $ | 654,966 | | $ | 578,297 | | $ | 656,469 | | $ | 529,757 | | $ | 442,449 | |
Ratio of gross expenses to average net assets | | 1.62 | % | | 1.61 | % | | 1.61 | % | | 1.64 | % | | 1.69 | % |
Ratio of net expenses to average net assets | | 1.62 | % | | 1.61 | % | | 1.61 | % | | 1.64 | % | | 1.69 | % |
Ratio of net investment income (loss) to average | | | | | | | | | | | | | | | |
net assets | | (0.48 | )% | | (0.41 | )% | | (0.57 | )% | | (0.55 | )% | | 0.17 | % |
Portfolio turnover rate | | 66.72 | % | | 94.56 | % | | 136.03 | %(ii) | 136.20 | %(iii) | | 124.43 | % |
See Notes to Financial Statements. | | | | | | | | | | | | | | | |
(i) Amount was computed based on average shares outstanding during the period.
(ii) Amount excludes redemption in kind transaction of $294,638,130.
(iii) Amount excludes redemption in kind transaction of $71,436,408
- 49 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | |
Alger Capital Appreciation | | | |
Institutional Fund | | Class Y | |
| From 2/28/2017 | |
| (commencement | |
| of operations) to | |
| 10/31/2017 | (i) |
Net asset value, beginning of period | $ | 28.85 | |
INCOME FROM INVESTMENT OPERATIONS: | | | |
Net investment income(ii) | | 0.02 | |
Net realized and unrealized gain on investments | 5.18 | |
Total from investment operations | | 5.20 | |
Net asset value, end of period | $ | 34.05 | |
Total return | | 18.02 | % |
RATIOS/SUPPLEMENTAL DATA: | | | |
Net assets, end of period (000's omitted) | $ | 97,889 | |
Ratio of gross expenses to average net assets | | 0.85 | % |
Ratio of expense reimbursements to average | | | |
net assets | | (0.10 | )% |
Ratio of net expenses to average net assets | | 0.75 | % |
Ratio of net investment income (loss) to average | | | |
net assets | | 0.10 | % |
Portfolio turnover rate | | 66.72 | % |
See Notes to Financial Statements. | | | |
(i) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(ii) Amount was computed based on average shares outstanding during the period.
- 50 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | |
Alger Capital Appreciation | | | | | | |
Institutional Fund | | Class Z-2 | |
| | | | From 10/14/2016 | |
| Year ended | | | (commencement of operations) to | |
| 10/31/2017 | | 10/31/2016 (i) | |
Net asset value, beginning of period | $ | 26.44 | | $ | 26.67 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | |
Net investment income(ii) | | 0.07 | | | 0.01 | |
Net realized and unrealized gain (loss) on | | | | | | |
investments | | 7.76 | | | (0.24 | ) |
Total from investment operations | | 7.83 | | | (0.23 | ) |
Distributions from net realized gains | | (0.19 | ) | | – | |
Net asset value, end of period | $ | 34.08 | | $ | 26.44 | |
Total return | | 29.83 | % | | (0.86 | )% |
RATIOS/SUPPLEMENTAL DATA: | | | | | | |
Net assets, end of period (000's omitted) | $ | 436,145 | | $ | 2,212 | |
Ratio of gross expenses to average net assets | | 0.84 | % | | 3.11 | % |
Ratio of expense reimbursements to average | | | | | | |
net assets | | – | | | (2.16 | )% |
Ratio of net expenses to average net assets | | 0.84 | % | | 0.95 | % |
Ratio of net investment income (loss) to average | | | | | | |
net assets | | 0.22 | % | | 1.29 | % |
Portfolio turnover rate | | 66.72 | % | | 94.56 | % |
See Notes to Financial Statements. | | | | | | |
(i) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(ii) Amount was computed based on average shares outstanding during the period.
- 51 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | | | | | | | | | | |
Alger Capital Appreciation Focus | | | | | | | | | | | | | | | |
Fund | | | | | | | | Class A | | | | | | | |
| | | | | | | | | | | | | From 12/31/2012 | |
Year ended | | | Year ended | | | Year ended | | | Year ended | | | (commencement of operations) to | |
| | 10/31/2017 | | | 10/31/2016 | | | 10/31/2015 | | | 10/31/2014 | | | 10/31/2013(i) | |
Net asset value, beginning of period | $ | 23.95 | | $ | 24.13 | | $ | 22.01 | | $ | 18.69 | | $ | 14.70 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | | | |
Net investment income (loss)(ii) | | 0.01 | | | (0.03 | ) | | (0.02 | ) | | (0.04 | ) | | (0.01 | ) |
Net realized and unrealized gain on investments | 7.78 | | | 0.12 | | | 2.14 | | | 3.36 | | | 4.00 | |
Total from investment operations | | 7.79 | | | 0.09 | | | 2.12 | | | 3.32 | | | 3.99 | |
Distributions from net realized gains | | – | | | (0.27 | ) | | – | | | – | | | – | |
Net asset value, end of period | $ | 31.74 | | $ | 23.95 | | $ | 24.13 | | $ | 22.01 | | $ | 18.69 | |
Total return(iii) | | 32.53 | % | | 0.36 | % | | 9.63 | % | | 17.76 | % | | 27.14 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | | | |
Net assets, end of period (000's omitted) | $ | 23,693 | | $ | 25,524 | | $ | 23,961 | | $ | 5,158 | | $ | 3,496 | |
Ratio of gross expenses to average net assets | | 1.11 | % | | 1.26 | % | | 1.48 | % | | 2.38 | % | | 2.49 | % |
Ratio of expense reimbursements to average | | | | | | | | | | | | | | | |
net assets | | – | | | (0.07 | )% | | (0.18 | )% | | (1.08 | )% | | (1.19 | )% |
Ratio of net expenses to average net assets | | 1.11 | % | | 1.19 | % | | 1.30 | % | | 1.30 | % | | 1.30 | % |
Ratio of net investment income (loss) to average | | | | | | | | | | | | | | | |
net assets | | 0.03 | % | | (0.13 | )% | | (0.08 | )% | | (0.19 | )% | | (0.09 | )% |
Portfolio turnover rate | | 98.57 | % | | 127.40 | % | | 182.58 | % | | 153.69 | % | | 166.61 | % |
See Notes to Financial Statements. | | | | | | | | | | | | | | | |
(i) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(ii) Amount was computed based on average shares outstanding during the period.
(iii) Does not reflect the effect of sales charges, if applicable.
- 52 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | | | | | | | | | | |
Alger Capital Appreciation Focus | | | | | | | | | | | | | | | |
Fund | | | | | | | | Class C | | | | | | | |
| | | | | | | | | | | | | From 12/31/2012 | |
| | Year ended | | | Year ended | | | Year ended | | | Year ended | | (commencement of operations) to | |
| | 10/31/2017 | | | 10/31/2016 | | | 10/31/2015 | | | 10/31/2014 | | 10/31/2013 (i) | |
Net asset value, beginning of period | $ | 23.27 | | $ | 23.62 | | $ | 21.71 | | $ | 18.58 | | $ | 14.70 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | | | |
Net investment loss(ii) | | (0.21 | ) | | (0.20 | ) | | (0.20 | ) | | (0.19 | ) | | (0.11 | ) |
Net realized and unrealized gain on investments | 7.53 | | | 0.12 | | | 2.11 | | | 3.32 | | | 3.99 | |
Total from investment operations | | 7.32 | | | (0.08 | ) | | 1.91 | | | 3.13 | | | 3.88 | |
Distributions from net realized gains | | – | | | (0.27 | ) | | – | | | – | | | – | |
Net asset value, end of period | $ | 30.59 | | $ | 23.27 | | $ | 23.62 | | $ | 21.71 | | $ | 18.58 | |
Total return(iii) | | 31.46 | % | | (0.36 | )% | | 8.80 | % | | 16.85 | % | | 26.39 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | | | |
Net assets, end of period (000's omitted) | $ | 18,660 | | $ | 12,021 | | $ | 6,542 | | $ | 2,635 | | $ | 1,913 | |
Ratio of gross expenses to average net assets | | 1.90 | % | | 2.03 | % | | 2.25 | % | | 3.14 | % | | 3.27 | % |
Ratio of expense reimbursements to average | | | | | | | | | | | | | | | |
net assets | | – | | | (0.10 | )% | | (0.20 | )% | | (1.09 | )% | | (1.22 | )% |
Ratio of net expenses to average net assets | | 1.90 | % | | 1.93 | % | | 2.05 | % | | 2.05 | % | | 2.05 | % |
Ratio of net investment income (loss) to average | | | | | | | | | | | | | | | |
net assets | | (0.79 | )% | | (0.87 | )% | | (0.85 | )% | | (0.94 | )% | | (0.83 | )% |
Portfolio turnover rate | | 98.57 | % | | 127.40 | % | | 182.58 | % | | 153.69 | % | | 166.61 | % |
See Notes to Financial Statements. | | | | | | | | | | | | | | | |
(i) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(ii) Amount was computed based on average shares outstanding during the period.
(iii) Does not reflect the effect of sales charges, if applicable.
- 53 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | | | | | | | | | | |
Alger Capital Appreciation Focus | | | | | | | | | | | | | | | |
Fund | | | | | | | | Class I | | | | | | | |
| Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | | 10/31/2013 | |
Net asset value, beginning of period | $ | 24.06 | | $ | 24.23 | | $ | 22.07 | | $ | 18.72 | | $ | 14.53 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | | | |
Net investment income (loss)(i) | | 0.01 | | | (0.02 | ) | | 0.01 | | | (0.01 | ) | | 0.15 | |
Net realized and unrealized gain on investments | 7.81 | | | 0.12 | | | 2.15 | | | 3.36 | | | 4.04 | |
Total from investment operations | | 7.82 | | | 0.10 | | | 2.16 | | | 3.35 | | | 4.19 | |
Distributions from net realized gains | | – | | | (0.27 | ) | | – | | | – | | | – | |
Net asset value, end of period | $ | 31.88 | | $ | 24.06 | | $ | 24.23 | | $ | 22.07 | | $ | 18.72 | |
Total return(ii) | | 32.50 | % | | 0.40 | % | | 9.79 | % | | 17.90 | % | | 28.84 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | | | |
Net assets, end of period (000's omitted) | $ | 23,952 | | $ | 22,527 | | $ | 24,487 | | $ | 12,897 | | $ | 8,684 | |
Ratio of gross expenses to average net assets | | 1.12 | % | | 1.30 | % | | 1.49 | % | | 2.36 | % | | 2.32 | % |
Ratio of expense reimbursements to average | | | | | | | | | | | | | | | |
net assets | | – | | | (0.15 | )% | | (0.34 | )% | | (1.21 | )% | | (0.94 | )% |
Ratio of net expenses to average net assets | | 1.12 | % | | 1.15 | % | | 1.15 | % | | 1.15 | % | | 1.38 | % |
Ratio of net investment income (loss) to average | | | | | | | | | | | | | | | |
net assets | | 0.02 | % | | (0.09 | )% | | 0.03 | % | | (0.04 | )% | | 0.95 | % |
Portfolio turnover rate | | 98.57 | % | | 127.40 | % | | 182.58 | % | | 153.69 | % | | 166.61 | % |
See Notes to Financial Statements. | | | | | | | | | | | | | | | |
(i) Amount was computed based on average shares outstanding during the period.
(ii) Does not reflect the effect of sales charges, if applicable.
- 54 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | |
Alger Capital Appreciation Focus | | | |
Fund | | Class Y | |
| From 2/28/2017 | |
| (commencement | |
| of operations) to | |
| 10/31/2017 | (i) |
Net asset value, beginning of period | $ | 26.86 | |
INCOME FROM INVESTMENT OPERATIONS: | | | |
Net investment loss(ii) | | (0.01 | ) |
Net realized and unrealized gain on investments | 5.48 | |
Total from investment operations | | 5.47 | |
Net asset value, end of period | $ | 32.33 | |
Total return(iii) | | 20.36 | % |
RATIOS/SUPPLEMENTAL DATA: | | | |
Net assets, end of period (000's omitted) | $ | 4,319 | |
Ratio of gross expenses to average net assets | | 1.51 | % |
Ratio of expense reimbursements to average | | | |
net assets | | (0.86 | )% |
Ratio of net expenses to average net assets | | 0.65 | % |
Ratio of net investment income (loss) to average | | | |
net assets | | (0.05 | )% |
Portfolio turnover rate | | 98.57 | % |
See Notes to Financial Statements. | | | |
(i) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(ii) Amount was computed based on average shares outstanding during the period.
(iii) Does not reflect the effect of sales charges, if applicable.
- 55 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | | | | | | | | | | |
Alger Capital Appreciation Focus | | | | | | | | | | | | | | | |
Fund | | | | | | | | Class Z | | | | | | | |
| | | | | | | | | | | | | From 12/31/2012 | |
| | Year ended | | | Year ended | | | Year ended | | | Year ended | | | (commencement of operations) to | |
| | 10/31/2017 | | | 10/31/2016 | | | 10/31/2015 | | | 10/31/2014 | | 10/31/2013(i) | |
Net asset value, beginning of period | $ | 24.30 | | $ | 24.41 | | $ | 22.17 | | $ | 18.75 | | $ | 14.70 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | | | |
Net investment income(ii) | | 0.07 | | | 0.03 | | | 0.07 | | | 0.05 | | | 0.04 | |
Net realized and unrealized gain on investments | 7.91 | | | 0.13 | | | 2.17 | | | 3.37 | | | 4.01 | |
Total from investment operations | | 7.98 | | | 0.16 | | | 2.24 | | | 3.42 | | | 4.05 | |
Distributions from net realized gains | | – | | | (0.27 | ) | | – | | | – | | | – | |
Net asset value, end of period | $ | 32.28 | | $ | 24.30 | | $ | 24.41 | | $ | 22.17 | | $ | 18.75 | |
Total return(iii) | | 32.84 | % | | 0.64 | % | | 10.10 | % | | 18.24 | % | | 27.55 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | | | |
Net assets, end of period (000's omitted) | $ | 61,721 | | $ | 15,693 | | $ | 3,683 | | $ | 1,262 | | $ | 128 | |
Ratio of gross expenses to average net assets | | 0.84 | % | | 1.05 | % | | 1.50 | % | | 4.78 | % | | 10.11 | % |
Ratio of expense reimbursements to average | | | | | | | | | | | | | | | |
net assets | | – | | | (0.12 | )% | | (0.61 | )% | | (3.89 | )% | | (9.22 | )% |
Ratio of net expenses to average net assets | | 0.84 | % | | 0.93 | % | | 0.89 | % | | 0.89 | % | | 0.89 | % |
Ratio of net investment income (loss) to average | | | | | | | | | | | | | | | |
net assets | | 0.25 | % | | 0.12 | % | | 0.30 | % | | 0.23 | % | | 0.32 | % |
Portfolio turnover rate | | 98.57 | % | | 127.40 | % | | 182.58 | % | | 153.69 | % | | 166.61 | % |
See Notes to Financial Statements. | | | | | | | | | | | | | | | |
(i) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(ii) Amount was computed based on average shares outstanding during the period.
(iii) Does not reflect the effect of sales charges, if applicable.
- 56 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | | | | | | | | | | |
Alger Mid Cap Growth Institutional | | | | | | | | | | | | | | | |
Fund | | | | | | | | Class I | | | | | | | |
| Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | | 10/31/2013 | |
Net asset value, beginning of period | $ | 21.59 | | $ | 22.54 | | $ | 22.18 | | $ | 19.43 | | $ | 14.59 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | | | |
Net investment loss(i) | | (0.13 | ) | | (0.05 | ) | | (0.13 | ) | | (0.07 | ) | | (0.03 | ) |
Net realized and unrealized gain (loss) on | | | | | | | | | | | | | | | |
investments | | 7.19 | | | (0.90 | ) | | 0.49 | | | 2.82 | | | 4.91 | |
Total from investment operations | | 7.06 | | | (0.95 | ) | | 0.36 | | | 2.75 | | | 4.88 | |
Dividends from net investment income | | – | | | – | | | – | | | – | | | (0.04 | ) |
Net asset value, end of period | $ | 28.65 | | $ | 21.59 | | $ | 22.54 | | $ | 22.18 | | $ | 19.43 | |
Total return | | 32.70 | % | | (4.21 | )% | | 1.62 | % | | 14.15 | % | | 33.41 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | | | |
Net assets, end of period (000's omitted) | $ | 85,890 | | $ | 81,782 | | $ | 114,984 | | $ | 132,426 | | $ | 157,391 | |
Ratio of gross expenses to average net assets | | 1.28 | % | | 1.25 | % | | 1.20 | % | | 1.30 | % | | 1.29 | % |
Ratio of net expenses to average net assets | | 1.28 | % | | 1.25 | % | | 1.20 | % | | 1.30 | % | | 1.29 | % |
Ratio of net investment income (loss) to average | | | | | | | | | | | | | | | |
net assets | | (0.50 | )% | | (0.24 | )% | | (0.55 | )% | | (0.32 | )% | | (0.19 | )% |
Portfolio turnover rate | | 157.49 | % | | 95.75 | % | | 120.97 | % | | 192.15 | % | | 153.89 | % |
See Notes to Financial Statements. | | | | | | | | | | | | | | | |
(i) Amount was computed based on average shares outstanding during the period.
- 57 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | | | | | | | | | | |
Alger Mid Cap Growth Institutional | | | | | | | | | | | | | | | |
Fund | | | | | | | | Class R | | | | | | | |
| Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | | 10/31/2013 | |
Net asset value, beginning of period | $ | 19.96 | | $ | 20.96 | | $ | 20.74 | | $ | 18.26 | | $ | 13.81 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | | | |
Net investment loss(i) | | (0.24 | ) | | (0.16 | ) | | (0.23 | ) | | (0.16 | ) | | (0.11 | ) |
Net realized and unrealized gain (loss) on | | | | | | | | | | | | | | | |
investments | | 6.63 | | | (0.84 | ) | | 0.45 | | | 2.64 | | | 4.63 | |
Total from investment operations | | 6.39 | | | (1.00 | ) | | 0.22 | | | 2.48 | | | 4.52 | |
Dividends from net investment income | | – | | | – | | | – | | | – | | | (0.07 | ) |
Net asset value, end of period | $ | 26.35 | | $ | 19.96 | | $ | 20.96 | | $ | 20.74 | | $ | 18.26 | |
Total return | | 32.01 | % | | (4.82 | )% | | 1.11 | % | | 13.58 | % | | 32.83 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | | | |
Net assets, end of period (000's omitted) | $ | 12,943 | | $ | 13,093 | | $ | 17,795 | | $ | 21,953 | | $ | 23,599 | |
Ratio of gross expenses to average net assets | | 1.81 | % | | 1.82 | % | | 1.74 | % | | 1.80 | % | | 1.79 | % |
Ratio of net expenses to average net assets | | 1.81 | % | | 1.82 | % | | 1.74 | % | | 1.80 | % | | 1.79 | % |
Ratio of net investment income (loss) to average | | | | | | | | | | | | | | | |
net assets | | (1.04 | )% | | (0.81 | )% | | (1.08 | )% | | (0.82 | )% | | (0.69 | )% |
Portfolio turnover rate | | 157.49 | % | | 95.75 | % | | 120.97 | % | | 192.15 | % | | 153.89 | % |
See Notes to Financial Statements. | | | | | | | | | | | | | | | |
(i) Amount was computed based on average shares outstanding during the period.
- 58 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | |
Alger Mid Cap Growth Institutional | | | | | | |
Fund | | Class Z-2 | |
| | | | From 10/14/2016 | |
| Year ended | | | (commencement of operations) to | |
| 10/31/2017 | | 10/31/2016(i) | |
Net asset value, beginning of period | $ | 21.59 | | $ | 21.95 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | |
Net investment income (loss)(ii) | | (0.08 | ) | | 0.04 | |
Net realized and unrealized gain (loss) on | | | | | | |
investments | | 7.21 | | | (0.40 | ) |
Total from investment operations | | 7.13 | | | (0.36 | ) |
Net asset value, end of period | $ | 28.72 | | $ | 21.59 | |
Total return | | 33.02 | % | | (1.64 | )% |
RATIOS/SUPPLEMENTAL DATA: | | | | | | |
Net assets, end of period (000's omitted) | $ | 8,810 | | $ | 113 | |
Ratio of gross expenses to average net assets | | 1.14 | % | | 32.21 | % |
Ratio of expense reimbursements to average | | | | | | |
net assets | | (0.09 | )% | | (31.16 | )% |
Ratio of net expenses to average net assets | | 1.05 | % | | 1.05 | % |
Ratio of net investment income (loss) to average | | | | | | |
net assets | | (0.31 | )% | | 4.35 | % |
Portfolio turnover rate | | 157.49 | % | | 95.75 | % |
See Notes to Financial Statements. | | | | | | |
(i) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(ii) Amount was computed based on average shares outstanding during the period.
- 59 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | | | | | | | | | | |
Alger Small Cap Growth | | | | | | | | | | | | | | | |
Institutional Fund | | | | | | | | Class I | | | | | | | |
| Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | | 10/31/2013 | |
Net asset value, beginning of period | $ | 14.83 | | $ | 23.10 | | $ | 28.14 | | $ | 33.48 | | $ | 28.16 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | | | |
Net investment loss(i) | | (0.14 | ) | | (0.10 | ) | | (0.20 | ) | | (0.20 | ) | | (0.11 | ) |
Net realized and unrealized gain (loss) on | | | | | | | | | | | | | | | |
investments | | 5.83 | | | (0.54 | ) | | 0.42 | | | 0.60 | | | 8.66 | |
Total from investment operations | | 5.69 | | | (0.64 | ) | | 0.22 | | | 0.40 | | | 8.55 | |
Distributions from net realized gains | | – | | | (7.63 | ) | | (5.26 | ) | | (5.74 | ) | | (3.23 | ) |
Net asset value, end of period | $ | 20.52 | | $ | 14.83 | | $ | 23.10 | | $ | 28.14 | | $ | 33.48 | |
Total return | | 38.37 | % | | (3.76 | )% | | 0.53 | % | | 1.21 | % | | 33.71 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | | | |
Net assets, end of period (000's omitted) | $ | 130,527 | | $ | 129,188 | | $ | 357,189 | | $ | 659,692 | | $ | 936,554 | |
Ratio of gross expenses to average net assets | | 1.32 | % | | 1.28 | % | | 1.25 | % | | 1.24 | % | | 1.25 | % |
Ratio of net expenses to average net assets | | 1.32 | % | | 1.28 | % | | 1.25 | % | | 1.24 | % | | 1.25 | % |
Ratio of net investment income (loss) to average | | | | | | | | | | | | | | | |
net assets | | (0.77 | )% | | (0.67 | )% | | (0.80 | )% | | (0.70 | )% | | (0.38 | )% |
Portfolio turnover rate | | 29.70 | % | | 55.08 | % | | 125.72 | % | | 84.10 | % | | 77.38 | % |
See Notes to Financial Statements. | | | | | | | | | | | | | | | |
(i) Amount was computed based on average shares outstanding during the period.
- 60 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | | | | | | | | | | |
Alger Small Cap Growth | | | | | | | | | | | | | | | |
Institutional Fund | | | | | | | | Class R | | | | | | | |
| Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | | 10/31/2013 | |
Net asset value, beginning of period | $ | 12.67 | | $ | 20.92 | | $ | 26.08 | | $ | 31.58 | | $ | 26.85 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | | | |
Net investment loss(i) | | (0.19 | ) | | (0.16 | ) | | (0.29 | ) | | (0.32 | ) | | (0.23 | ) |
Net realized and unrealized gain (loss) on | | | | | | | | | | | | | | | |
investments | | 4.96 | | | (0.46 | ) | | 0.39 | | | 0.56 | | | 8.19 | |
Total from investment operations | | 4.77 | | | (0.62 | ) | | 0.10 | | | 0.24 | | | 7.96 | |
Distributions from net realized gains | | – | | | (7.63 | ) | | (5.26 | ) | | (5.74 | ) | | (3.23 | ) |
Net asset value, end of period | $ | 17.44 | | $ | 12.67 | | $ | 20.92 | | $ | 26.08 | | $ | 31.58 | |
Total return | | 37.65 | % | | (4.22 | )% | | 0.02 | % | | 0.74 | % | | 33.05 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | | | |
Net assets, end of period (000's omitted) | $ | 11,253 | | $ | 12,675 | | $ | 18,577 | | $ | 31,062 | | $ | 41,022 | |
Ratio of gross expenses to average net assets | | 1.82 | % | | 1.80 | % | | 1.74 | % | | 1.72 | % | | 1.73 | % |
Ratio of net expenses to average net assets | | 1.82 | % | | 1.80 | % | | 1.74 | % | | 1.72 | % | | 1.73 | % |
Ratio of net investment income (loss) to average | | | | | | | | | | | | | | | |
net assets | | (1.27 | )% | | (1.20 | )% | | (1.30 | )% | | (1.18 | )% | | (0.83 | )% |
Portfolio turnover rate | | 29.70 | % | | 55.08 | % | | 125.72 | % | | 84.10 | % | | 77.38 | % |
See Notes to Financial Statements. | | | | | | | | | | | | | | | |
(i) Amount was computed based on average shares outstanding during the period.
- 61 -
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period
| | | | | | |
Alger Small Cap Growth | | | | | | |
Institutional Fund | | Class Z-2 | |
| | | | From 8/1/2016 | |
| Year ended | | | (commencement of operations) to | |
| 10/31/2017 | | 10/31/2016 (i) | |
Net asset value, beginning of period | $ | 14.84 | | $ | 15.35 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | |
Net investment loss(ii) | | (0.09 | ) | | (0.03 | ) |
Net realized and unrealized gain (loss) on | | | | | | |
investments | | 5.85 | | | (0.48 | ) |
Total from investment operations | | 5.76 | | | (0.51 | ) |
Net asset value, end of period | $ | 20.60 | | $ | 14.84 | |
Total return | | 38.81 | % | | (3.32 | )% |
RATIOS/SUPPLEMENTAL DATA: | | | | | | |
Net assets, end of period (000's omitted) | $ | 67,268 | | $ | 41,787 | |
Ratio of gross expenses to average net assets | | 1.03 | % | | 1.07 | % |
Ratio of expense reimbursements to average | | | | | | |
net assets | | (0.04 | )% | | (0.08 | )% |
Ratio of net expenses to average net assets | | 0.99 | % | | 0.99 | % |
Ratio of net investment income (loss) to average | | | | | | |
net assets | | (0.51 | )% | | (0.76 | )% |
Portfolio turnover rate | | 29.70 | % | | 55.08 | % |
See Notes to Financial Statements. | | | | | | |
(i) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(ii) Amount was computed based on average shares outstanding during the period.
- 62 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS
NOTE 1 — General:
The Alger Institutional Funds (the “Trust”) is a diversified, open-end registered
investment company organized as a business trust under the laws of the Commonwealth
of Massachusetts. The Trust qualifies as an investment company as defined in Financial
Accounting Standards Board Accounting Standards Codification 946-Financial Services
– Investment Companies. The Trust operates as a series company and currently offers
an unlimited number of shares of beneficial interest in four funds — Alger Capital
Appreciation Institutional Fund, Alger Capital Appreciation Focus Fund, Alger Mid Cap
Growth Institutional Fund and Alger Small Cap Growth Institutional Fund (collectively,
the “Funds” or individually, each a “Fund”). The Funds normally invest primarily in equity
securities and each has an investment objective of long-term capital appreciation.
Each Fund offers one or more of the following share classes: Class A, C, I, R, Y, Z and
Z-2. Class A shares are generally subject to an initial sales charge while Class C shares are
generally subject to a deferred sales charge. Class I, R, Y, Z and Z-2 shares are sold to
institutional investors without an initial or deferred sales charge. Each class has identical
rights to assets and earnings except that each share class bears the pro rata allocation of the
Fund’s expenses other than a class expense (not including advisory or custodial fees or other
expenses related to the management of the Fund’s assets) to a share class.
Alger Capital Appreciation Institutional Fund and Alger Capital Appreciation Focus Fund
started offering Class Y shares on February 28, 2017.
NOTE 2 — Significant Accounting Policies:
(a) Investment Valuation: The Funds value their financial instruments (including escrow
receivable) at fair value using independent dealers or pricing services under policies approved
by the Trust’s Board of Trustees (“Board”). Investments are valued on each day the New
York Stock Exchange (the “NYSE”) is open, as of the close of the NYSE (normally 4:00
p.m. Eastern Standard Time).
Equity securities, including traded rights, warrants and option contracts for which valuation
information is readily available are valued at the last quoted sales price or official closing
price as reported by an independent pricing service on the primary market or exchange on
which they are traded. In the absence of quoted sales, such securities are valued at the bid
price or, in the absence of a recent bid price, the equivalent as obtained from one or more
of the major market makers for the securities to be valued.
Debt securities generally trade in the over-the-counter market. Debt securities with
remaining maturities of more than sixty days at the time of acquisition are valued on
the basis of last available bid prices or current market quotations provided by dealers
or pricing services. In determining the value of a particular investment, pricing services
may use certain information with respect to transactions in such investments, quotations
from dealers, pricing matrixes, market transactions in comparable investments, various
relationships observed in the market between investments and calculated yield measures
based on valuation technology commonly employed in the market for such investments.
Asset-backed and mortgage-backed securities are valued by independent pricing services
- 63 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
using models that consider estimated cash flows of each tranche of the security, establish a
benchmark yield and develop an estimated tranche-specific spread to the benchmark yield
based on the unique attributes of the tranche. Debt securities with a remaining maturity of
sixty days or less are valued at amortized cost which approximates market value.
Securities for which market quotations are not readily available (including escrow receivable)
are valued at fair value, as determined in good faith pursuant to procedures established by
the Board.
Securities in which the Funds invest may be traded in foreign markets that close before the
close of the NYSE. Developments that occur between the close of the foreign markets
and the close of the NYSE may result in adjustments to the foreign closing prices to reflect
what the investment adviser, pursuant to policies established by the Board, believes to be
the fair value of these securities as of the close of the NYSE. The Funds may also fair value
securities in other situations, for example, when a particular foreign market is closed but the
Funds are open.
Financial Accounting Standards Board Accounting Standards Codification 820 – Fair Value
Measurements and Disclosures (“ASC 820”) defines fair value as the price that the Funds
would receive upon selling an investment in a timely transaction to an independent buyer
in the principal or most advantageous market of the investment. ASC 820 established a
three-tier hierarchy to maximize the use of observable market data and minimize the use of
unobservable inputs and to establish classification of fair value measurements for disclosure
purposes. Inputs refer broadly to the assumptions that market participants would use in
pricing the asset or liability and may be observable or unobservable. Observable inputs
are based on market data obtained from sources independent of the Funds. Unobservable
inputs are inputs that reflect the Funds’ own assumptions based on the best information
available in the circumstances. The three-tier hierarchy of inputs is summarized in the three
broad Levels listed below.
• Level 1 – quoted prices in active markets for identical investments
• Level 2 – significant other observable inputs (including quoted prices for similar
investments, interest rates, prepayment speeds, credit risk, etc.)
• Level 3 – significant unobservable inputs (including the Funds’ own assumptions in
determining the fair value of investments)
The Funds’ valuation techniques are generally consistent with either the market or the
income approach to fair value. The market approach considers prices and other relevant
information generated by market transactions involving identical or comparable assets
to measure fair value. The income approach converts future amounts to a current, or
discounted, single amount. These fair value measurements are determined on the basis
of the value indicated by current market expectations about such future events. Inputs
for Level 1 include exchange-listed prices and broker quotes in an active market. Inputs
for Level 2 include the last trade price in the case of a halted security, an exchange-listed
price which has been adjusted for fair value factors, and prices of closely related securities.
Additional Level 2 inputs include an evaluated price which is based upon a compilation of
- 64 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
observable market information such as spreads for fixed income and preferred securities.
Inputs for Level 3 include revenue multiples, earnings before interest, taxes, depreciation
and amortization (“EBITDA”) multiples, discount rates, and the probabilities of success of
certain outcomes. Such unobservable market information may be obtained from a company’s
financial statements and from industry studies, market data, and market indicators such as
benchmarks and indexes. Because of the inherent uncertainty and often limited markets for
restricted securities, the values may significantly differ from the values if there was an active
market.
Valuation processes are determined by a Valuation Committee (“Committee”) established
by the Board and comprised of representatives of the Trust’s investment adviser. The
Committee reports its fair valuation determinations to the Board which is responsible for
approving valuation policy and procedures.
While the Committee meets on an as-needed basis, the Committee generally meets
quarterly to review and evaluate the effectiveness of the procedures for making fair value
determinations. The Committee considers, among other things, the results of quarterly
back testing of the fair value model for foreign securities, pricing comparisons between
primary and secondary price sources, the outcome of price challenges put to the Funds’
pricing vendor, and variances between transactional prices and previous mark-to-markets.
The Funds will record a change to a security’s fair value level if new inputs are available
or it becomes evident that inputs previously considered for leveling have changed or are
no longer relevant. Transfers between Levels 1, 2 and 3 are recognized at the end of the
reporting period.
(b) Cash and Cash Equivalents: Cash and cash equivalents include U.S. dollars and overnight
time deposits.
(c) Securities Transactions and Investment Income: Securities transactions are recorded on a
trade date basis. Realized gains and losses from securities transactions are recorded on the
identified cost basis. Dividend income is recognized on the ex-dividend date and interest
income is recognized on the accrual basis.
Premiums and discounts on debt securities purchased are amortized or accreted over the
lives of the respective securities.
(d) Foreign Currency Translations: The books and records of the Funds are maintained in U.S.
dollars. Foreign currencies, investments and other assets and liabilities are translated into
U.S. dollars at the prevailing rates of exchange on the valuation date. Purchases and sales
of investment securities and income and expenses are translated into U.S. dollars at the
prevailing exchange rates on the respective dates of such transactions.
Net realized gains and losses on foreign currency transactions represent net gains and losses
from the disposition of foreign currencies, currency gains and losses realized between the
trade dates and settlement dates of security transactions, and the difference between the
amount of net investment income accrued and the U.S. dollar amount actually received.
The effects of changes in foreign currency exchange rates on investments in securities
- 65 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
are included in realized and unrealized gain or loss on investments in the accompanying
Statements of Operations.
(e) Lending of Fund Securities: The Funds may lend their securities to financial institutions,
provided that the market value of the securities loaned will not at any time exceed one
third of a Fund’s total assets, as defined in its prospectuses. The Funds earn fees on the
securities loaned, which are included in interest income in the accompanying Statements
of Operations. In order to protect against the risk of failure by the borrower to return the
securities loaned or any delay in the delivery of such securities, the loan is collateralized by
cash or securities that are maintained with the Custodian in an amount equal to at least 102
percent of the current market value of U.S. loaned securities or 105 percent for non-U.S.
loaned securities. The market value of the loaned securities is determined at the close of
business of the Fund. Any required additional collateral is delivered to the Custodian and
any excess collateral is returned to the borrower on the next business day. In the event the
borrower fails to return the loaned securities when due, the Funds may take the collateral
to replace the securities. If the value of the collateral is less than the purchase cost of
replacement securities, the Custodian shall be responsible for any shortfall, but only to
the extent that the shortfall is not due to any diminution in collateral value, as defined in
the securities lending agreement. The Funds are required to maintain the collateral in a
segregated account and determine its value each day until the loaned securities are returned.
Cash collateral may be invested as determined by the Funds. Collateral is returned to the
borrower upon settlement of the loan. There were no securities loaned as of October 31,
2017.
(f) Dividends to Shareholders: Dividends and distributions payable to shareholders are recorded
by the Funds on the ex-dividend date. Dividends from net investment income, if available,
and distributions from net realized gains, offset by any loss carryforward, are declared and
paid annually after the end of the fiscal year in which earned.
Each class is treated separately in determining the amounts of dividends from net investment
income payable to holders of its shares.
The characterization of distributions to shareholders for financial reporting purposes is
determined in accordance with federal income tax rules. Therefore, the source of a Fund’s
distributions may be shown in the accompanying financial statements as either from, or in
excess of, net investment income, net realized gain on investment transactions or return of
capital, depending on the type of book/tax differences that may exist. Capital accounts within
the financial statements are adjusted for permanent book/tax differences. Reclassifications
result primarily from the difference in tax treatment of net operating losses, passive foreign
investment companies, and foreign currency transactions. The reclassifications are done
annually at fiscal year end and have no impact on the net asset values of the Funds and are
designed to present each Fund’s capital accounts on a tax basis.
(g) Federal Income Taxes: It is each Fund’s policy to comply with the requirements of the
Internal Revenue Code Subchapter M applicable to regulated investment companies and
to distribute all of its taxable income to its shareholders. Provided that the Funds maintain
- 66 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
such compliance, no federal income tax provision is required. Each Fund is treated as a
separate entity for the purpose of determining such compliance.
Financial Accounting Standards Board Accounting Standards Codification 740 – Income
Taxes (“ASC 740”) requires the Funds to measure and recognize in their financial statements
the benefit of a tax position taken (or expected to be taken) on an income tax return
if such position will more likely than not be sustained upon examination based on the
technical merits of the position. No tax years are currently under investigation. The Funds
file income tax returns in the U.S., as well as New York State and New York City. The
statute of limitations on the Funds’ tax returns remains open for the tax years 2013-2016.
Management does not believe there are any uncertain tax positions that require recognition
of a tax liability.
(h) Allocation Methods: The Trust accounts separately for the assets, liabilities and operations
of each Fund. Expenses directly attributable to each Fund are charged to that Fund’s
operations; expenses which are applicable to all Funds are allocated among them based on
net assets. Income, realized and unrealized gains and losses, and expenses of each Fund
are allocated among the Fund’s classes based on relative net assets, with the exception of
distribution fees, transfer agency fees, and shareholder servicing and related fees.
(i) Estimates: These financial statements have been prepared in accordance with accounting
principles generally accepted in the United States of America, which require using estimates
and assumptions that affect the reported amounts therein. Actual results may differ from
those estimates. All such estimates are of normal recurring nature.
NOTE 3 — Investment Advisory Fees and Other Transactions with Affiliates:
(a) Investment Advisory Fees: Fees incurred by each Fund, pursuant to the provisions of
the Trust’s Investment Advisory Agreement with Fred Alger Management, Inc. (“Alger
Management” or the “Manager”), are payable monthly and computed based on the following
rates. The actual rate paid as a percentage of average daily net assets, for the year ended
October 31, 2017, is set forth below under the heading “Actual Rate.”
| | | | | | | | | | | | | | | | | | | | |
| | Tier 1 | | Tier 2 | | | Tier 3 | | | | Tier 4 | | | | Tier 5 | | | Actual Rate | |
Alger Capital | | | | | | | | | | | | | | | | | | | | |
Appreciation | | | | | | | | | | | | | | | | | | | | |
Institutional Fund(a) | 0.810 | % | 0.650 | % | | 0.600 | % | | | 0.550 | % | | | 0.450 | % | | 0.740 | % |
Alger Capital | | | | | | | | | | | | | | | | | | | | |
Appreciation Focus | | | | | | | | | | | | | | | | | | | | |
Fund(c) | | 0.550 | % | — | | | — | | | | — | | | | — | | | 0.550 | % |
Alger Mid Cap | | | | | | | | | | | | | | | | | | | | |
Growth Institutional | | | | | | | | | | | | | | | | | | | | |
Fund(b) | | 0.760 | % | 0.700 | % | | — | | | | — | | | | — | | | 0.760 | % |
Alger Small Cap | | | | | | | | | | | | | | | | | | | | |
Growth Institutional | | | | | | | | | | | | | | | | | | | | |
Fund(b) | | 0.810 | % | 0.750 | % | | — | | | | — | | | | — | | | 0.810 | % |
(a) Tier 1 rate is paid on assets up to $2 billion, Tier 2 rate is paid on assets between $2 and
$3 billion, Tier 3 rate is paid on assets between $3 and $4 billion, Tier 4 rate is paid on assets
between $4 and $5 billion, and Tier 5 rate is paid on assets in excess of $5 billion.
- 67 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
(b) Tier 1 rate is paid on assets up to $1 billion and Tier 2 rate is paid on assets in excess of
$1 billion.
(c) Tier 1 rate is paid on all assets.
Alger Management has established expense caps for several shares classes, effective through
February 28, 2018, whereby it reimburses the share classes if annualized operating expenses
(excluding interest, taxes, brokerage, dividend expenses and extraordinary expenses) exceed
the rates, based on average daily net assets, listed below.
Also, Alger Management has contractually agreed to reimburse Alger Capital Appreciation
Institutional Fund Class Y shares expenses (excluding interest, taxes, brokerage and
extraordinary expenses) through August 29, 2018 to the extent necessary to limit the total
annual fund operating expenses to the actual investment advisory fee plus incurred custody
fee. This expense reimbursement cannot be terminated.
| | | | | | | | | | | |
| | | | | | | | | FEES WAIVED |
| | | | | | | | | / REIMBURSED |
| | | | | | | | | FOR THE YEAR |
| | | | CLASS | | | | | | ENDED |
| | | | | | | | | OCTOBER 31, |
| A | C | I | Y | | Z | Z-2 | | | 2017 |
Alger Capital Appreciation Institutional Fund | – | – | – | 0.75 | % | – | 0.95 | % | | $ | 17,543 |
Alger Capital Appreciation Focus Fund | 1.15% | 1.90% | 1.15% | 0.65 | % | 0.95% | – | | | $ | 2,763 |
Alger Mid Cap Growth Institutional Fund | – | – | – | – | | – | 1.05 | % | | $ | 4,607 |
Alger Small Cap Growth Institutional Fund | – | – | – | – | | – | 0.99 | % | | $ | 21,769 |
Fred Alger Management, Inc. may, during the one-year term of the expense reimbursement
contract, recoup any expenses waived or reimbursed pursuant to the expense reimbursement
contract to the extent that such recoupment would not cause the expense ratio to exceed the
lesser of the stated limitation in effect at the time of (i) the waiver or reimbursement and
(ii) the recoupment. For the year ended October 31, 2017, the recoupments made by the
Funds to the Investment Manager for the Alger Capital Appreciation Institutional Fund,
Alger Capital Appreciation Focus Fund, Alger Mid Cap Growth Institutional Fund and
Alger Small Cap Growth Institutional Fund were $0, $1,527, $0 and $0, respectively as of
October 31, 2017; the total repayments that may potentially be made by the Funds to the
Investment Manager for the Alger Capital Appreciation Institutional Fund, Alger Capital
Appreciation Focus Fund, Alger Mid Cap Growth Institutional Fund and Alger Small Cap
Growth Institutional Fund are $4,377, $730, $191 and $1,051, respectively which will expire
August 28, 2018.
(b) Administration Fees: Fees incurred by each Fund, pursuant to the provisions of the Trust’s
Administration Agreement with Fred Alger Management, Inc., are payable monthly and
computed based on the average daily net assets of each Fund at the annual rate of 0.0275%.
(c) Distribution Fees:
Class A Shares: The Trust has adopted a Distribution Plan pursuant to which Class A shares
of Alger Capital Appreciation Focus Fund pay Fred Alger & Company, Incorporated, the
Fund’s distributor (the “Distributor” or “Alger Inc.”) and an affiliate of Alger Management,
- 68 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
a fee at the annual rate of 0.25% of the respective average daily net assets of the Class A
shares of the Fund to compensate Alger Inc. for its activities and expenses incurred in
distributing and servicing the Class A shares. The fees paid may be more or less than the
expenses incurred by Alger Inc.
Class C Shares: The Trust has adopted a Distribution Plan pursuant to which Class C shares
of Alger Capital Appreciation Focus Fund pay Alger Inc. a fee at the annual rate of 1% of
the average daily net assets of the Class C shares of the Fund to compensate Alger Inc. for
its activities and expenses incurred in distributing and servicing the Class C shares. The fees
paid may be more or less than the expenses incurred by Alger Inc.
Class R Shares: The Trust has adopted a Distribution Plan pursuant to which Class R
shares of each Fund issuing such shares pay Alger Inc. a fee at the annual rate of 0.50%
of the respective average daily net assets of the Class R shares of the designated Fund to
compensate Alger Inc. for its activities and expenses incurred in distributing and servicing
the Class R shares. The fees paid may be more or less than the expenses incurred by the
Distributor.
(d) Sales Charges: Purchases and sales of shares of the Alger Capital Appreciation Focus
Fund may be subject to initial sales charges or contingent deferred sales charges. The
contingent deferred sales charges are used by Alger Inc. to offset distribution expenses
previously incurred. Sales charges do not represent expenses of the Trust. For the year
ended October 31, 2017, the initial sales charges and contingent deferred sales charges
imposed, all of which were retained by Alger Inc., were as follows:
| | | | |
| | | CONTINGENT |
| INITIAL SALES | DEFERRED SALES |
| | CHARGES | | CHARGES |
Alger Capital Appreciation Focus Fund | $ | 65 | $ | 4,748 |
(e) Brokerage Commissions: During the year ended October 31, 2017, Alger Capital
Appreciation Institutional Fund, Alger Capital Appreciation Focus Fund, Alger Mid Cap
Growth Institutional Fund and Alger Small Cap Growth Institutional Fund paid Alger Inc.
commissions of $389,221, $25,894, $35,983 and $9,605, respectively, in connection with
securities transactions.
(f) Shareholder Administrative Fees: The Trust has entered into a shareholder administrative
services agreement with Alger Management to compensate Alger Management for its liaison
and administrative oversight of Boston Financial Data Services, Inc., the transfer agent, and
other related services. The Funds compensate Alger Management at the annual rate of
0.0165% of their respective average daily net assets for the Class A and Class C shares and
0.01% of their respective average daily net assets of the Class I, Class R, Class Z and Class
Z-2 shares for these services.
Alger Management makes payments to intermediaries that provide sub-accounting services
to omnibus accounts invested in the Funds. A portion of the fees paid by Alger Management
to intermediaries that provide sub-accounting services are charged back to the appropriate
Fund, subject to certain limitations, as approved by the Trust’s Board of Trustees. For
- 69 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
the year ended October 31, 2017, Alger Management charged back to Alger Capital
Appreciation Institutional Fund, Alger Capital Appreciation Focus Fund, Alger Mid Cap
Growth Institutional Fund, and Alger Small Cap Growth Institutional Fund, $1,511,002,
$ 19,769, $ 58,855 and $ 102,485, respectively, for these services, which are included in the
transfer agent fees and expenses in the accompanying Statements of Operations.
(g) Trustees’ Fees: Effective March 1, 2016, each Independent Trustee receives a fee of
$27,250 for each board meeting attended, to a maximum of $109,000 per annum, paid pro
rata by each fund in the Alger Fund Complex, plus travel expenses incurred for attending
the meeting. The term “Alger Fund Complex” refers to the Trust, the Alger Funds II,
Alger Global Growth Fund, the Alger Portfolios and the Alger Funds, each of which is a
registered investment company managed by Fred Alger Management, Inc. The Independent
Trustee appointed as Chairman of the Board of Trustees receives additional compensation
of $26,000 per annum paid pro rata by each fund in the Alger Fund Complex. Additionally,
each member of the Audit Committee receives a fee of $2,500 for each Audit Committee
meeting attended to a maximum of $10,000 per annum, paid pro rata by each fund in the
Alger Fund Complex.
(h) Interfund Trades: The Funds engage in purchase and sale transactions with funds that have
a common investment adviser. For the year ended October 31, 2017, these purchases and
sales were as follows:
| | | | | |
| | | | Realized | |
| | Purchases | Sales | Gain/(loss) | |
Alger Small Cap Growth | | | | | |
Institutional Fund | $ | 3,915,791 | – | – | |
(i) Interfund Loans: The Funds may borrow money from other funds advised by Alger
Management for temporary or emergency purposes. If a fund has borrowed from other
funds and has aggregate borrowings from all sources that exceed 10% of the fund’s total
assets, such fund will secure all of its loans from other funds. The interest rate charged on
interfund loans is equal to the average of the overnight time deposit rate and bank loan rate
available to the funds. There were no interfund loans outstanding as of October 31, 2017.
During the year ended October 31, 2017, Alger Capital Appreciation Institutional Fund,
Alger Capital Appreciation Focus Fund, Alger Mid Cap Growth Institutional Fund and
Alger Small Cap Growth Institutional Fund incurred interest expense of $4,140, $190, $72
and $963, respectively, in connection with interfund loans.
(j) Other Transactions With Affiliates: Certain officers of the Trust are directors and officers
of Alger Management and the Distributor. At October 31, 2017, Alger Management and its
affiliated entities owned the following shares:
| | | | | | | | |
| | | | | SHARE CLASS | | |
| | | A | C | I | Y | Z | Z-2 |
Alger Capital Appreciation Institutional Fund | – | – | – | 347 | – | 3,777 |
Alger Capital Appreciation Focus Fund | 6,878 | 6,880 | – | 372 | 35,366 | – |
Alger Mid Cap Growth Institutional Fund | – | – | – | – | – | 4,556 |
Alger Small Cap Growth Institutional Fund | – | – | – | – | – | 6,515 |
- 70 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
(k) Shareholder Servicing Fees: The Trust has entered into a shareholder servicing agreement
with Alger Inc. whereby Alger Inc. provides Class I shares and Class R shares of the Trust
with ongoing servicing of shareholder accounts. As compensation for such services, the
Class I shares and Class R shares of each Fund pay Alger Inc. a monthly fee at an annual
rate of 0.25% of the value of the average daily net assets of those classes. The fees paid
may be more or less than the expenses incurred by the Distributor.
NOTE 4 — Securities Transactions:
The following summarizes the securities transactions by the Funds other than short-term
securities for the year ended October 31, 2017:
| | | | | | |
| | | PURCHASES | | | SALES |
Alger Capital Appreciation Institutional Fund | | $ | 2,253,165,544 | | $ | 2,888,103,552 |
Alger Capital Appreciation Focus Fund | | | 123,808,742 | | | 96,052,848 |
Alger Mid Cap Growth Institutional Fund | | | 151,856,728 | | | 161,045,471 |
Alger Small Cap Growth Institutional Fund | | | 55,579,216 | | | 94,138,077 |
Transactions in foreign securities may involve certain considerations and risks not typically
associated with those of U.S. companies because of, among other factors, the level of
governmental supervision and regulation of foreign security markets, and the possibility
of political or economic instability. Additional risks associated with investing in emerging
markets include increased volatility, limited liquidity, and less stringent regulatory and legal
system.
NOTE 5 — Borrowing:
The Funds may borrow from their custodian on an uncommitted basis. Each Fund pays the
custodian a market rate of interest, generally based upon the London Interbank Offered
Rate. The Funds may also borrow from other funds advised by Alger Management, as
discussed in Note 3(i). For the year ended October 31, 2017, the Funds had the following
borrowings:
| | | | | |
| AVERAGE DAILY | WEIGHTED AVERAGE | |
| BORROWING | INTEREST RATE | |
Alger Capital Appreciation Institutional Fund | $ | 233,723 | | 1.94 | % |
Alger Capital Appreciation Focus Fund | | 14,692 | | 1.73 | |
Alger Mid Cap Growth Institutional Fund | | 14,125 | | 2.29 | |
Alger Small Cap Growth Institutional Fund | | 88,836 | | 1.82 | |
The highest amount borrowed during the year ended October 31, 2017 for each Fund was
as follows:
| | | |
| HIGHEST BORROWING |
Alger Capital Appreciation Institutional Fund | | $ | 10,706,211 |
Alger Capital Appreciation Focus Fund | | | 4,381,000 |
Alger Mid Cap Growth Institutional Fund | | | 568,000 |
Alger Small Cap Growth Institutional Fund | | | 3,147,295 |
- 71 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
NOTE 6 — Share Capital:
(a) The Trust has an unlimited number of authorized shares of beneficial interest of $.001
par value which are presently divided into four series. Each series is divided into separate
classes. The transactions of shares of beneficial interest were as follows:
| | | | | | | | | | | | | | |
| | | FOR THE YEAR ENDED | | FOR THE YEAR ENDED | |
| | | OCTOBER 31, 2017 | | OCTOBER 31, 2016 | |
| | | SHARES | | | | AMOUNT | | SHARES | | | | AMOUNT | |
Alger Capital Appreciation Institutional Fund | | | | | | | | | | | |
Class I: | | | | | | | | | | | | | | |
Shares sold | | | 16,153,920 | | $ | | 476,641,428 | | 31,404,149 | | | $ | 813,769,276 | |
Dividends reinvested | | | 718,981 | | | | 19,268,689 | | 8,328,490 | | | | 222,703,812 | |
Shares redeemed | | | (56,847,411 | ) | | | (1,620,341,276 | ) | (39,710,653 | ) | | (1,033,949,797 | ) |
Net increase (decrease) | | (39,974,510 | ) | $ | | (1,124,431,159 | ) | 21,986 | | | $ | 2,523,291 | |
Class R: | | | | | | | | | | | | | | |
Shares sold | | | 3,468,162 | | $ | | 92,794,162 | | 4,897,737 | | | $ | 116,200,047 | |
Dividends reinvested | | | 178,580 | | | | 4,344,841 | | 1,958,801 | | | | 47,814,339 | |
Shares redeemed | | | (6,378,683 | ) | | | (169,954,336 | ) | (7,855,308 | ) | | (186,269,122 | ) |
Net decrease | | (2,731,941 | ) | $ | | (72,815,333 | ) | (998,770 | ) | | $ | (22,254,736 | ) |
Class Y: | | | | | | | | | | | | | | |
Shares sold | | | 2,938,772 | | $ | | 94,267,571 | | — | | | $ | — | |
Shares redeemed | | | (63,899 | ) | | | (2,091,302 | ) | — | | | | — | |
Net increase | | | 2,874,873 | | $ | | 92,176,269 | | — | | | $ | — | |
Class Z-2: | | | | | | | | | | | | | | |
Shares sold | | | 17,233,735 | | $ | | 490,233,250 | | 83,652 | | | $ | 2,241,803 | |
Dividends reinvested | | | 44,346 | | | | 1,189,367 | | — | | | | — | |
Shares redeemed | | | (4,562,899 | ) | | | (139,712,867 | ) | — | | | | — | |
Net increase | | 12,715,182 | | $ | | 351,709,750 | | 83,652 | | | $ | 2,241,803 | |
- 72 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | | | | | | | | | | | |
| | FOR THE YEAR ENDED | | | FOR THE YEAR ENDED | |
| | OCTOBER 31, 2017 | | | OCTOBER 31, 2016 | |
| | SHARES | | | | AMOUNT | | | SHARES | | | | AMOUNT | |
Alger Capital Appreciation Focus Fund | | | | | | | | | | | | |
Class A: | | | | | | | | | | | | | | |
Shares sold | | 238,196 | | $ | | 6,398,589 | | | 739,124 | | | $ | 17,427,842 | |
Dividends reinvested | | — | | | | — | | | 12,944 | | | | 312,984 | |
Shares redeemed | | (557,255 | ) | | | (14,257,177 | ) | | (679,452 | ) | | | (15,850,906 | ) |
Net increase (decrease) | | (319,059 | ) | $ | | (7,858,588 | ) | | 72,616 | | | $ | 1,889,920 | |
Class C: | | | | | | | | | | | | | | |
Shares sold | | 238,598 | | $ | | 5,944,197 | | | 319,341 | | | $ | 7,354,428 | |
Dividends reinvested | | — | | | | — | | | 3,659 | | | | 86,524 | |
Shares redeemed | | (145,227 | ) | (3,844,373 | ) | | (83,332 | ) | | | (1,913,105 | ) |
Net increase | | 93,371 | | $ | | 2,099,824 | | | 239,668 | | | $ | 5,527,847 | |
Class I: | | | | | | | | | | | | | | |
Shares sold | | 394,922 | | $ | | 10,973,042 | | | 477,738 | | | $ | 11,361,669 | |
Dividends reinvested | | — | | | | — | | | 9,363 | | | | 227,418 | |
Shares redeemed | | (579,798 | ) | | | (15,640,234 | ) | | (561,466 | ) | | | (13,260,188 | ) |
Net decrease | | (184,876 | ) | $ | | (4,667,192 | ) | | (74,365 | ) | | $ | (1,671,101 | ) |
Class Y: | | | | | | | | | | | | | | |
Shares sold | | 136,508 | | $ | | 4,223,668 | | | — | | | $ | — | |
Shares redeemed | | (2,934 | ) | | | (92,002 | ) | | — | | | | — | |
Net increase | | 133,574 | | $ | | 4,131,666 | | | — | | | $ | — | |
Class Z: | | | | | | | | | | | | | | |
Shares sold | | 1,675,218 | | $ | | 45,981,326 | | | 787,965 | | | $ | 19,023,071 | |
Dividends reinvested | | — | | — | | | 4,919 | | | | 120,412 | |
Shares redeemed | | (409,196 | ) | | | (11,814,488 | ) | | (298,013 | ) | | | (6,956,934 | ) |
Net increase | | 1,266,022 | | $ | | 34,166,838 | | | 494,871 | | | $ | 12,186,549 | |
|
Alger Mid Cap Growth Institutional Fund | | | | | | | | | | | | |
Class I: | | | | | | | | | | | | | | |
Shares sold | | 393,700 | | $ | | 9,942,979 | | | 468,253 | | | $ | 10,046,363 | |
Shares redeemed | | (1,184,092 | ) | | | (28,871,701 | ) | | (1,780,941 | ) | | | (38,571,631 | ) |
Net decrease | | (790,392 | ) | $ | | (18,928,722 | ) | | (1,312,688 | ) | | $ | (28,525,268 | ) |
Class R: | | | | | | | | | | | | | | |
Shares sold | | 102,239 | | $ | | 2,357,701 | | | 134,848 | | | $ | 2,706,730 | |
Shares redeemed | | (266,903 | ) | | | (6,180,169 | ) | | (327,778 | ) | | | (6,575,334 | ) |
Net decrease | | (164,664 | ) | $ | | (3,822,468 | ) | | (192,930 | ) | | $ | (3,868,604 | ) |
Class Z-2: | | | | | | | | | | | | | | |
Shares sold | | 336,377 | | $ | | 8,195,951 | | | 5,241 | | | $ | 115,000 | |
Shares redeemed | | (34,849 | ) | | | (894,948 | ) | | — | | | | — | |
Net increase | | 301,528 | | $ | | 7,301,003 | | | 5,241 | | | $ | 115,000 | |
- 73 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | | | | | | | | | | | |
| | FOR THE YEAR ENDED | | | | FOR THE YEAR ENDED | |
| | OCTOBER 31, 2017 | | | | OCTOBER 31, 2016 | |
| | SHARES | | | AMOUNT | | | | SHARES | | | | AMOUNT | |
Alger Small Cap Growth Institutional Fund | | | | | | | | | | | | |
Class I: | | | | | | | | | | | | | | |
Shares sold | | 1,256,731 | | $ | 22,874,804 | | | | 2,557,038 | | | $ | 40,363,890 | |
Dividends reinvested | | — | | | — | | | | 7,154,149 | | | | 109,458,479 | |
Shares redeemed | | (3,607,295 | ) | | (61,669,792 | ) | | | (16,460,370 | ) | | (250,251,908 | ) |
Net decrease | (2,350,564 | ) | $ | (38,794,988 | ) | | (6,749,183 | ) | | $ | (100,429,539 | ) |
Class R: | | | | | | | | | | | | | | |
Shares sold | | 172,015 | | $ | 2,578,445 | | | | 182,259 | | | $ | 2,391,486 | |
Dividends reinvested | | — | | | — | | | | 449,925 | | | | 5,907,509 | |
Shares redeemed | | (527,393 | ) | | (7,849,419 | ) | | | (519,276 | ) | | | (7,069,366 | ) |
Net increase (decrease) | | (355,378 | ) | $ | (5,270,974 | ) | | | 112,908 | | | $ | 1,229,629 | |
Class Z-2: | | | | | | | | | | | | | | |
Shares sold | | 1,507,588 | | $ | 26,380,218 | | | | 2,959,159 | | | $ | 46,531,746 | |
Shares redeemed | | (1,058,368 | ) | | (18,691,576 | ) | | | (143,150 | ) | | | (2,218,266 | ) |
Net increase | | 449,220 | | $ | 7,688,642 | | | | 2,816,009 | | | $ | 44,313,480 | |
NOTE 7 — Income Tax Information:
The tax character of distributions paid during the year ended October 31, 2017 and the year
ended October 31, 2016 were as follows:
| | | | | | |
| FOR THE YEAR ENDED | FOR THE YEAR ENDED |
| | OCTOBER 31, 2017 | | OCTOBER 31, 2016 |
Alger Capital Appreciation | | | | | | |
Institutional Fund | | | | | | |
Distributions paid from: | | | | | | |
Ordinary Income | | | — | | | — |
Long-term capital gain | | | 25,634,655 | | | 280,036,930 |
Total distributions paid | $ | 25,634,655 | $ | 280,036,930 |
|
Alger Capital Appreciation Focus | | | | | | |
Fund | | | | | | |
Distributions paid from: | | | | | | |
Ordinary Income | | | — | | | — |
Long-term capital gain | | | — | | | 799,008 |
Total distributions paid | $ | — | $ | 799,008 |
|
Alger Mid Cap Growth Institutional | | | | | | |
Fund | | | | | | |
Distributions paid from: | | | | | | |
Ordinary Income | | | — | | | — |
Long-term capital gain | | | — | | | — |
Total distributions paid | $ | — | $ | — |
- 74 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | | | |
| FOR THE YEAR ENDED | FOR THE YEAR ENDED |
| | OCTOBER 31, 2017 | | OCTOBER 31, 2016 |
Alger Small Cap Growth Institutional | | | | | | |
Fund | | | | | | |
Distributions paid from: | | | | | | |
Ordinary Income | | | — | | | — |
Long-term capital gain | | | — | | | 118,489,594 |
Total distributions paid | $ | — | $ | 118,489,594 |
As of October 31, 2017 the components of accumulated gains (losses) on a tax basis were
as follows:
| | | | |
Alger Capital Appreciation Institutional Fund | | | | |
Undistributed ordinary income | | | 5,934,858 | |
Undistributed long-term gains | | | 230,087,548 | |
Net accumulated earnings | | | 236,022,406 | |
Capital loss carryforwards | | | — | |
Net unrealized appreciation | | 1,015,073,828 | |
Total accumulated earnings | $ | 1,251,096,234 | |
|
Alger Capital Appreciation Focus Fund | | | | |
Undistributed ordinary income | | | 1,047,023 | |
Undistributed long-term gains | | | 4,186,445 | |
Net accumulated earnings | | | 5,233,468 | |
Capital loss carryforwards | | | — | |
Net unrealized appreciation | | | 25,662,609 | |
Total accumulated earnings | | $ | 30,896,077 | |
|
Alger Mid Cap Growth Institutional Fund | | | | |
Undistributed ordinary income | | | — | |
Undistributed long-term gains | | | — | |
Net accumulated earnings | | | — | |
Capital loss carryforwards | | | — | |
Late year ordinary income losses | | | (609,257 | ) |
Net unrealized appreciation | | | 6,659,637 | |
Total accumulated earnings | | $ | 6,050,380 | |
|
Alger Small Cap Growth Institutional Fund | | | | |
Undistributed ordinary income | | | — | |
Undistributed long-term gains | | | 5,884,188 | |
Net accumulated earnings | | | 5,884,188 | |
Capital loss carryforwards | | | — | |
Late year ordinary income losses | | | (2,028,401 | ) |
Net unrealized appreciation | | | 65,118,203 | |
Total accumulated earnings | | $ | 68,973,990 | |
At October 31, 2017, the Funds, for federal income tax purposes, had no capital loss
carryforwards.
- 75 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
During the year ended October 31, 2017, Alger Mid Cap Growth Institutional Fund utilized
$22,850,923 of its capital loss carryforwards.
Under the Regulated Investment Company Modernization Act of 2010, capital losses
incurred by the Funds will not be subject to expiration.
The difference between book-basis and tax-basis unrealized appreciation (depreciation) is
determined annually and is attributable primarily to the tax deferral of losses on wash sales,
U.S. Internal Revenue Code Section 988 currency transactions, nondeductible expenses
on dividends sold short, the tax treatment of partnerships investments, the realization of
unrealized appreciation of passive foreign investment companies, and return of capital from
real estate investment trust investments.
Permanent differences, primarily from net operating losses and real estate investment trusts
and partnership investments sold by the Fund, resulted in the following reclassifications
among the Fund’s components of net assets at October 31, 2017.
The Funds accrue tax on unrealized gains in foreign jurisdictions that impose a foreign
capital tax.
| | | |
Alger Capital Appreciation Institutional Fund | | | |
Accumulated undistributed net investment income (accumulated loss) | $ | 4,507,896 | |
Accumulated net realized gain (accumulated realized loss) | $ | (4,691,706 | ) |
Paid-in Capital | $ | 183,810 | |
|
Alger Capital Appreciation Focus Fund | | | |
Accumulated undistributed net investment income (accumulated loss) | $ | 271,471 | |
Accumulated net realized gain (accumulated realized loss) | $ | (271,470 | ) |
Paid-in Capital | $ | (1 | ) |
|
Alger Mid Cap Growth Institutional Fund | | | |
Accumulated undistributed net investment income (accumulated loss) | $ | 369,497 | |
Accumulated net realized gain (accumulated realized loss) | $ | 257,352,119 | |
Paid-in Capital | $ | (257,721,616 | ) |
|
Alger Small Cap Growth Institutional Fund | | | |
Accumulated undistributed net investment income (accumulated loss) | $ | 1,239,514 | |
Accumulated net realized gain (accumulated realized loss) | $ | 235,374 | |
Paid-in Capital | $ | (1,474,888 | ) |
NOTE 8 — Fair Value Measurements
The following is a summary of the inputs used as of October 31, 2017 in valuing the Funds’
investments carried at fair value on a recurring basis. Based upon the nature, characteristics,
and risks associated with their investments, the Funds have determined that presenting them
by security type and sector is appropriate.
- 76 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | | | | | | | | | | | | |
Alger Capital Appreciation | | | | | | | | | | | | | | | |
Institutional Fund | | | | TOTAL FUND | | | LEVEL 1 | | LEVEL 2 | | LEVEL 3 | |
COMMON STOCKS | | | | | | | | | | | | | | | |
Consumer Discretionary | $ | 658,369,297 | $ | 647,889,408 | $ | 10,479,889 | | | — | |
Consumer Staples | | | | 76,455,644 | | 76,455,644 | | | — | | | — | |
Energy | | | | 46,277,566 | | 46,277,566 | | | — | | | — | |
Financials | | | | 204,118,502 | | 204,118,502 | | | — | | | — | |
Health Care | | | | 474,595,571 | | 474,595,571 | | | — | | | — | |
Industrials | | | | 221,856,936 | | 221,856,936 | | | — | | | — | |
Information Technology | | | | 1,669,088,530 | | 1,667,714,107 | | | — | | $ | 1,374,423 | * |
Materials | | | | 137,022,706 | | 137,022,706 | | | — | | | — | |
Telecommunication Services | | | | 13,590,323 | | 13,590,323 | | | — | | | — | |
TOTAL COMMON STOCKS | $ | | | | 3,501,375,075 | $ | | 3,489,520,763 | $ | | 10,479,889 | | $ | 1,374,423 | |
CORPORATE BONDS | | | | | | | | | | | | | | | |
Information Technology | | | | | — | | | — | | | — | | | —* | |
MASTER LIMITED PARTNERSHIP | | | | | | | | | | |
Financials | | | | 36,660,413 | | 36,660,413 | | | — | | | — | |
PREFERRED STOCKS | | | | | | | | | | | | | | | |
Health Care | | | | | 6,412,347 | | | — | | | — | | | 6,412,347 | |
Information Technology | | | | | 6,335,626 | | | — | | | — | | | 6,335,626 | * |
TOTAL PREFERRED | | | | | | | | | | | | | | | |
STOCKS | $ | 12,747,973 | | | — | | | — | | $ | 12,747,973 | |
REAL ESTATE INVESTMENT TRUST | | | | | | | | | | |
Real Estate | | | | 79,369,960 | | 79,369,960 | | | — | | | — | |
WARRANTS | | | | | | | | | | | | | | | |
Information Technology | | | | | — | | | — | | | — | | | —* | |
TOTAL INVESTMENTS IN | | | | | | | | | | | | | | | |
SECURITIES | $ | | | 3,630,153,421 | $ | | 3,605,551,136 | $ | | 10,479,889 | | $ | 14,122,396 | |
*Alger Capital Appreciation Institutional Fund’s shares of Choicestream Inc. common
stock, preferred stock, corporate bonds and warrants are classified as a Level 3 investment
and are fair valued at zero as of October 31, 2017.
- 77 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | | | | | | | | | | |
Alger Capital Appreciation | | | | | | | | | | | | | |
Focus Fund | | TOTAL FUND | | | LEVEL 1 | | | LEVEL 2 | LEVEL 3 | |
COMMON STOCKS | | | | | | | | | | | | | |
Consumer Discretionary | $ | 21,948,281 | $ | 21,948,281 | | | | — | | — | |
Consumer Staples | | | 906,287 | | | 906,287 | | | | — | | — | |
Energy | | | 2,087,596 | | | 2,087,596 | | | | — | | — | |
Financials | | | 8,561,828 | | | 8,561,828 | | | | — | | — | |
Health Care | | 17,710,596 | | 17,710,596 | | | | — | | — | |
Industrials | | | 7,515,137 | | | 7,515,137 | | | | — | | — | |
Information Technology | | 59,801,768 | | 59,801,768 | | | | — | | — | |
Materials | | | 2,539,401 | | | 2,539,401 | | | | — | | — | |
Telecommunication Services | | | 743,359 | | | 743,359 | | | | — | | — | |
TOTAL COMMON STOCKS | $ | 121,814,253 | $ | | 121,814,253 | | | | — | | — | |
MASTER LIMITED PARTNERSHIP | | | | | | | | | | |
Financials | | | 2,254,232 | | | 2,254,232 | | | | — | | — | |
PREFERRED STOCKS | | | | | | | | | | | | | |
Health Care | | | 239,694 | | | — | | | | — | $ | 239,694 | |
REAL ESTATE INVESTMENT TRUST | | | | | | | | | | |
Real Estate | | | 4,294,530 | | | 4,294,530 | | | | — | | — | |
TOTAL INVESTMENTS IN | | | | | | | | | | | | | |
SECURITIES | $ | 128,602,709 | $ | | 128,363,015 | | | | — | $ | 239,694 | |
|
Alger Mid Cap Growth | | | | | | | | | | | | | |
Institutional Fund | | TOTAL FUND | | | LEVEL 1 | | | LEVEL 2 | LEVEL 3 | |
COMMON STOCKS | | | | | | | | | | | | | |
Consumer Discretionary | $ | 14,934,156 | $ | 14,934,156 | | | | — | | — | |
Consumer Staples | | | 2,014,938 | | | 2,014,938 | | | | — | | — | |
Energy | | | 1,204,710 | | | 1,204,710 | | | | — | | — | |
Financials | | | 7,449,363 | | | 7,449,363 | | | | — | | — | |
Health Care | | | 20,671,292 | | | 20,671,292 | | | | — | | — | |
Industrials | | 14,764,937 | | 14,764,937 | | | | — | | — | |
Information Technology | | | 31,582,521 | | | 31,511,071 | | | | — | $ | 71,450 | * |
Materials | | | 5,721,348 | | | 5,721,348 | | | | — | | — | |
TOTAL COMMON STOCKS | $ | 98,343,265 | $ | 98,271,815 | | | | — | $ | 71,450 | |
CORPORATE BONDS | | | | | | | | | | | | | |
Information Technology | | | — | | | — | | | | — | | —* | |
PREFERRED STOCKS | | | | | | | | | | | | | |
Consumer Discretionary | | | — | | | — | | | | — | | — | |
Health Care | | | 953,727 | | | — | | | | — | $ | 953,727 | |
Information Technology | | | 329,343 | | | — | | | | — | | 329,343 | * |
TOTAL PREFERRED | | | | | | | | | | | | | |
STOCKS | $ | 1,283,070 | | | — | | | | — | $ | 1,283,070 | |
- 78 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | | | | | | |
Alger Mid Cap Growth | | | | | | | | | |
Institutional Fund | TOTAL FUND | | LEVEL 1 | LEVEL 2 | | LEVEL 3 |
RIGHTS | | | | | | | | | |
Health Care | $ | 1,207,798 | | — | | — | | $ | 1,207,798 |
REAL ESTATE INVESTMENT TRUST | | | | | | | |
Real Estate | | 2,479,923 | $ | 2,479,923 | | — | | | — |
SPECIAL PURPOSE VEHICLE | | | | | | | | |
Financials | | 290,165 | | — | | — | | | 290,165 |
WARRANTS | | | | | | | | | |
Information Technology | | — | | — | | — | | | —* |
TOTAL INVESTMENTS IN | | | | | | | | | |
SECURITIES | $ | 103,604,221 | $ | 100,751,738 | | — | | $ | 2,852,483 |
Escrow Receivable | $ | 486,113 | | — | $ | 486,113 | ** | | — |
* Alger Mid Cap Growth Institutional Fund’s shares of Choicestream Inc. common stock
preferred stock, corporate bonds and warrants are classified as a Level 3 investment and are
fair valued at zero as of October 31, 2017.
** Amounts held for indemnification claims of Sumitomo Dainippon Pharma Co., Ltd.
following its acquisition of Tolero Pharmaceuticals, Inc.
| | | | | | | | | | | | | | |
Alger Small Cap Growth | | | | | | | | | | | | | | |
Institutional Fund | | TOTAL FUND | | | LEVEL 1 | | | LEVEL 2 | LEVEL 3 |
COMMON STOCKS | | | | | | | | | | | | | | |
Consumer Discretionary | $ | 11,413,263 | $ | 11,413,263 | | | | — | | — |
Consumer Staples | | | | | 2,151,008 | | | 2,151,008 | | | | — | | — |
Energy | | | | | 2,518,276 | | | 2,518,276 | | | | — | | — |
Financials | | | | | 9,428,712 | | | 9,428,712 | | | | — | | — |
Health Care | | | | 78,087,930 | | 78,087,930 | | | | — | | — |
Industrials | | | | 12,089,212 | | 12,089,212 | | | | — | | — |
Information Technology | | | | 77,806,299 | | 77,806,299 | | | | — | | — |
Materials | | | | | 3,871,348 | | | 3,871,348 | | | | — | | — |
TOTAL COMMON STOCKS | $ | 197,366,048 | $ | | 197,366,048 | | | | — | $ | — |
PREFERRED STOCKS | | | | | | | | | | | | | | |
Health Care | | | | | 2,784,079 | | | — | | | | — | $ | 2,784,079 |
REAL ESTATE INVESTMENT TRUST | | | | | | | | | |
Real Estate | | | | | 2,002,665 | | | 2,002,665 | | | | — | | — |
RIGHTS | | | | | | | | | | | | | | |
Health Care | | | | | 1,570,945 | | | — | | | | —* | | 1,570,945 |
SPECIAL PURPOSE VEHICLE | | | | | | | | | | | | |
Financials | | | | | 935,742 | | | — | | | | — | | 935,742 |
TOTAL INVESTMENTS IN | | | | | | | | | | | | | | |
SECURITIES | $ | 204,659,479 | $ | 199,368,713 | | | | — | $ | 5,290,766 |
Escrow Receivable | $ | | | | 607,526 | | | — | | | $ | 607,526** | | — |
*Alger Small Cap Growth Institutional Fund’s holding of Neuralstem Inc. rights is classified
as a Level 2 investment and fair valued at zero as of October 31, 2017.
** Amounts held for indemnification claims of Sumitomo Dainippon Pharma Co., Ltd.
following its acquisition of Tolero Pharmaceuticals, Inc.
- 79 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | |
| FAIR VALUE | |
| MEASUREMENTS | |
| | | USING | |
| SIGNIFICANT | |
| UNOBSERVABLE | |
| INPUTS (LEVEL 3) | |
Alger Capital Appreciation Institutional Fund | Common Stocks | |
Opening balance at November 1, 2016 | $ | 1,828,579 | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | – | |
Included in net unrealized gain (loss) on investments | | (454,156 | ) |
Purchases and sales | | | | |
Purchases | | – | |
Sales | | – | |
Closing balance at October 31, 2017 | | | 1,374,423 | * |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | (454,156 | ) |
|
Alger Capital Appreciation Institutional Fund | Corporate Bonds | |
Opening balance at November 1, 2016 | $ | 574,662 | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Accrued discount | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | – | |
Included in net unrealized gain (loss) on investments | | (574,662 | ) |
Purchases and sales | | | | |
Purchases | | – | |
Sales | | – | |
Closing balance at October 31, 2017 | | | 0 | * |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | (574,662 | ) |
|
Alger Capital Appreciation Institutional Fund | Preferred Stocks | |
Opening balance at November 1, 2016 | $ | 16,273,256 | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | – | |
Included in net unrealized gain (loss) on investments | | (3,525,283 | ) |
Purchases and sales | | | | |
Purchases | | – | |
Sales | | – | |
Closing balance at October 31, 2017 | | | 12,747,973 | * |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | (3,525,283 | ) |
- 80 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | |
| FAIR VALUE | |
| MEASUREMENTS | |
| | | USING | |
| SIGNIFICANT | |
| UNOBSERVABLE | |
| INPUTS (LEVEL 3) | |
Alger Capital Appreciation Institutional Fund | | | Warrants | |
Opening balance at November 1, 2016 | $ | 563,169 | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | – | |
Included in net unrealized gain (loss) on investments | | (563,169 | ) |
Purchases and sales | | | | |
Purchases | | – | |
Sales | | – | |
Closing balance at October 31, 2017 | | | 0 | * |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | (563,169 | ) |
|
| FAIR VALUE | |
| MEASUREMENTS | |
| | | USING | |
| SIGNIFICANT | |
| UNOBSERVABLE | |
| INPUTS (LEVEL 3) | |
Alger Capital Appreciation Focus Fund | Preferred Stocks | |
Opening balance at November 1, 2016 | $ | 310,373 | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | – | |
Included in net unrealized gain (loss) on investments | | (70,679 | ) |
Purchases and sales | | | | |
Purchases | | – | |
Sales | | – | |
Closing balance at October 31, 2017 | | | 239,694 | |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | (70,679 | ) |
- 81 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | |
| FAIR VALUE | |
| MEASUREMENTS | |
| | | USING | |
| SIGNIFICANT | |
| UNOBSERVABLE | |
| INPUTS (LEVEL 3) | |
Alger Mid Cap Growth Institutional Fund | Common Stocks | |
Opening balance at November 1, 2016 | $ | 95,059 | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | – | |
Included in net unrealized gain (loss) on investments | | (23,609 | ) |
Purchases and sales | | | | |
Purchases | | – | |
Sales | | – | |
Closing balance at October 31, 2017 | | | 71,450 | * |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | (23,609 | ) |
|
Alger Mid Cap Growth Institutional Fund | Corporate Bonds | |
Opening balance at November 1, 2016 | $ | 17,128 | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | – | |
Included in net unrealized gain (loss) on investments | | (17,128 | ) |
Purchases and sales | | | | |
Purchases | | – | |
Sales | | – | |
Closing balance at October 31, 2017 | | | 0 | * |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | (17,128 | ) |
|
Alger Mid Cap Growth Institutional Fund | Preferred Stocks | |
Opening balance at November 1, 2016 | $ | 2,084,875 | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | 2,359,646 | |
Included in net unrealized gain (loss) on investments | | 268,518 | |
Purchases and Sales/Conversion | | | | |
Purchases | | – | |
Sales/Conversions | | (3,429,969 | ) |
Closing balance at October 31, 2017 | | | 1,283,070 | * |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | 2,628,164 | |
- 82 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | |
| FAIR VALUE | |
| MEASUREMENTS | |
| | | USING | |
| SIGNIFICANT | |
| UNOBSERVABLE | |
| INPUTS (LEVEL 3) | |
Alger Mid Cap Growth Institutional Fund | | | Rights | |
Opening balance at November 1, 2016 | $ | — | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | — | |
Included in net unrealized gain (loss) on investments | | 981,612 | |
Purchases and sales | | | | |
Purchases | | 226,186 | |
Sales | | | |
Closing balance at October 31, 2017 | | | 1,207,798 | |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | 981,612 | |
|
| Special Purpose | |
Alger Mid Cap Growth Institutional Fund | | | Vehicle | |
Opening balance at November 1, 2016 | $ | 249,760 | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | – | |
Included in net unrealized gain (loss) on investments | | 40,405 | |
Purchases and sales | | | | |
Purchases | | – | |
Sales | | – | |
Closing balance at October 31, 2017 | | | 290,165 | |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | 40,405 | |
|
Alger Mid Cap Growth Institutional Fund | | | Warrants | |
Opening balance at November 1, 2016 | $ | 16,785 | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | – | |
Included in net unrealized gain (loss) on investments | | (16,785 | ) |
Purchases and sales | | | | |
Purchases | | – | |
Sales | | – | |
Closing balance at October 31, 2017 | | | 0 | * |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | (16,785 | ) |
- 83 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | |
Alger Small Cap Growth Institutional Fund | Preferred Stocks | |
Opening balance at November 1, 2016 | $ | 3,468,884 | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | 2,938,664 | |
Included in net unrealized gain (loss) on investments | | 667,265 | |
Purchases Sales/Conversion | | | | |
Purchases | | – | |
Sales/Conversions | | (4,290,734 | ) |
Closing balance at October 31, 2017 | | | 2,784,079 | |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | 3,605,929 | |
|
Alger Small Cap Growth Institutional Fund | | | Rights | |
Opening balance at November 1, 2016 | $ | — | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | – | |
Included in net unrealized gain (loss) on investments | | 1,285,220 | |
Purchases and sales | | | | |
Purchases | | 285,725 | |
Sales | | – | |
Closing balance at October 31, 2017 | | 1,570,945 | |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | 1,285,220 | |
|
| Special Purpose | |
Alger Small Cap Growth Institutional Fund | | | Vehicle | |
Opening balance at November 1, 2016 | $ | 805,442 | |
Transfers into Level 3 | | | — | |
Transfers out of Level 3 | | | — | |
Total gains or losses | | | | |
Included in net realized gain (loss) on investments | | – | |
Included in net unrealized gain (loss) on investments | | 130,300 | |
Purchases and sales | | | | |
Purchases | | – | |
Sales | | – | |
Closing balance at October 31, 2017 | | | 935,742 | |
Net change in unrealized appreciation (depreciation) attributable to | | | | |
investments still held at October 31, 2017 | $ | 130,300 | |
* Level 3 securities are fair valued at zero at the end of the period.
The following table provides quantitative information about our Level 3 fair value
measurements of our investments as of October 31, 2017. In addition to the techniques
and inputs noted in the table below, according to our valuation policy we may also use other
- 84 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
valuation techniques and methodologies when determining our fair value measurements.
The table below is not intended to be all-inclusive, but rather provides information on the
Level 3 inputs as they relate to our fair value measurements.
| | | | | | | | |
| | Fair Value | | | | | | |
| | October 31, | Valuation | Unobservable | | | Weighted Average | |
| | 2017 | Methodology | Input | Input/Range | | Inputs | |
Alger Capital Appreciation Institutional Fund | | | | | |
Common Stocks | $ | 1,374,423 | Market | Market | N/A* | | N/A | |
| | | Approach | Quotation | | | | |
Preferred Stocks | | 12,747,973 | Market | Time to Exit | 2 years | | N/A | |
| | | Approach | Volatility | 80.5% | | | |
| | | | Market Quotation | N/A* | | | |
|
|
Alger Capital Appreciation Focus Fund | | | | | |
Preferred Stocks | $ | 239,694 | Income | Discount Rate | 38%-42% | | N/A | |
| | | Approach | | | | | |
|
Alger Mid Cap Growth Institutional Fund | | | | | |
Common Stocks | $ | 71,450 | Market | Market | N/A* | | N/A | |
| | | Approach | Quotation | | | | |
Preferred Stocks | | 517,948 | Income | Discount Rate | 38%-42% | | N/A | |
| | | Approach | | | | | |
Preferred Stocks | | 765,122 | Market | Time to Exit | 2 years | | N/A | |
| | | Approach | Volatility | 80.5% | | | |
| | | | Market Quotation | N/A* | | N/A | |
Special Purpose Vehicle | | 290,165 | Market | Revenue Multiple | 2.9x-4.2x | | N/A | |
| | | Approach | | | | | |
Rights | | 1,207,798 | Income | Discount Rate | 5.14%-30.72% | | N/A | |
| | | Approach | | | | | |
|
Alger Small Cap Growth Institutional Fund | | | | | |
|
Preferred Stocks | | 415,781 | Income | Discount Rate | 38%-42% | | N/A | |
| | | Approach | | | | | |
Preferred Stocks | | 2,368,298 | Market | Time to Exit | 2 years | | N/A | |
| | | Approach | Volatility | 80.5% | | | |
Special Purpose Vehicle | | 935,742 | Market | Revenue Multiple | 2.9x-4.2x | | N/A | |
| | | Approach | | | | | |
Rights | | 1,570,945 | Income | Discount Rate | 2.05%-30.72% | | 17.31% | |
| | | Approach | | | | | |
* The Fund utilized a market approach to fair value this security. The significant unobservable input used in the
valuation model was a market quotation available to the Fund at October 31, 2017.
The significant unobservable inputs used in the fair value measurement of the Fund’s
securities are revenue and EBITDA multiples, discount rates, and the probabilities of
success of certain outcomes. Significant increases and decreases in these inputs in isolation
- 85 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
and interrelationships between those inputs could result in significantly higher or lower fair
value measurements than those noted in the table above.
On October 31, 2017, there were no transfers of securities between Level 1 and Level 2.
Certain of the Funds’ assets and liabilities are held at carrying amount or face value, which
approximates fair value for financial statement purposes. As of October 31, 2017, such
assets are categorized within the disclosure hierarchy as follows:
| | | | | | | | | | |
| TOTAL FUND | | LEVEL 1 | | LEVEL 2 | | LEVEL 3 |
Cash, Foreign cash and Cash equivalents: | | | | | | | | |
Alger Capital Appreciation Institutional Fund | $ | 2,628,274 | | | — | $ | 2,628,274 | | | — |
Alger Capital Appreciation Focus Fund | | 4,069,153 | | | — | | 4,069,153 | | | — |
Alger Mid Cap Growth Institutional Fund | | 5,690,657 | | | — | | 5,690,657 | | | — |
Alger Small Cap Growth Institutional Fund | | 4,934,292 | | | — | | 4,934,292 | | | — |
NOTE 9 — Derivatives:
Financial Accounting Standards Board Accounting Standards Codification 815 – Derivatives
and Hedging (“ASC 815”) requires qualitative disclosures about objectives and strategies for
using derivatives, quantitative disclosures about fair value amounts of and gains and losses
on derivative instruments, and disclosures about credit-risk-related contingent features in
derivative agreements.
Options— The Funds seek to capture the majority of the returns associated with equity
market investments. To meet this investment goal, the Funds invest in a broadly diversified
portfolio of common stocks, while also buying and selling call and put options on equities
and equity indexes. The Funds purchase call options to increase their exposure to the stock
market and also provide diversification of risk. The Funds purchase put options in order
to protect from significant market declines that may occur over a short period of time. The
Funds will write covered call and cash secured put options to generate cash flows while
reducing the volatility of the Funds’ portfolios. The cash flows may be an important source
of the Funds’ returns, although written call options may reduce the Funds’ ability to profit
from increases in the value of the underlying security or equity portfolio. The value of a
call option generally increases as the price of the underlying stock increases and decreases
as the stock decreases in price. Conversely, the value of a put option generally increases as
the price of the underlying stock decreases and decreases as the stock increases in price.
The combination of the diversified stock portfolio and the purchase and sale of options
is intended to provide the Funds with the majority of the returns associated with equity
market investments but with reduced volatility and returns that are augmented with the cash
flows from the sale of options.
The Funds’ option contracts were not subject to any rights of offset with any counterparty.
All of the Funds’ options were exchange traded which utilize a clearing house that acts as an
intermediary between buyer and seller, receiving initial and maintenance margin from both,
and guaranteeing performance of the option contract.
- 86 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
There were no open derivative instruments throughout the period or as of October 31,
2017.
NOTE 10 — Principal Risks:
As of October 31, 2017, the Funds invested a significant portion of their assets in securities
in the information technology, consumer discretionary and health care sectors. Changes in
economic conditions affecting such sectors would have a greater impact on the Funds and
could affect the value, income and/or liquidity of positions in such securities.
In the normal course of business, the Funds invest in securities and enter into transactions
where risks exist due to fluctuations in the market (market risk) or failure of the issuer
of a security to meet all its obligations (issuer credit risk). The value of securities held by
the Funds may decline in response to certain events, including those directly involving the
issuers whose securities are owned by the Funds; conditions affecting the general economy;
overall market changes; local, regional or global political, social or economic instability; and
currency and interest rate and price fluctuations. Similar to issuer credit risk, the Funds may
be exposed to counterparty credit risk, or the risk that an entity with which the Funds have
unsettled or open transactions may fail to or be unable to perform on its commitments. The
Funds manage counterparty credit risk by entering into transactions only with counterparties
that they believe have the financial resources to honor their obligations and by monitoring
the financial stability of those counterparties. Financial assets, which potentially expose
the Funds to market, issuer and counterparty credit risks, consist principally of financial
instruments and receivables due from counterparties. The extent of the Funds’ exposure to
market, issuer and counterparty credit risks with respect to these financial assets is generally
approximated by its value recorded in the Statement of Assets and Liabilities, less any
collateral held by the Funds.
The Funds invest in companies that are not yet available in the public markets and that are
accessible only through private equity investments. The Funds may also invest in venture
capital or private equity funds, direct private equity investments and other investments that
may have limited liquidity. There may be no trading market for these securities, and their
sale or transfer may be limited or prohibited by contract or legal requirements, or may be
dependent on an exit strategy, such as an initial public offering or the sale of a business,
which may not occur, or may be dependent on managerial assistance provided by other
investors and their willingness to provide additional financial support. The securities may
be able to be liquidated, if at all, at disadvantageous prices. As a result, the Funds may be
required to hold these positions for several years, if not longer, regardless of adverse price
movements. Such positions may cause the Funds to be less liquid than would otherwise be
the case.
NOTE 11 — Affiliated Securities:
The issuers of the securities listed below are deemed to be affiliates of the Funds because
the Funds or their affiliates owned 5% or more of the issuer’s voting securities during all
or part of the year ended October 31, 2017. Purchase and sale transactions and dividend
income earned during the period were as follows:
- 87 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | Net Increase | | | | |
| Shares/ | | | | Shares/ | | | | | | | | (Decrease) | | | | |
| Par at | | | | Par at | | | | | | | | | in | | | Value at |
| October 31, | Purchases/ | Sales/ | | October 31, | | Interest | | Realized | | | Unrealized | | | October 31, |
Security | 2016 | Conversion | Conversion | | 2017 | | Income | | Gain (Loss) | | | | App(Dep) | | | 2017 |
Alger Capital Appreciation Institutional Fund | | | | | | | | | | | | | | | | |
Common Stocks | | | | | | | | | | | | | | | | | | |
Choicestream, Inc. | 124,658 | – | – | | 124,658 | $ | | – | $ | – | $ | | | – | | $ | | 0 |
Preferred Stocks | | | | | | | | | | | | | | | | | | |
Choicestream, Inc. , | | | | | | | | | | | | | | | | | | |
Series A | 1,074,935 | – | – | | 1,074,935 | | | – | | – | | | | – | | | | 0 |
Choicestream, Inc. , | | | | | | | | | | | | | | | | | | |
Series B | 2,500,538 | – | – | | 2,500,538 | | | – | | – | | | (1,475,318 | ) | | | 0 |
Warrants | | | | | | | | | | | | | | | | | | |
Choicestream, Inc. , | 574,662 | – | – | | 574,662 | | | – | | – | | | | (563,169 | ) | | | 0 |
Corporate Bonds | | | | | | | | | | | | | | | | | | |
Choicestream, Inc. , | | | | | | | | | | | | | | | | | | |
11.00%, 8/05/18 | 574,662 | – | – | | 574,662 | | 11,368 | | – | | | | (574,662 | ) | | | 0 |
Total | | | | | | $ | 11,368 | $ | – | $ | (2,613,149 | ) | $ | 0 |
|
|
| | | | | | | | | | | | | Net Increase | | | | |
| Shares/ | | | | Shares/ | | | | | | | | (Decrease) | | | | |
| Par at | | | | Par at | | | | | | | | | in | | | Value at |
| October 31, | Purchases/ | Sales/ | | October 31, | | Interest | | Realized | | | Unrealized | | | October 31, |
Security | 2016 | Conversion | Conversion | | 2017 | | Income | | Gain (Loss) | | | | App(Dep) | | | 2017 |
Alger Capital Appreciation Focus Fund | | | | | | | | | | | | | | | | |
Preferred Stocks | | | | | | | | | | | | | | | | | | |
Prosetta Biosciences, | | | | | | | | | | | | | | | | | | |
Inc. , Series D | 76,825 | – | – | | 76,825 | $ | | – | $ | – | $ | | | (70,680 | ) | | $ | 239,694 |
Total | | | | | | $ | | – | $ | – | $ | | | (70,680 | ) | | $ | 239,694 |
|
|
| | | | | | | | | | | | | Net Increase | | | | |
| Shares/ | | | | Shares/ | | | | | | | | (Decrease) | | | | |
| Par at | | | | Par at | | | | | | | | | in | | | Value at |
| October 31, | Purchases/ | Sales/ | | October 31, | | Interest | | Realized | | | Unrealized | | | October 31, |
Security | 2016 | Conversion | Conversion | | 2017 | | Income | | Gain (Loss) | | | | App(Dep) | | | 2017 |
Alger Mid Cap Growth Institutional Fund | | | | | | | | | | | | | | | | |
Common Stocks | | | | | | | | | | | | | | | | | | |
Choicestream, Inc. | 8,930 | – | – | | 8,930 | | | – | $ | – | $ | | | – | | | $ | 0 |
Preferred Stocks | | | | | | | | | | | | | | | | | | |
Choicestream, Inc. , | | | | | | | | | | | | | | | | | | |
Series A | 77,008 | – | – | | 77,008 | | | – | | – | | | | – | | | | 0 |
Choicestream, Inc. , | | | | | | | | | | | | | | | | | | |
Series B | 144,793 | – | – | | 144,793 | | | – | | – | | | | (85,428 | ) | | | 0 |
Prosetta Biosciences, | | | | | | | | | | | | | | | | | | |
Inc. , Series D | 166,009 | – | – | | 166,009 | | | – | | – | | | | (152,728 | ) | | | 517,948 |
Warrants | | | | | | | | | | | | | | | | | | |
Choicestream, Inc. | 17,128 | – | – | | 17,128 | | | – | | – | | | | (16,785 | ) | | | 0 |
Corporate Bonds | | | | | | | | | | | | | | | | | | |
Choicestream, Inc. | 17,128 | – | – | | 17,128 | | 337 | | – | | | | (17,128 | ) | | | 0 |
Tolero | | | | | | | | | | | | | | | | | | |
Pharmaceuticals, | | | | | | | | | | | | | | | | | | |
Inc. , Series B* | 354,870 | – | (354,870 | ) | – * | | | – | | 2,359,646 | | | | – | | | | – * |
Total | | | | | | | 337 | $ | 2,359,646 | $ | | | (272,069 | ) | $ | 517,948 |
- 88 -
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Continued)
| | | | | | | | | | | | | | |
| | | | | | | | | Net Increase | | | |
| Shares/ | | | Shares/ | | | | | (Decrease) | | | |
| Par at | | | Par at | | | | | | | in | | Value at |
| October 31, | Purchases/ | Sales/ | October 31, | Interest | | | Realized | | Unrealized | | | October 31, |
Security | 2016 | Conversion | Conversion | 2017 | Income | | | Gain (Loss) | | App(Dep) | | | 2017 |
Alger Small Cap Growth Institutional Fund | | | | | | | | | | | | |
Preferred Stocks | | | | | | | | | | | | | | |
Prosetta Biosciences, | | | | | | | | | | | | | | |
Inc. , Series D | 133,263 | – | – | 133,263 | $ | – | | $ | – | $ | (122,602 | ) | $ | 415,781 |
Tolero | | | | | | | | | | | | | | |
Pharmaceuticals Inc. , | | | | | | | | | | | | | | |
Series B* | 448,284 | – | 448,284 | – * | | – | | 2,938,664 | | – | | | – * |
Total | | | | | $ | – | | $ | 2,938,664 | $ | (122,602 | ) | $ | 415,781 |
*On February 6, 2017, Tolero Pharmaceuticals, Inc., Series B was no longer an affiliated security of the Funds.
NOTE 12 — Subsequent Events:
Management of each Fund has evaluated events that have occurred subsequent to October
31, 2017 through the issuance date of the Financial Statements. No such events have been
identified which require recognition and/or disclosure.
- 89 -
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Trustees of The Alger Institutional Funds and Shareholders of Alger
Capital Appreciation Institutional Fund, Alger Capital Appreciation Focus Fund, Alger Mid
Cap Growth Institutional Fund, and Alger Small Cap Growth Institutional Fund:
We have audited the accompanying statements of assets and liabilities, including the
schedules of investments, of The Alger Institutional Funds, comprised of the Alger Capital
Appreciation Institutional Fund, Alger Capital Appreciation Focus Fund, Alger Mid Cap
Growth Institutional Fund, and Alger Small Cap Growth Institutional Fund (the “Funds”)
as of October 31, 2017, and the related statements of operations for the year then ended,
the statements of changes in net assets for each of the two years in the period then ended,
and the financial highlights for each of the periods presented. These financial statements
and financial highlights are the responsibility of the Funds’ management. Our responsibility
is to express an opinion on these financial statements and financial highlights based on our
audits.
We conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial statements and
financial highlights are free of material misstatement. The Funds are not required to have,
nor were we engaged to perform, an audit of their internal control over financial reporting.
Our audits included consideration of internal control over financial reporting as a basis for
designing audit procedures that are appropriate in the circumstances, but not for the purpose
of expressing an opinion on the effectiveness of the Funds’ internal control over financial
reporting. Accordingly, we express no such opinion. An audit also includes examining, on
a test basis, evidence supporting the amounts and disclosures in the financial statements,
assessing the accounting principles used and significant estimates made by management,
as well as evaluating the overall financial statement presentation. Our procedures included
confirmation of securities owned as of October 31, 2017, by correspondence with the
custodian and brokers; when replies were not received from brokers, we performed other
auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements and financial highlights referred to above present
fairly, in all material respects, the financial position of each of the portfolios constituting
The Alger Institutional Funds as of October 31, 2017, the results of their operations for the
year then ended, the changes in their net assets for each of the two years in the period then
ended, and the financial highlights for each of the periods presented, in conformity with
accounting principles generally accepted in the United States of America.
Deloitte & Touche LLP
New York, New York
December 22, 2017
- 90 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited)
Shareholder Expense Example
As a shareholder of a Fund, you incur two types of costs: transaction costs, if applicable,
including sales charges (loads) and redemption fees; and ongoing costs, including
management fees, distribution (12b-1) fees, if applicable, and other fund expenses. This
example is intended to help you understand your ongoing costs (in dollars) of investing in
the Fund and to compare these costs with the ongoing costs of investing in other mutual
funds.
The example below is based on an investment of $1,000 invested at the beginning of the
six-month period starting May 1, 2017 and ending October 31, 2017.
Actual Expenses
The first line for each class of shares in the table below provides information about actual
account values and actual expenses. You may use the information in this line, together
with the amount you invested, to estimate the expenses that you would have paid over the
period. Simply divide your account value by $1,000 (for example, an $8,600 account value
divided by $1,000 = 8.6), then multiply the result by the number in the first line under the
heading entitled “Expenses Paid during the Period” to estimate the expenses you paid on
your account during this period.
Hypothetical Example for Comparison Purposes
The second line for each class of shares in the table below provides information about
hypothetical account values and hypothetical expenses based on the Fund’s actual expense
ratios for each class of shares and an assumed rate of return of 5% per year before expenses,
which is not the Fund’s actual return. The hypothetical account values and expenses may not
be used to estimate the actual ending account balance or expenses you paid for the period.
You may use this information to compare the ongoing costs of investing in the Fund and
other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical
examples that appear in the shareholder reports of other funds.
Please note that the expenses shown in the table are meant to highlight your ongoing costs
only and do not reflect any transaction costs, such as sales charges (loads) and redemption
fees. Therefore, the second line under each class of shares in the table is useful in comparing
ongoing costs only, and will not help you determine the relative total costs of owning
different funds. In addition, if these transactional costs were included, your costs would
have been higher.
- 91 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
| | | | | | | | | | |
| | | | | | | | | Annualized | |
| | | | | | Expenses | | Expense | |
| | | | | | Paid During | | Ratio | |
| | | | | Ending | | the Six | | For the | |
| | Beginning | | Account | | Months | | Six Months | |
| | Account | | Value | | Ended | | Ended | |
| | | Value | | October 31, | October 31, | | October 31, | |
| | May 1, 2017 | | 2017 | | 2017 | (a) | 2017 | (b) |
Alger Capital Appreciation Institutional Fund | | | | | | | |
Class I | Actual | $ | 1,000.00 | $ | 1,128.20 | $ | 6.12 | | 1.14 | % |
| Hypothetical(c) | | 1,000.00 | | 1,019.46 | | 5.80 | | 1.14 | |
Class R | Actual | | 1,000.00 | | 1,125.80 | | 8.68 | | 1.62 | |
| Hypothetical(c) | | 1,000.00 | | 1,017.04 | | 8.24 | | 1.62 | |
Class Y | Actual | | 1,000.00 | | 1,131.20 | | 4.03 | | 0.75 | |
| Hypothetical(c) | | 1,000.00 | | 1,021.42 | | 3.82 | | 0.75 | |
Class | | | | | | | | | | |
Z-2 | Actual | | 1,000.00 | | 1.130.30 | | 4.51 | | 0.84 | |
| Hypothetical(c) | | 1,000.00 | | 1,020.97 | | 4.28 | | 0.84 | |
| | | | | | | | | | |
Alger Capital Appreciation Focus Fund | | | | | | | | |
Class A | Actual | $ | 1,000.00 | $ | 1,084.40 | $ | 5.83 | | 1.11 | % |
| Hypothetical(c) | | 1,000.00 | | 1,019.61 | | 5.65 | | 1.11 | |
Class C | Actual | | 1,000.00 | | 1,129.70 | | 10.20 | | 1.90 | |
| Hypothetical(c) | | 1,000.00 | | 1,015.63 | | 9.65 | | 1.90 | |
Class I | Actual | | 1,000.00 | | 1,144.30 | | 6.07 | | 1.12 | |
| Hypothetical(c) | | 1,000.00 | | 1,019.54 | | 5.70 | | 1.12 | |
Class Y | Actual | | 1,000.00 | | 1,147.30 | | 3.52 | | 0.65 | |
| Hypothetical(c) | | 1,000.00 | | 1,021.93 | | 3.31 | | 0.65 | |
Class Z | Actual | | 1,000.00 | | 1,145.90 | | 4.54 | | 0.84 | |
| Hypothetical(c) | | 1,000.00 | | 1,020.97 | | 4.28 | | 0.84 | |
| | | | | | | | | | |
Alger Mid Cap Growth Institutional Fund | | | | | | | |
Class I | Actual | $ | 1,000.00 | $ | 1,127.10 | $ | 6.86 | | 1.28 | % |
| Hypothetical(c) | | 1,000.00 | | 1,018.75 | | 6.51 | | 1.28 | |
Class R | Actual | | 1,000.00 | | 1,124.60 | | 9.69 | | 1.81 | |
| Hypothetical(c) | | 1,000.00 | | 1,016.08 | | 9.20 | | 1.81 | |
Class | | | | | | | | | | |
Z-2 | Actual | | 1,000.00 | | 1,128.50 | | 5.63 | | 1.05 | |
| Hypothetical(c) | | 1,000.00 | | 1,019.91 | | 5.35 | | 1.05 | |
| | | | | | | | | | |
Alger Small Cap Growth Institutional Fund | | | | | | | |
Class I | Actual | $ | 1,000.00 | $ | 1,152.80 | $ | 7.16 | | 1.32 | % |
| Hypothetical(c) | | 1,000.00 | | 1,018.55 | | 6.72 | | 1.32 | |
Class R | Actual | | 1,000.00 | | 1,150.40 | | 9.86 | | 1.82 | |
| Hypothetical(c) | | 1,000.00 | | 1,016.03 | | 9.25 | | 1.82 | |
Class | | | | | | | | | | |
Z-2 | Actual | | 1,000.00 | | 1,154.70 | | 5.38 | | 0.99 | |
| Hypothetical(c) | | 1,000.00 | | 1,020.21 | | 5.04 | | 0.99 | |
- 92 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
(a) Expenses are equal to the annualized expense ratio of the respective share class, multiplied by the
average account value over the period, multiplied by 181/365 (to reflect the one-half year period).
(b) Annualized.
(c) 5% annual return before expenses.
- 93 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
Trustees and Officers of the Trust
Information about the trustees and officers of the Trust is set forth below. In the table the
term "Alger Fund Complex" refers to the Trust, The Alger Portfolios, The Alger Global
Growth Fund, The Alger Funds and The Alger Funds II, each of which is a registered
investment company managed by Fred Alger Management, Inc. ("Alger Management").
Each Trustee serves until an event of termination, such as death or resignation, or until his
or her successor is duly elected; each officer's term of office is one year. Unless otherwise
noted, the address of each person named below is 360 Park Avenue South, New York, NY
10010.
- 94 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
| | | |
| | | Number |
| | | of Funds |
| | | in the |
| | | Alger |
| | | Fund |
| | | Complex |
| | Trustee | which are |
Name, Age, | | and/or | Overseen |
Position with the | | Officer | by |
Fund | Principal Occupations | Since | Trustee |
INTERESTED TRUSTEE | | | |
|
Hilary M. Alger (56) | Director of Development, Pennsylvania Ballet 2004- | 2003 | 24 |
| 2013; Associate Director of Development, College | | |
| of Arts and Science and Graduate School, University | | |
| of Virginia 1999-2003. | | |
NON-INTERESTED | | | |
TRUSTEE | | | |
|
Charles F. Baird, Jr. (64) | Managing Director of North Castle Partners, | 2000 | 24 |
| a private equity securities group; Chairman of | | |
| Elizabeth Arden Red Door Spas and Barry’s | | |
| Bootcamp, former Chairman of Cascade Helmets, | | |
| gloProfessional (makeup and skincare business), | | |
| Contigo (manufacturer of mugs and water bottles), | | |
| and International Fitness. | | |
Roger P. Cheever (72) | Associate Vice President for Principal Gifts and | 2000 | 24 |
| Senior Associate Dean for Development in the | | |
| Faculty of Arts and Sciences at Harvard University; | | |
| Formerly Deputy Director of the Harvard College | | |
| Fund. | | |
Stephen E. O'Neil (84) | Attorney. Private Investor since 1981. Formerly of | 1986 | 24 |
| Counsel to the law firm of Kohler & Barnes. | | |
David Rosenberg (55) | Associate Professor of Law since January 2006 | 2007 | 24 |
| (Assistant Professor 2000-2005), Zicklin School of | | |
| Business, Baruch College, City University of New | | |
| York. | | |
Nathan E. Saint-Amand | Medical doctor in private practice; Member of the | 1986 | 24 |
M. D. (79) | Board of the Manhattan Institute (non-profit policy | | |
| research) since 1988; Formerly Co-Chairman, Special | | |
| Projects Committee, Memorial Sloan Kettering. | | |
Ms. Alger is an “interested person” (as defined in the Investment Company Act) of the
Trust because of her affiliations with Alger Management. No Trustee is a director of any
public company except as indicated under “Principal Occupations”.
- 95 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
| | | | |
| | | | Number |
| | | | of Funds |
| | | | in the |
| | | | Alger |
| | | | Fund |
| | | | Complex |
| | | Trustee | which are |
Name, Age, Position with | | | and/or | Overseen |
the | | | Officer | by |
Fund | Principal Occupations | | Since | Trustee |
OFFICERS | | | | |
Hal Liebes (53) | Executive Vice President, Chief Operating Officer | | 2005 | N/A |
President | and Secretary of Alger Management and Alger Inc. ; | | | |
| Director since 2006 of Alger Management, Alger | | | |
| Inc. and Analyst Resources, Inc. | | | |
Tina Payne (43) | Senior Vice President, General Counsel and | | 2017 | N/A |
Secretary, Chief Compliance | Chief Compliance Officer of Alger Management | | | |
Officer | since 2017. Formerly, Senior Vice President and | | | |
| Associate General Counsel, Cohen & Steers Capital | | | |
| Management, from 2007 to 2017 | | | |
Lisa A. Moss (52) | Senior Vice President and Assistant General Counsel | | 2006 | N/A |
Assistant Secretary | of Alger Management. | | | |
Michael D. Martins (52) | Senior Vice President of Alger Management. | | 2005 | N/A |
Treasurer | | | | |
Anthony S. Caputo (62) | Vice President of Alger Management. | | 2007 | N/A |
Assistant Treasurer | | | | |
Sergio M. Pavone (56) | Vice President of Alger Management. | | 2007 | N/A |
Assistant Treasurer | | | | |
Christopher E. Ullman (32) | Associate Counsel of Alger Management since | | 2016 | N/A |
Assistant Secretary | 2016. Formerly, Associate, Legal and Compliance, | | | |
| BlackRock from 2015 to 2016; Compliance | | | |
| Associate, Bridgewater Associates, from 2013 to | | | |
| 2014; and full-time student fro m 2010 to 2013. | | |
- 96 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
Investment Management Agreement Renewal
At an in-person meeting held on September 12, 2017, the Trustees, including the Independent
Trustees, unanimously approved renewal of the Investment Advisory Agreement (the
“Agreement”) between the Trust and Fred Alger Management, Inc. (“Alger Management”).
The Independent Trustees were assisted in their review by independent legal counsel and met
with such counsel in executive session separate from representatives of Alger Management.
In evaluating the Agreement, the Trustees drew on materials that they had requested and
which were provided to them in advance of the meeting by Alger Management and by
counsel. The materials covered, among other matters, (i) the nature, extent and quality
of the services provided by Alger Management under the Agreement, (ii) the investment
performance of each of the Trust’s portfolios (each a “Fund”), (iii) the costs to Alger
Management of its services and the profits realized by Alger Management and Fred Alger
& Company, Incorporated (“Alger Inc.”), from their relationship with the Trust, and (iv)
the extent to which economies of scale would be realized if and as the Funds grow and
whether the fee levels in the Agreement reflected such economies of scale. These materials
included a presentation and analysis of the Funds and Alger Management’s services by
FUSE Research Network LLC (“FUSE”), an independent consulting firm selected by the
Trust’s Chief Compliance Officer and having no other material relationship with Alger
Management or its affiliates
In deciding whether to approve renewal of the Agreement, the Trustees considered various
factors, including those enumerated above. They also considered other direct and indirect
benefits to Alger Management and its affiliates from their relationship with the Trust.
Nature, Extent and Quality of Services. In considering the nature, extent and quality of
the services provided by Alger Management pursuant to the Agreement, the Trustees relied
on their prior experience as Trustees of the Trust, their familiarity with the personnel and
resources of Alger Management and its affiliates (derived in part from quarterly meetings
with and presentations by Fund investment management and distribution personnel), and the
materials provided at the meeting. They noted that under the Agreement Alger Management
is responsible for managing the investment operations of the Funds. The Trustees reviewed
the background and experience of Alger Management's senior investment management
personnel, including the individuals currently responsible for the investment operations
of the Funds. They also considered the resources and practices of Alger Management
in managing each Fund's portfolio, as well as Alger Management's overall investment
management business. They noted especially Alger Management's established expertise
in managing portfolios of "growth" stocks and that, according to an analysis provided
by FUSE, the characteristics of each Fund had been consistent with those of a growth-
oriented fund. They also noted that during the year Alger Management had continued
its ongoing efforts to strengthen its investment management team through strategic hires,
realignment of portfolio management responsibilities, and similar measures. The Trustees
concluded that Alger Management's experience, resources and strength in the areas of
importance to the Funds are considerable. They also noted that certain administrative,
compliance, reporting and accounting services necessary for the conduct of the Trust's
- 97 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
affairs are provided separately under a Fund Administration Agreement and a Shareholder
Administrative Services Agreement with Alger Management. The Trustees considered the
strengthened legal, control and compliance environment at Alger Management and within
the Trust and Alger Management’s ongoing implementation of a firm-wide cybersecurity
facility, including software and hardware installations, extensive security procedures and
intensive personnel training.
Investment Performance of the Funds. Drawing upon information provided at the
meeting by Alger Management as well as FUSE and upon reports provided to the Trustees
by Alger Management throughout the preceding year, the Trustees reviewed each Fund’s
returns for the year-to-date (at 6/30/17), second-quarter of 2017, 1-, 3- and 5-year, and
longer periods to the extent available (and its year-by-year returns), and compared them with
benchmark and peer-group data for the same periods. They also consulted supplemental
performance data through 7/31/17. They noted that the Capital Appreciation Focus Fund,
Mid Cap Institutional Fund and Small Cap Institutional Fund had shown almost uniformly
strong results against their peer medians and benchmarks for the quarter-end, year-to-date
and one-year periods ended 6/30/17, the one exception being the Mid Cap Institutional
Fund Class R Shares, which nevertheless matched the peer median for the 6/30/17 quarter.
They also noted that the Capital Appreciation Institutional Fund had fallen off against its
peers (but not its benchmark) in the quarter ended 6/30/17, with its share classes placing
just slightly above (Class Z-2), at (Class I), or below (Classes R and Y) the peer median,
but that it still showed generally strong performance against its peers for the year-to-date
and longer periods (while showing generally disappointing results during the 3- and 5-year
periods against its benchmark).
As had been the practice at every quarterly meeting of the Trustees throughout the year,
representatives of Alger Management discussed the Funds’ performance with the Trustees.
Throughout, the Trustees were mindful of conditions and trends in the current market in
equity securities, including growth stocks, and their impact on the performance and assets
of the Funds. On the basis of their review and the discussions with Alger Management, the
Trustees determined that the performance of the Funds was acceptable.
Fund Fees and Expense Ratios; Profitability to Alger Management and its Affiliates.
The Trustees reviewed each Fund's management fee and expense ratio and compared
them with those of a group of comparable funds. In order to assist the Trustees in this
comparison, FUSE had provided the Trustees with comparative information with respect to
the advisory fees and expense ratios of relevantly similar funds. That information indicated
that the advisory fees of two of the Funds were below the median for their comparison
groups, the fee of the Mid Cap Fund was slightly above the median, and the fee of the
Capital Appreciation Institutional Fund was further above the applicable median but less
than halfway into the next higher quartile. Of the 15 expense ratios for the Funds’ various
share classes, eight were equal to or below their peer medians. Four of the remaining
seven were for share classes of small asset size that suffered thereby in comparison with
their peers. Only one share class of the remaining three placed in the top quartile of the
applicable reference group; this was the Capital Appreciation Fund Class R Shares, whose
- 98 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
comparatively high 12b-1 and service fee charges exceeded those of many funds in the
class’s reference group, with the result that the class’s expenses were not compared solely
with those of true peers. The Trustees determined that such information should be taken
into account in weighing the size of the fee against the nature, extent and quality of the
services provided.
The Trustees also considered fees paid to Alger Management by five other types of clients,
specifically mutual funds for which Alger Management was sub-adviser, other pooled
investment vehicles (including UCITS and hedge funds), separately managed institutional
accounts, “wrap programs,” and collective investment trusts. The Trustees determined that
in all five cases the fees were of doubtful relevance for purposes of comparison with those
of the Funds because of the differences in services provided by Alger Management to those
types of clients as opposed to the Funds, but that to the extent that meaningful comparison
was practicable, the differences in services adequately explained the differences in the fees.
The Trustees then considered the profitability of the Investment Advisory Agreement to
Alger Management and its affiliates, and the methodology used by Alger Management in
determining such profitability. The Trustees reviewed previously-provided data on each
Fund's profitability to Alger Management and its affiliates for the year ended June 30, 2017.
After discussing with representatives of FUSE the expense-allocation practices, which
FUSE reported to be consistent with accepted industry practice, used in computing the
costs that formed the bases of the profitability calculations, the Trustees turned to the
profitability data provided. After analysis and discussion, they concluded in each case that,
to the extent that Alger Management’s and its affiliates’ relationships with the Fund had
been profitable, the profit margin was not unacceptable.
Economies of Scale. On the basis of their discussions with management and their
analysis of information provided at the meeting, the Trustees determined that the nature of
the Funds and their operations is such that Alger Management is likely to realize economies
of scale in the management of each Fund at some point as (and if) it grows in size. In
that connection, they noted that the advisory fee schedules in the Agreement include fee
reductions for each Fund at specified Fund asset levels (“breakpoints”); these have the effect
of lowering a Fund’s overall management fee as the Fund grows past a breakpoint, thus
sharing with the Fund’s shareholders economies of scale achieved by Alger Management in
managing the growing Fund.
Other Benefits to Alger Management. The Trustees considered whether Alger
Management benefits in other ways from its relationship with the Trust. They noted that
Alger Management maintains soft-dollar arrangements in connection with the Funds'
brokerage transactions, reports on which are regularly supplied to the Trustees at their
quarterly meetings and summaries of which, listing commissions by Fund for the twelve
months through June 30, 2017, had been included in the materials supplied prior to the
meeting. The Trustees also noted that Alger Management receives fees from the Funds
under the Fund Administration Agreement and the Shareholder Administrative Services
Agreement, and that Alger Inc. provides a considerable portion of the Funds' equity
brokerage and receives shareholder servicing fees from the Funds as well. The Trustees
- 99 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
had been provided with information regarding, and had considered, the administration fee,
shareholder administrative services fee, brokerage and shareholder servicing fee benefits in
connection with their review of the profitability to Alger Management and its affiliates of
their relationships with the Funds. As to other benefits received, the Trustees determined
that none were so significant as to render Alger Management's fees excessive.
Conclusions and Determinations. At the conclusion of these discussions, each of the
Independent Trustees expressed the opinion that he had been furnished with sufficient
information to make an informed business decision with respect to renewal of the
Investment Advisory Agreement. Based on its discussions and considerations as described
above, the Board made the following conclusions and determinations in respect of each
Fund:
• The Board concluded that the nature, extent and quality of the services provided
to the Fund by Alger Management are adequate and appropriate.
• The Board determined that the Fund’s performance was acceptable.
• The Board concluded that the advisory fee paid to Alger Management by the
Fund was reasonable in light of comparative performance and expense and
advisory fee information, costs of the services provided and profits to be realized
and benefits derived or to be derived by Alger Management and its affiliates from
the relationship with the Fund. As with the other Funds, the Trustees noted that
Alger Management had undertaken to cap Fund expenses for one or more share
classes through expense reimbursements and fee waivers, thus in effect lowering
the fees it actually received from the Fund.
• The Board accepted Alger Management’s acknowledgement that economies of
scale were likely to be achieved in the management of the Fund as (and if) it grew
in size and determined that the fee breakpoints in the Agreement provided a
means by which Alger Management would share the benefits of such economies
with Fund shareholders.
The Board considered these conclusions and determinations and, without any one factor
being dispositive, determined with respect to each Fund that renewal of the Investment
Advisory Agreement was in the best interests of the Fund and its shareholders.
- 100 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
Privacy Policy
U.S. Consumer Privacy Notice Rev. 12/20/16
| | |
FACTS | WHAT DOES ALGER DO WITH YOUR PERSONAL INFORMATION? |
Why? | Financial companies choose how they share your personal information. Federal law |
| gives consumers the right to limit some but not all sharing. Federal law also requires us |
| to tell you how we collect, share, and protect your personal information. Please read this |
| notice carefully to understand what we do. |
What? | The types of personal information we collect and share depend on the product or service |
| you have with us. This information can include: |
| • | Social Security number and |
| • | Account balances and |
| • | Transaction history and |
| • | Purchase history and |
| • | Assets |
| When you are no longer our customer, we continue to share your information as |
| described in this notice. |
How? | All financial companies need to share personal information to run their everyday business. |
| In the section below, we list the reasons financial companies can share personal |
| information; the reasons Alger chooses to share; and whether you can limit this sharing. |
| | |
Reasons we can share your | Does | Can you limit |
personal information | Alger share? | this sharing? |
For our everyday business | Yes | No |
purposes — such as to process your | | |
transactions, maintain your account(s), | | |
respond to court orders and legal | | |
investigations, or report to credit bureaus | | |
For our marketing purposes — to | Yes | No |
offer our products and services to you | | |
For joint marketing with other | No | We don’t share |
financial companies | | |
For our affiliates’ everyday | Yes | No |
business purposes — information about | | |
your transactions and experiences | | |
For our affiliates’ everyday | No | We don’t share |
business purposes — information about | | |
your creditworthiness | | |
For nonaffiliates to market to you | No | We don’t share |
Questions? Call 1-800-342-2186 | | |
- 101 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
| |
Who we are | |
Who is providing this notice? | • Alger includes Fred Alger Management, Inc. and Fred |
| Alger & Company, Incorporated as well as the following |
| funds: The Alger Funds, The Alger Funds II, The Alger |
| Institutional Funds, The Alger Portfolios, and Alger |
| Global Growth Fund. |
|
|
What we do | |
How does Alger | To protect your personal information from unauthorized |
protect my personal | access and use, we use security measures that comply |
information? | with federal law. These measures include computer |
| safeguards and secured files and buildings. |
How does Alger | We collect your personal information, for |
collect my personal | example, when you: |
information? | |
| • Open an account or |
| • Make deposits or withdrawals from your account or |
| • Give us your contact information or |
| • Provide account information or |
| • Pay us by check. |
|
|
Why can’t I limit all sharing? | Federal law gives you the right to limit only |
| • sharing for affiliates’ everyday business purposes |
| information about your credit worthiness |
| • affiliates from using your information to market to you |
| • sharing for nonaffiliates to market to you |
| State laws and individual companies may give you |
| additional rights to limit sharing. |
|
|
Definitions | |
Affiliates | Companies related by common ownership or control. |
| They can be financial and nonfinancial companies. |
| • Our affiliates include Fred Alger Management, Inc. |
| and Fred Alger & Company, Incorporated as well as the |
| following funds: The Alger Funds, The Alger Funds II, |
| The Alger Institutional Funds, The Alger Portfolios, and |
| Alger Global Growth Fund. |
Nonaffiliates | Companies not related by common ownership or |
| control. They can be financial and nonfinancial |
| companies. |
Joint marketing | A formal agreement between nonaffiliated financial |
| companies that together market financial products or |
| services to you. |
Other important information | |
- 102 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
Proxy Voting Policies
A description of the policies and procedures the Trust uses to determine how to vote
proxies relating to portfolio securities and information regarding how the Fund voted
proxies relating to portfolio securities during the most recent 12-month period ended June
30 are available, without charge, by calling (800) 992-3863 or online on the Funds’ website
at www.alger.com or on the SEC’s website at www.sec.gov.
Fund Holdings
The Board of Trustees has adopted policies and procedures relating to disclosure of the
Funds’ portfolio securities. These policies and procedures recognize that there may be
legitimate business reasons for holdings to be disclosed and seek to balance those interests
to protect the proprietary nature of the trading strategies and implementation thereof by
the Funds.
Generally, the policies prohibit the release of information concerning portfolio holdings
which have not previously been made public to individual investors, institutional investors,
intermediaries that distribute the Funds’ shares and other parties which are not employed
by the Manager or its affiliates except when the legitimate business purposes for selective
disclosure and other conditions (designed to protect the Funds) are acceptable.
The Funds make their full holdings available semi-annually in shareholder reports filed on
Form N-CSR and after the first and third fiscal quarters in regulatory filings on Form N-Q.
These shareholder reports and regulatory filings are filed with the SEC, as required by federal
securities laws, and are generally available within sixty (60) days of the end of the Funds’
fiscal quarter. The Funds’ Forms N-Q are available online on the SEC’s website at www.
sec.gov or may be reviewed and copied at the SEC’s Public Reference Room in Washington,
D.C. Information regarding the operation of the SEC’s Public Reference Room may be
obtained by calling 1-800-SEC-0330.
In addition, the Funds make publicly available their respective month-end top 10 holdings
with a 10 day lag and their month-end full portfolios with a 60 day lag on their website www.
alger.com and through other marketing communications (including printed advertising/
sales literature and/or shareholder telephone customer service centers). No compensation
or other consideration is received for the non-public disclosure of portfolio holdings
information.
In accordance with the foregoing, the Funds provide portfolio holdings information to
service providers who provide necessary or beneficial services when such service providers
need access to this information in the performance of their services and are subject to
duties of confidentiality (1) imposed by law, including a duty not to trade on non-public
information, and/or (2) pursuant to an agreement that confidential information is not to
be disclosed or used (including trading on such information) other than as required by law.
From time to time, the Funds will communicate with these service providers to confirm
that they understand the Funds’ policies and procedures regarding such disclosure. This
- 103 -
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
agreement must be approved by the Funds’ Chief Compliance Officer, President, Secretary
or Assistant Secretary.
The Board of Trustees periodically reviews a report disclosing the third parties to whom
each Fund’s holdings information has been disclosed and the purpose for such disclosure,
and it considers whether or not the release of information to such third parties is in the best
interest of the Fund and its shareholders.
In addition to material the Funds routinely provide to shareholders, the Manager may,
upon request, make additional statistical information available regarding the Funds. Such
information will include, but not be limited to, relative weightings and characteristics of
a Fund’s portfolio versus its peers or an index (such as P/E ratio, alpha, beta, capture
ratio, maximum drawdown, standard deviation, EPS forecasts, Sharpe ratio, information
ratio, R-squared, and market cap analysis), security specific impact on overall portfolio
performance, month-end top ten contributors to and detractors from performance,
breakdown of High Unit Volume Growth holdings vs. Positive Lifecycle Change holdings,
portfolio turnover, and requests of a similar nature. Please contact the Funds at (800) 992-
3863 to obtain such information.
- 104 -
THE ALGER INSTITUTIONAL FUNDS
360 Park Avenue South
New York, NY 10010
(800) 992-3863
www.alger.com
Investment Manager
Fred Alger Management, Inc.
360 Park Avenue South
New York, NY 10010
Distributor
Fred Alger & Company, Incorporated
360 Park Avenue South
New York, NY 10010
Transfer Agent and Dividend Disbursing Agent
Boston Financial Data Services, Inc.
P.O. Box 8480
Boston, MA 02266
Custodian
Brown Brothers Harriman & Company
50 Post Office Square
Boston, MA 02110
This report is submitted for the general information of the shareholders of The Alger
Institutional Funds. It is not authorized for distribution to prospective investors unless
accompanied by an effective Prospectus for the Trust, which contains information
concerning the Trust’s investment policies, fees and expenses as well as other pertinent
information.
- 105 -
(This page has been intentionally left blank.)
(This page has been intentionally left blank.)
(This page has been intentionally left blank.)
(This page has been intentionally left blank.)
ITEM 2. CODE OF ETHICS.
(a) The Registrant has adopted a code of ethics (the "Code of Ethics") that applies to its
principal executive officer, principal financial officer, principal accounting officer or
controller, or persons performing similar functions.
(b) Not applicable.
(c) The Registrant has not amended its Code of Ethics during the period covered by the
shareholder report presented in Item 1 hereto.
(d) The Registrant has not granted a waiver or an implicit waiver from a provision of its
Code of Ethics during the period covered by the shareholder report presented in Item 1
hereto.
(e) Not applicable.
(f) The Registrant's Code of Ethics is attached as an Exhibit hereto.
ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT.
The Board of Trustees of the Registrant determined that Stephen E. O’Neil is an audit committee
financial expert (within the meaning of that phrase specified in the instructions to Form N-CSR)
on the Registrant’s audit committee. Mr. O’Neil is an “independent” trustee – i.e., he is not an
interested person of the Registrant as defined in the Investment Company Act of 1940, nor has
he accepted directly or indirectly any consulting, advisory or other compensatory fee from the
Registrant, other than in his capacity as Trustee.
ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES.
| | |
a) Audit Fees: | | |
October 31, 2017 | $ | 137,500 |
October 31, 2016 | $ | 134,000 |
| | |
October 31, 2017 | $ | 19,400 |
October 31, 2016 | $ | 24,050 |
|
d) All Other Fees: | | |
October 31, 2017 | $ | 7,808 |
October 31, 2016 | $ | 7,680 |
Other fees include a review and consent for Registrants registration statement filing and
a review of the semi-annual financial statements.
e) 1) Audit Committee Pre-Approval Policies And Procedures:
Audit and non-audit services provided by the Registrant’s independent registered public
accounting firm (the “Auditors”) on behalf the Registrant must be pre-approved by the
Audit Committee. Non-audit services provided by the Auditors on behalf of the
Registrant’s Investment Adviser or any entity controlling, controlled by, or under
b) Audit-Related Fees: NONE
c) Tax Fees for tax advice, tax compliance and tax planning:
common control with the Investment Adviser must be pre-approved by the Audit
Committee if such non-audit services directly relate to the operations or financial
reporting of the Registrant.
2) All fees in item 4(b) through 4(d) above were approved by the Registrants’ Audit
Committee.
f) Not Applicable
g) Non-Audit Fees:
| | | |
October 31, 2017 | $ | 224,414 , €94,197 |
October 31, 2016 | $ | 219,975 , €93,631 |
h) The audit committee of the board of trustees has considered whether the provision of the
non-audit services that were rendered to the registrant's investment adviser and any entity
controlling, controlled by, or under common control, with the adviser that provides ongoing
services to the registrant that were not approved pursuant to (c)(7)(ii) of Rule 2-01 of
Regulation S-X is compatible with maintaining the principle accountant's independence.
ITEM 5. AUDIT COMMITTEE OF LISTED REGISTRANTS.
Not applicable
ITEM 6. INVESTMENTS.
Not applicable
ITEM 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT
INVESTMENT COMPANIES.
Not applicable
ITEM 8. PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
Not applicable
ITEM 9. PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY
AND AFFILIATED PURCHASERS.
Not applicable
ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
None
ITEM 11. CONTROLS AND PROCEDURES.
(a) The Registrant’s principal executive officer and principal financial officer have concluded
that the Registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under
the Investment Company Act of 1940, as amended) are effective based on their evaluation
of the disclosure controls and procedures as of a date within 90 days of the filing date of
this document.
(b) No changes in the Registrant’s internal control over financial reporting occurred during
the Registrant’s second fiscal half-year that materially affected, or are reasonably likely to
materially affect, the Registrant’s internal control over financial reporting.
ITEM 12. EXHIBITS.
(a) (1) Code of Ethics as Exhibit 99.CODE ETH
(a) (2) Certifications of principal executive officer and principal financial officer as required by
rule 30a-2(a) under the Investment Company Act of 1940 are attached as Exhibit 99.CERT
(b) Certifications of principal executive officer and principal financial officer as required by rule
30a-2(b) under the Investment Company Act of 1940 are attached as Exhibit 99.906CERT
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment
Company Act of 1940, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
The Alger Institutional Funds
By: /s/Hal Liebes
Hal Liebes
President
Date: December 11, 2017
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment
Company Act of 1940, this report has been signed below by the following persons on behalf
of the registrant and in the capacities and on the dates indicated.
By: /s/Hal Liebes
Hal Liebes
President
Date: December 11, 2017
By: /s/Michael D. Martins
Michael D. Martins
Treasurer
Date: December 11, 2017